{"title":"Cancer Care","description":null,"products":[{"product_id":"tabrecta-or-rahika-capmatinib-200mg-x-60-tablets","title":"Tabrecta or Rahika (Capmatinib) 200mg x 60 Tablets","description":"\n\u003ch4\u003eTabrecta (Capmatinib) 200mg x 60 Tablets - Product Description\u003c\/h4\u003e\n\u003cp\u003eTabrecta, also known by its generic name Capmatinib, is an oral medication used for the treatment of certain types of non-small cell lung cancer (NSCLC) that are associated with MET exon 14 alterations. This targeted therapy works by inhibiting the MET receptor tyrosine kinase, which plays a crucial role in the growth and spread of cancer cells.\u003c\/p\u003e\n\n\u003ch4\u003eIndications\u003c\/h4\u003e\n\u003cp\u003eTabrecta is indicated for adult patients with metastatic NSCLC that is positive for MET exon 14 alterations as detected by an Clinically Approved Pharmaceuticals test. It is prescribed for patients who have not received prior treatment or have progressed on prior therapies.\u003c\/p\u003e\n\n\u003ch4\u003eDosage and Administration\u003c\/h4\u003e\n\u003cp\u003eThe recommended dosage of Tabrecta is 200 mg taken orally twice daily with or without food. It is important to take the medication at the same times each day to maintain even levels in the bloodstream.\u003c\/p\u003e\n\n\u003ch4\u003eSide Effects\u003c\/h4\u003e\n\u003cp\u003eCommon side effects of Tabrecta may include:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eNausea\u003c\/li\u003e\n    \u003cli\u003eFatigue\u003c\/li\u003e\n    \u003cli\u003eDiarrhea\u003c\/li\u003e\n    \u003cli\u003eSwelling (edema)\u003c\/li\u003e\n    \u003cli\u003eLoss of appetite\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003ePatients should report any severe side effects to their healthcare provider immediately.\u003c\/p\u003e\n\n\u003ch4\u003eWarnings and Precautions\u003c\/h4\u003e\n\u003cp\u003eBefore starting Tabrecta, patients should inform their healthcare provider of any existing medical conditions, especially liver problems, as dosage adjustments may be necessary. Regular monitoring of liver function is recommended during treatment.\u003c\/p\u003e\n\n\u003ch4\u003eDrug Interactions\u003c\/h4\u003e\n\u003cp\u003eCapmatinib may interact with other medications, including certain antifungals, antibiotics, and anti-seizure medications. Patients should provide a list of all medications they are taking to their healthcare provider to avoid potential interactions.\u003c\/p\u003e\n\n\u003ch4\u003eStorage\u003c\/h4\u003e\n\u003cp\u003eStore Tabrecta at room temperature, away from moisture and heat. Keep out of reach of children and pets.\u003c\/p\u003e\n\n\u003ch4\u003eConclusion\u003c\/h4\u003e\n\u003cp\u003eTabrecta (Capmatinib) is a promising treatment option for patients with specific types of non-small cell lung cancer. As with any medication, it is essential to follow the healthcare provider's instructions and report any adverse effects promptly.\u003c\/p\u003e\n","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735707746587,"sku":"Tabrecta (Rahika) 200mg","price":3895.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0992\/3303\/8619\/files\/untitled_design_-_2025-07-18t205827.396.png?v=1770407489"},{"product_id":"kisqali-or-kryxana-ribociclib200mg-x-21-tablets","title":"Kisqali or Kryxana (Ribociclib)200mg x 21 Tablets","description":"\n\u003ch4\u003eProduct Description for Kisqali (Ribociclib) 200mg x 21 Tablets\u003c\/h4\u003e\n\u003cp\u003eKisqali, also known by its generic name Ribociclib, is an oral medication used in combination with aromatase inhibitors for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR-positive, HER2-negative) breast cancer in postmenopausal women. It is specifically indicated for use in combination with letrozole as initial endocrine-based therapy or with an aromatase inhibitor after progression on endocrine therapy.\u003c\/p\u003e\n\n\u003ch4\u003eHow It Works\u003c\/h4\u003e\n\u003cp\u003eKisqali works by inhibiting specific proteins (cyclin-dependent kinases 4 and 6) that are involved in cell division. By blocking these proteins, Kisqali helps to slow down or stop the growth of cancer cells. This targeted therapy is part of a comprehensive treatment strategy aimed at managing advanced breast cancer.\u003c\/p\u003e\n\n\u003ch4\u003eDosage and Administration\u003c\/h4\u003e\n\u003cp\u003eThe recommended dosage of Kisqali is 600 mg (three 200 mg tablets) taken once daily for 21 consecutive days, followed by 7 days off treatment. It is important to take Kisqali at the same time each day and to follow your healthcare provider's instructions carefully.\u003c\/p\u003e\n\n\u003ch4\u003ePossible Side Effects\u003c\/h4\u003e\n\u003cp\u003eCommon side effects may include fatigue, nausea, vomiting, diarrhea, and decreased appetite. More serious side effects can occur, such as liver problems, low blood cell counts, and lung inflammation. Regular monitoring by a healthcare provider is essential to manage any potential adverse effects.\u003c\/p\u003e\n\n\u003ch4\u003eDrug Interactions\u003c\/h4\u003e\n\u003cp\u003eKisqali can interact with other medications, which may affect how it works or increase the risk of serious side effects. Inform your healthcare provider about all medications you are currently taking, including over-the-counter drugs and supplements.\u003c\/p\u003e\n\n\u003ch4\u003eImportant Information\u003c\/h4\u003e\n\u003cp\u003eWomen who are pregnant or breastfeeding should not use Kisqali, as it may harm the fetus or nursing infant. Effective contraception is recommended during treatment and for at least 3 weeks after the last dose.\u003c\/p\u003e\n\n\u003ch4\u003eConclusion\u003c\/h4\u003e\n\u003cp\u003eKisqali represents a significant advancement in the treatment of HR-positive breast cancer, providing patients with a targeted therapy option. Always consult with your healthcare provider for personalized medical advice and to determine if Kisqali is the right choice for your treatment plan.\u003c\/p\u003e\n","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735707779355,"sku":"Kisqali or Kryxana 200mg x 21 Tablets","price":500.29,"currency_code":"USD","in_stock":true}]},{"product_id":"jakavi-ruxolitinib-5mg-x-30-tablets","title":"JAKAVI (Ruxolitinib) 5MG x 30 Tablets","description":"\n\u003cdiv class=\"product-description\"\u003e\n    \u003ch4\u003eJAKAVI (Ruxolitinib) 5MG x 30 Tablets\u003c\/h4\u003e\n    \u003cp\u003eJAKAVI (Ruxolitinib) is a prescription medication used to treat certain conditions related to the immune system, specifically for patients with myelofibrosis and polycythemia vera. It works by inhibiting specific enzymes that play a crucial role in the signaling pathways of the immune system, helping to reduce symptoms and improve quality of life.\u003c\/p\u003e\n    \n    \u003ch4\u003eIndications\u003c\/h4\u003e\n    \u003cp\u003eJAKAVI is indicated for the treatment of:\u003c\/p\u003e\n    \u003cul\u003e\n        \u003cli\u003eMyelofibrosis\u003c\/li\u003e\n        \u003cli\u003ePolycythemia vera\u003c\/li\u003e\n    \u003c\/ul\u003e\n\n    \u003ch4\u003eHow It Works\u003c\/h4\u003e\n    \u003cp\u003eRuxolitinib is a Janus kinase (JAK) inhibitor that selectively inhibits JAK1 and JAK2 enzymes, which are involved in the signaling of various hematopoietic and immune system processes. By blocking these enzymes, JAKAVI helps to decrease inflammation and reduce the overproduction of blood cells.\u003c\/p\u003e\n\n    \u003ch4\u003eDosage and Administration\u003c\/h4\u003e\n    \u003cp\u003eThe recommended dosage of JAKAVI may vary based on the specific condition being treated and the patient's individual response. It is crucial to follow the prescribing physician's instructions regarding dosage and administration.\u003c\/p\u003e\n\n    \u003ch4\u003ePossible Side Effects\u003c\/h4\u003e\n    \u003cp\u003eLike all medications, JAKAVI may cause side effects. Common side effects include:\u003c\/p\u003e\n    \u003cul\u003e\n        \u003cli\u003eHeadache\u003c\/li\u003e\n        \u003cli\u003eNausea\u003c\/li\u003e\n        \u003cli\u003eFatigue\u003c\/li\u003e\n        \u003cli\u003eDiarrhea\u003c\/li\u003e\n    \u003c\/ul\u003e\n    \u003cp\u003ePatients should report any severe or persistent side effects to their healthcare provider.\u003c\/p\u003e\n\n    \u003ch4\u003ePrecautions\u003c\/h4\u003e\n    \u003cp\u003eBefore starting treatment with JAKAVI, inform your healthcare provider about any existing medical conditions, particularly:\u003c\/p\u003e\n    \u003cul\u003e\n        \u003cli\u003eInfections\u003c\/li\u003e\n        \u003cli\u003eLiver problems\u003c\/li\u003e\n        \u003cli\u003eBlood disorders\u003c\/li\u003e\n    \u003c\/ul\u003e\n    \u003cp\u003eRegular monitoring may be required during treatment.\u003c\/p\u003e\n\n    \u003ch4\u003eConsult Your Doctor\u003c\/h4\u003e\n    \u003cp\u003eIt is essential to consult your healthcare provider for personalized medical advice and to discuss any potential interactions with other medications you may be taking.\u003c\/p\u003e\n\u003c\/div\u003e\n","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735707812123,"sku":"JAKAVI (Ruxolitinib) 5MG","price":1195.56,"currency_code":"USD","in_stock":true}]},{"product_id":"jakavi-ruxolitinib-15mg-x-30-tablets","title":"JAKAVI (Ruxolitinib) 15mg x 30 Tablets","description":"\n\u003ch4\u003eProduct Description for JAKAVI (Ruxolitinib) 15mg x 30 Tablets\u003c\/h4\u003e\n\u003cp\u003eJAKAVI (Ruxolitinib) is a medication used for the treatment of certain conditions related to the immune system, including myelofibrosis and polycythemia vera. It belongs to a class of drugs known as Janus kinase (JAK) inhibitors, which work by blocking specific enzymes involved in the inflammatory process.\u003c\/p\u003e\n\n\u003ch4\u003eIndications\u003c\/h4\u003e\n\u003cp\u003eJAKAVI is indicated for the treatment of:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eMyelofibrosis\u003c\/li\u003e\n    \u003cli\u003ePolycythemia vera in patients who have had an inadequate response to or are intolerant of hydroxyurea\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003eDosage and Administration\u003c\/h4\u003e\n\u003cp\u003eThe recommended dosage of JAKAVI is tailored to the individual patient's needs and should be determined by a healthcare professional. It is typically taken twice daily, with or without food.\u003c\/p\u003e\n\n\u003ch4\u003eMechanism of Action\u003c\/h4\u003e\n\u003cp\u003eRuxolitinib works by inhibiting the activity of JAK1 and JAK2 enzymes, which play a crucial role in the signaling pathways of various cytokines involved in hematopoiesis and immune response. By blocking these enzymes, JAKAVI helps reduce inflammation and control symptoms associated with myelofibrosis and polycythemia vera.\u003c\/p\u003e\n\n\u003ch4\u003ePossible Side Effects\u003c\/h4\u003e\n\u003cp\u003eCommon side effects of JAKAVI may include:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eIncreased risk of infections\u003c\/li\u003e\n    \u003cli\u003eHeadache\u003c\/li\u003e\n    \u003cli\u003eFatigue\u003c\/li\u003e\n    \u003cli\u003eDizziness\u003c\/li\u003e\n    \u003cli\u003eBlood count changes\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003ePatients should consult their healthcare provider for a comprehensive list of potential side effects and to discuss any concerns.\u003c\/p\u003e\n\n\u003ch4\u003eDrug Interactions\u003c\/h4\u003e\n\u003cp\u003eJAKAVI may interact with other medications. It is essential to inform your healthcare provider about all other medications you are taking to avoid potential interactions.\u003c\/p\u003e\n\n\u003ch4\u003eStorage Instructions\u003c\/h4\u003e\n\u003cp\u003eStore JAKAVI at room temperature, away from moisture and heat. Keep out of reach of children.\u003c\/p\u003e\n\n\u003ch4\u003eConclusion\u003c\/h4\u003e\n\u003cp\u003eJAKAVI (Ruxolitinib) is a vital treatment option for patients with specific blood disorders. Always follow your healthcare provider's instructions regarding the use of this medication.\u003c\/p\u003e\n","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735707844891,"sku":"JAKAVI (Ruxolitinib) 15mg x 30 Tablets","price":2242.08,"currency_code":"USD","in_stock":true}]},{"product_id":"jakavi-ruxolitinib-20mg-x-30-tablets","title":"JAKAVI (Ruxolitinib) 20mg x 30 Tablets","description":"\n\u003ch4\u003eJAKAVI (Ruxolitinib) 20mg x 30 Tablets\u003c\/h4\u003e\n\u003cp\u003eJAKAVI, containing the active ingredient Ruxolitinib, is a medication used for the treatment of certain conditions related to the immune system and blood disorders. It is primarily indicated for patients with myelofibrosis and polycythemia vera.\u003c\/p\u003e\n\n\u003ch4\u003eMechanism of Action\u003c\/h4\u003e\n\u003cp\u003eRuxolitinib is a Janus kinase (JAK) inhibitor that works by blocking the activity of specific enzymes involved in the signaling pathways that contribute to the growth and activation of blood cells. This helps to reduce inflammation and control the symptoms associated with these conditions.\u003c\/p\u003e\n\n\u003ch4\u003eIndications\u003c\/h4\u003e\n\u003cul\u003e\n    \u003cli\u003eMyelofibrosis\u003c\/li\u003e\n    \u003cli\u003ePolycythemia Vera\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003eDosage and Administration\u003c\/h4\u003e\n\u003cp\u003eJAKAVI is typically taken orally, with or without food. Dosage is determined by a healthcare professional based on the patient's condition and response to treatment. It is important to follow the prescribed dosage and schedule.\u003c\/p\u003e\n\n\u003ch4\u003ePotential Side Effects\u003c\/h4\u003e\n\u003cp\u003eLike all medications, JAKAVI may cause side effects. Common side effects include:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eIncreased risk of infections\u003c\/li\u003e\n    \u003cli\u003eHeadache\u003c\/li\u003e\n    \u003cli\u003eDizziness\u003c\/li\u003e\n    \u003cli\u003eElevated liver enzymes\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003ePatients should report any unusual symptoms or side effects to their healthcare provider promptly.\u003c\/p\u003e\n\n\u003ch4\u003ePrecautions\u003c\/h4\u003e\n\u003cp\u003eBefore starting treatment with JAKAVI, inform your doctor about any existing medical conditions, particularly:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eHistory of infections\u003c\/li\u003e\n    \u003cli\u003eLiver problems\u003c\/li\u003e\n    \u003cli\u003eLow blood cell counts\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRegular monitoring may be required during treatment to ensure safety and effectiveness.\u003c\/p\u003e\n\n\u003ch4\u003eStorage Instructions\u003c\/h4\u003e\n\u003cp\u003eStore JAKAVI at room temperature, away from moisture and heat. Keep out of reach of children.\u003c\/p\u003e\n\n\u003ch4\u003eConsultation\u003c\/h4\u003e\n\u003cp\u003eAlways consult your healthcare provider for personalized advice and before starting any new medication, including JAKAVI.\u003c\/p\u003e\n","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735707877659,"sku":"JAKAVI (Ruxolitinib) 20mg x 30 Tablets","price":2361.44,"currency_code":"USD","in_stock":true}]},{"product_id":"xtandi-enzalutamide-40mg-x-112-soft-capsules","title":"Xtandi (Enzalutamide) 40mg x 112 Soft Capsules","description":"\n\u003ch4\u003eXtandi (Enzalutamide) 40mg x 112 Soft Capsules\u003c\/h4\u003e\n\u003cp\u003eXtandi, the brand name for enzalutamide, is a prescription medication used primarily for the treatment of prostate cancer. It is designed for patients with metastatic castration-resistant prostate cancer (mCRPC) and has shown significant efficacy in extending overall survival and delaying disease progression.\u003c\/p\u003e\n\n\u003ch4\u003eKey Benefits\u003c\/h4\u003e\n\u003cul\u003e\n    \u003cli\u003eTargets prostate cancer cells by inhibiting androgen receptor signaling.\u003c\/li\u003e\n    \u003cli\u003eHelps in reducing tumor size and slowing cancer growth.\u003c\/li\u003e\n    \u003cli\u003eOral administration for convenient use.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003eHow It Works\u003c\/h4\u003e\n\u003cp\u003eEnzalutamide works by blocking the effects of androgens (male hormones) that can promote the growth of prostate cancer cells. By interfering with androgen receptor signaling, Xtandi helps to inhibit cancer cell proliferation and induces apoptosis (programmed cell death).\u003c\/p\u003e\n\n\u003ch4\u003eDosing Information\u003c\/h4\u003e\n\u003cp\u003eThe typical dosage of Xtandi is 160 mg taken once daily, with or without food. It is crucial to follow your healthcare provider's instructions regarding dosage and administration.\u003c\/p\u003e\n\n\u003ch4\u003ePossible Side Effects\u003c\/h4\u003e\n\u003cp\u003eCommon side effects may include fatigue, hot flashes, hypertension, and gastrointestinal disturbances. It is important to report any severe or persistent side effects to your healthcare provider.\u003c\/p\u003e\n\n\u003ch4\u003ePrecautions\u003c\/h4\u003e\n\u003cp\u003eBefore starting Xtandi, inform your healthcare provider about any pre-existing conditions, allergies, or other medications you may be taking. Regular monitoring of blood pressure and other health parameters is recommended during treatment.\u003c\/p\u003e\n\n\u003ch4\u003eConsult Your Doctor\u003c\/h4\u003e\n\u003cp\u003eAlways consult your healthcare provider for personalized medical advice and to ensure that Xtandi is the right option for your treatment plan. This medication is only available with a prescription and should be used under medical supervision.\u003c\/p\u003e\n","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735707910427,"sku":"Xtandi (Enzalutamide) 40mg x 112 Soft Capsules","price":5640.0,"currency_code":"USD","in_stock":true}]},{"product_id":"xtandi-enzalutamide-40mg-x-112-soft-capsules-1","title":"Xtandi (Enzalutamide) 40mg x 112 Soft Capsules","description":"\n\u003ch4\u003eProduct Description\u003c\/h4\u003e\n\u003cp\u003eXtandi (Enzalutamide) 40mg x 112 Soft Capsules is a prescription medication used for the treatment of prostate cancer. It works by inhibiting the androgen receptor signaling pathway, which is crucial for the growth and spread of cancer cells in men with metastatic castration-resistant prostate cancer (mCRPC).\u003c\/p\u003e\n\n\u003ch4\u003eIndications\u003c\/h4\u003e\n\u003cp\u003eXtandi is indicated for the treatment of:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eMetastatic castration-resistant prostate cancer (mCRPC)\u003c\/li\u003e\n    \u003cli\u003eNon-metastatic castration-resistant prostate cancer (nmCRPC)\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003eDosage and Administration\u003c\/h4\u003e\n\u003cp\u003eThe recommended dosage of Xtandi is 160 mg (four 40 mg soft capsules) taken orally once daily. It can be taken with or without food. It is important to swallow the capsules whole and not to chew or open them.\u003c\/p\u003e\n\n\u003ch4\u003eSide Effects\u003c\/h4\u003e\n\u003cp\u003eCommon side effects of Xtandi may include:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eFatigue\u003c\/li\u003e\n    \u003cli\u003eHot flashes\u003c\/li\u003e\n    \u003cli\u003eHypertension\u003c\/li\u003e\n    \u003cli\u003eDiarrhea\u003c\/li\u003e\n    \u003cli\u003eNausea\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003ePatients should report any severe side effects to their healthcare provider immediately.\u003c\/p\u003e\n\n\u003ch4\u003ePrecautions\u003c\/h4\u003e\n\u003cp\u003eBefore starting treatment with Xtandi, patients should inform their healthcare provider of any pre-existing conditions, especially:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eSeizure disorders\u003c\/li\u003e\n    \u003cli\u003eHistory of heart problems\u003c\/li\u003e\n    \u003cli\u003eLiver function impairment\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003eDrug Interactions\u003c\/h4\u003e\n\u003cp\u003eXtandi may interact with other medications. Patients should provide their healthcare provider with a complete list of all medications, supplements, and herbal products they are currently taking.\u003c\/p\u003e\n\n\u003ch4\u003eStorage\u003c\/h4\u003e\n\u003cp\u003eStore Xtandi at room temperature, away from moisture and heat. Keep out of reach of children.\u003c\/p\u003e\n\n\u003ch4\u003eConclusion\u003c\/h4\u003e\n\u003cp\u003eXtandi (Enzalutamide) offers a targeted approach to managing prostate cancer, providing patients with an effective treatment option. Always consult with a healthcare professional before starting any new medication.\u003c\/p\u003e\n","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735707943195,"sku":"Generic Equivalent to Xtandi (Enzalutamide) 40mg","price":736.2,"currency_code":"USD","in_stock":true}]},{"product_id":"imbruvica-ibrutinib-140mg-x-30-tablets","title":"Imbruvica (Ibrutinib) 140mg x 30 Tablets","description":"\n\u003ch4\u003eImbruvica (Ibrutinib) 140mg x 30 Tablets\u003c\/h4\u003e\n\u003cp\u003eImbruvica (Ibrutinib) is a prescription medication used in the treatment of various types of blood cancers, including chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and others. It is classified as a Bruton’s tyrosine kinase (BTK) inhibitor, which works by disrupting the signaling pathways that are essential for the survival and proliferation of cancer cells.\u003c\/p\u003e\n\n\u003ch4\u003eIndications\u003c\/h4\u003e\n\u003cp\u003eImbruvica is indicated for the treatment of:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eChronic lymphocytic leukemia (CLL)\u003c\/li\u003e\n    \u003cli\u003eMantle cell lymphoma (MCL)\u003c\/li\u003e\n    \u003cli\u003eWaldenström's macroglobulinemia\u003c\/li\u003e\n    \u003cli\u003eMarginal zone lymphoma (MZL)\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003eDosage and Administration\u003c\/h4\u003e\n\u003cp\u003eThe recommended dose of Imbruvica is 140 mg taken orally once daily. It is important to take the medication consistently at the same time each day. Patients should swallow the tablets whole with a glass of water and avoid taking them with certain foods that may affect absorption, such as grapefruit or Seville oranges.\u003c\/p\u003e\n\n\u003ch4\u003ePotential Side Effects\u003c\/h4\u003e\n\u003cp\u003eCommon side effects of Imbruvica may include:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eDiarrhea\u003c\/li\u003e\n    \u003cli\u003eFatigue\u003c\/li\u003e\n    \u003cli\u003eNausea\u003c\/li\u003e\n    \u003cli\u003eRash\u003c\/li\u003e\n    \u003cli\u003eLow blood counts (anemia, neutropenia, thrombocytopenia)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSerious side effects can occur, including bleeding problems, infections, and heart rhythm issues. Patients should report any unusual symptoms to their healthcare provider promptly.\u003c\/p\u003e\n\n\u003ch4\u003ePrecautions\u003c\/h4\u003e\n\u003cp\u003eBefore starting Imbruvica, patients should inform their healthcare provider about any other medications they are taking, as well as any history of heart problems or bleeding disorders. Regular monitoring may be required during treatment to assess blood counts and liver function.\u003c\/p\u003e\n\n\u003ch4\u003eConclusion\u003c\/h4\u003e\n\u003cp\u003eImbruvica (Ibrutinib) offers a targeted therapy option for patients with specific types of blood cancers, providing an alternative to traditional chemotherapy. Always consult with a healthcare professional for personalized medical advice and treatment plans.\u003c\/p\u003e\n","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735707975963,"sku":"Generic Equivalent to Imbruvica (Ibrutinib) 140mg x 30 Tablets","price":354.0,"currency_code":"USD","in_stock":true}]},{"product_id":"imbruvica-ibrutinib-140mg-x-120-tablets","title":"Imbruvica (Ibrutinib) 140mg x 120 Tablets","description":"\n\u003ch4\u003eImbruvica (Ibrutinib) 140mg x 120 Tablets\u003c\/h4\u003e\n\u003cp\u003eImbruvica is an oral medication that contains the active ingredient Ibrutinib, a targeted therapy used primarily for the treatment of certain types of blood cancers, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). It works by inhibiting a specific protein that promotes cancer cell growth, thereby helping to slow down or stop the progression of the disease.\u003c\/p\u003e\n\n\u003ch4\u003eIndications\u003c\/h4\u003e\n\u003cp\u003eImbruvica is indicated for the treatment of:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eChronic Lymphocytic Leukemia (CLL)\u003c\/li\u003e\n    \u003cli\u003eMantle Cell Lymphoma (MCL)\u003c\/li\u003e\n    \u003cli\u003eWaldenström's Macroglobulinemia\u003c\/li\u003e\n    \u003cli\u003eChronic Graft-versus-Host Disease (cGVHD)\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003eDosage and Administration\u003c\/h4\u003e\n\u003cp\u003eThe recommended dosage of Imbruvica is 140mg taken orally once daily. It is important to take the medication at the same time each day, with or without food. Patients should follow their healthcare provider's instructions regarding dosage adjustments and duration of treatment.\u003c\/p\u003e\n\n\u003ch4\u003eSide Effects\u003c\/h4\u003e\n\u003cp\u003eCommon side effects of Imbruvica may include:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eDiarrhea\u003c\/li\u003e\n    \u003cli\u003eFatigue\u003c\/li\u003e\n    \u003cli\u003eNausea\u003c\/li\u003e\n    \u003cli\u003eMuscle and joint pain\u003c\/li\u003e\n    \u003cli\u003eIncreased risk of infections\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003ePatients should report any severe or persistent side effects to their healthcare provider.\u003c\/p\u003e\n\n\u003ch4\u003ePrecautions\u003c\/h4\u003e\n\u003cp\u003eBefore starting Imbruvica, patients should inform their healthcare provider of any pre-existing conditions, especially:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eHeart problems\u003c\/li\u003e\n    \u003cli\u003eLiver disease\u003c\/li\u003e\n    \u003cli\u003eHistory of bleeding disorders\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eImbruvica may interact with other medications, so it is essential to discuss all current medications with a healthcare provider.\u003c\/p\u003e\n\n\u003ch4\u003eStorage\u003c\/h4\u003e\n\u003cp\u003eStore Imbruvica at room temperature, away from moisture and heat. Keep out of reach of children and pets.\u003c\/p\u003e\n\n\u003ch4\u003eConclusion\u003c\/h4\u003e\n\u003cp\u003eImbruvica (Ibrutinib) offers an effective treatment option for patients with specific types of blood cancers. With proper medical guidance, it can help manage symptoms and improve quality of life.\u003c\/p\u003e\n","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735708008731,"sku":"Imbruvica (Ibrutinib) 140mg x 120 Tablets","price":6840.0,"currency_code":"USD","in_stock":true}]},{"product_id":"temodar-temozolomide-20mg-x-5-capsules","title":"Temodar (Temozolomide) 20mg x 5 Capsules","description":"\n\u003ch4\u003eTemodar (Temozolomide) 20mg x 5 Capsules\u003c\/h4\u003e\n\u003cp\u003e\u003cstrong\u003eOverview:\u003c\/strong\u003e Temodar is a prescription medication that contains the active ingredient temozolomide. It is primarily used for the treatment of specific types of brain tumors, including glioblastoma multiforme and anaplastic astrocytoma. Temozolomide works by interfering with the growth and spread of cancer cells in the body.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eIndications:\u003c\/strong\u003e Temodar is indicated for the treatment of adults with:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eGlioblastoma multiforme (GBM)\u003c\/li\u003e\n    \u003cli\u003eAnaplastic astrocytoma (AA)\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eDosage and Administration:\u003c\/strong\u003e The dosage of Temodar is determined by the treating physician based on the patient's condition and response to treatment. It is typically taken orally, with or without food. It is important to follow the prescribed dosage regimen and schedule.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e Common side effects of Temodar may include:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eNausea and vomiting\u003c\/li\u003e\n    \u003cli\u003eFatigue\u003c\/li\u003e\n    \u003cli\u003eHeadaches\u003c\/li\u003e\n    \u003cli\u003eConstipation\u003c\/li\u003e\n    \u003cli\u003eLoss of appetite\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSerious side effects are also possible and should be reported to a healthcare provider immediately, including symptoms of infection, severe allergic reactions, or unusual bleeding.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003ePrecautions:\u003c\/strong\u003e Before taking Temodar, inform your healthcare provider about any medical conditions, allergies, or medications you are currently taking. Regular blood tests may be required to monitor your blood cell counts and liver function during treatment.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eStorage:\u003c\/strong\u003e Store Temodar at room temperature, away from light and moisture. Keep out of reach of children and pets.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eConsultation:\u003c\/strong\u003e Always consult your healthcare provider for personalized medical advice and before making any changes to your medication regimen.\u003c\/p\u003e\n","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735708041499,"sku":"Generic Equivalent to Temodar (Temozolomide) 20mg x 5 Capsules","price":24.2,"currency_code":"USD","in_stock":true}]},{"product_id":"temodar-temozolomide-100mg-x-5-capsules","title":"Temodar (Temozolomide) 100mg x 5 Capsules","description":"\n\u003ch4\u003eProduct Description for Temodar (Temozolomide) 100mg x 5 Capsules\u003c\/h4\u003e\n\u003cp\u003eTemodar (Temozolomide) is an oral chemotherapy medication used primarily to treat certain types of brain tumors, including glioblastoma multiforme and anaplastic astrocytoma. This medication works by interfering with the growth and spread of cancer cells in the body.\u003c\/p\u003e\n\n\u003ch4\u003eKey Features\u003c\/h4\u003e\n\u003cul\u003e\n    \u003cli\u003eActive Ingredient: Temozolomide\u003c\/li\u003e\n    \u003cli\u003eDosage: 100mg per capsule\u003c\/li\u003e\n    \u003cli\u003ePack Size: 5 capsules\u003c\/li\u003e\n    \u003cli\u003eAdministration: Oral\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003eHow It Works\u003c\/h4\u003e\n\u003cp\u003eTemozolomide is an alkylating agent that damages the DNA of cancer cells, preventing them from dividing and growing. This mechanism of action helps to slow down or stop the progression of tumors in patients undergoing treatment.\u003c\/p\u003e\n\n\u003ch4\u003eUsage Instructions\u003c\/h4\u003e\n\u003cp\u003eTemodar should be taken as prescribed by your healthcare provider. It is usually taken once daily for a specific cycle, which may vary based on the treatment plan. It is recommended to take the capsules on an empty stomach, at least one hour before or two hours after a meal.\u003c\/p\u003e\n\n\u003ch4\u003ePossible Side Effects\u003c\/h4\u003e\n\u003cp\u003eCommon side effects may include nausea, vomiting, fatigue, and loss of appetite. It's important to discuss potential side effects with your healthcare provider and report any severe or persistent symptoms.\u003c\/p\u003e\n\n\u003ch4\u003ePrecautions\u003c\/h4\u003e\n\u003cp\u003eBefore starting Temodar, inform your doctor about any pre-existing conditions, allergies, or medications you are currently taking. Regular blood tests may be required to monitor your blood count and liver function during treatment.\u003c\/p\u003e\n\n\u003ch4\u003eStorage Instructions\u003c\/h4\u003e\n\u003cp\u003eStore Temodar at room temperature, away from moisture and heat. Keep out of reach of children and do not use after the expiration date.\u003c\/p\u003e\n\n\u003ch4\u003eConsult Your Healthcare Provider\u003c\/h4\u003e\n\u003cp\u003eAlways consult your healthcare provider for personalized medical advice and before starting any new medication. Your doctor will provide you with detailed information tailored to your specific health needs.\u003c\/p\u003e\n","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735708074267,"sku":"Generic Equivalent to Temodar (Temozolomide) 100mg x 5 Capsules","price":78.0,"currency_code":"USD","in_stock":true}]},{"product_id":"temodar-temozolomide-250mg-x-5-capsules","title":"Temodar (Temozolomide) 250mg x 5 Capsules","description":"\n\u003ch4\u003eProduct Description for Temodar (Temozolomide) 250mg x 5 Capsules\u003c\/h4\u003e\n\u003cp\u003eTemodar (Temozolomide) is an oral chemotherapy medication used primarily to treat certain types of brain tumors, including glioblastoma multiforme and anaplastic astrocytoma. This medication works by interfering with the growth and spread of cancer cells in the body.\u003c\/p\u003e\n\n\u003ch4\u003eIndications\u003c\/h4\u003e\n\u003cp\u003eTemozolomide is indicated for the treatment of:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eGlioblastoma multiforme in adults\u003c\/li\u003e\n    \u003cli\u003eAnaplastic astrocytoma in adults\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003eDosage and Administration\u003c\/h4\u003e\n\u003cp\u003eTemozolomide is typically taken once daily, with or without food. It is important to follow your healthcare provider's instructions regarding dosage and duration of treatment.\u003c\/p\u003e\n\n\u003ch4\u003eSide Effects\u003c\/h4\u003e\n\u003cp\u003eCommon side effects of Temozolomide may include:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eNausea and vomiting\u003c\/li\u003e\n    \u003cli\u003eFatigue\u003c\/li\u003e\n    \u003cli\u003eLoss of appetite\u003c\/li\u003e\n    \u003cli\u003eConstipation\u003c\/li\u003e\n    \u003cli\u003eHeadaches\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSerious side effects may occur, including low blood cell counts, which can increase the risk of infection or bleeding. Report any unusual symptoms to your doctor immediately.\u003c\/p\u003e\n\n\u003ch4\u003ePrecautions\u003c\/h4\u003e\n\u003cp\u003eBefore taking Temozolomide, inform your doctor of any allergies, medical conditions, or medications you are currently taking. Regular blood tests may be required to monitor your health during treatment.\u003c\/p\u003e\n\n\u003ch4\u003eDrug Interactions\u003c\/h4\u003e\n\u003cp\u003eInform your healthcare provider about all medications and supplements you are taking, as some drugs may interact with Temozolomide. This includes prescription, over-the-counter medications, and herbal products.\u003c\/p\u003e\n\n\u003ch4\u003eStorage\u003c\/h4\u003e\n\u003cp\u003eStore Temozolomide at room temperature, away from moisture and heat. Keep out of reach of children and pets.\u003c\/p\u003e\n\n\u003ch4\u003eConclusion\u003c\/h4\u003e\n\u003cp\u003eTemodar (Temozolomide) offers a targeted approach to treating aggressive brain tumors. Consult your healthcare provider for more information on how this medication can be part of your treatment plan.\u003c\/p\u003e\n","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735708107035,"sku":"Generic Equivalent to Temodar (Temozolomide) 250mg x 5 Capsules","price":181.84,"currency_code":"USD","in_stock":true}]},{"product_id":"temodar-or-temizole-temozolomide-140mg-x-5-capsules","title":"Temodar or Temizole (Temozolomide) 140mg x 5 Capsules","description":"\n\u003ch4\u003eTemodar (Temozolomide) 140mg - 5 Capsules\u003c\/h4\u003e\n\u003cp\u003eTemodar, also known by its generic name Temozolomide, is an oral chemotherapy medication primarily used in the treatment of certain types of brain tumors, including glioblastoma multiforme and anaplastic astrocytoma. It works by inhibiting the growth of cancer cells, allowing for more effective management of these aggressive tumors.\u003c\/p\u003e\n\n\u003ch4\u003eIndications\u003c\/h4\u003e\n\u003cp\u003eTemozolomide is indicated for:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eTreatment of newly diagnosed glioblastoma multiforme in combination with radiotherapy.\u003c\/li\u003e\n    \u003cli\u003eAdjuvant treatment for patients with anaplastic astrocytoma.\u003c\/li\u003e\n    \u003cli\u003eTreatment of recurrent malignant glioma after prior therapy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003eDosage and Administration\u003c\/h4\u003e\n\u003cp\u003eTemozolomide is typically administered once daily for a specified duration, often in cycles. It is crucial to follow the prescribed dosage by your healthcare provider to ensure the best therapeutic outcomes while minimizing potential side effects.\u003c\/p\u003e\n\n\u003ch4\u003eSide Effects\u003c\/h4\u003e\n\u003cp\u003eCommon side effects of Temozolomide may include:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eNausea and vomiting\u003c\/li\u003e\n    \u003cli\u003eFatigue\u003c\/li\u003e\n    \u003cli\u003eLoss of appetite\u003c\/li\u003e\n    \u003cli\u003eHeadaches\u003c\/li\u003e\n    \u003cli\u003eConstipation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSerious side effects can occur and should be reported to a healthcare professional immediately.\u003c\/p\u003e\n\n\u003ch4\u003ePrecautions\u003c\/h4\u003e\n\u003cp\u003ePrior to using Temozolomide, inform your healthcare provider of any existing health conditions, especially:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eBone marrow problems\u003c\/li\u003e\n    \u003cli\u003eHistory of allergic reactions\u003c\/li\u003e\n    \u003cli\u003ePregnancy or breastfeeding status\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003eStorage\u003c\/h4\u003e\n\u003cp\u003eStore Temodar capsules at room temperature, away from moisture and heat. Keep out of reach of children and pets.\u003c\/p\u003e\n\n\u003ch4\u003eConclusion\u003c\/h4\u003e\n\u003cp\u003eTemodar (Temozolomide) is a vital component in the management of specific brain tumors. Consult with your healthcare provider for a comprehensive understanding of how this medication fits into your treatment plan.\u003c\/p\u003e\n","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735708139803,"sku":"Generic Equivalent to Temodar or Temizole (Temozolomide)","price":251.57,"currency_code":"USD","in_stock":true}]},{"product_id":"generic-orgovyx-relugolix-120mg-x-30-tablets-xelucip-cipla","title":"Generic Orgovyx (Relugolix) 120mg x 30 Tablets | Xelucip (Cipla)","description":"\u003ch4\u003eWhat is Orgovyx (Relugolix) 120mg x 30 Tablets?\u003c\/h4\u003e\r\n\u003cp\u003eOrgovyx (Relugolix) 120mg x 30 Tablets is a tablet supplied in 120mg. Use only under medical supervision.\u003c\/p\u003e\r\n\u003cdiv class=\"erp-sidecar:h-fit erp-sidecar:pb-0 mx-auto h-full\"\u003e\r\n\u003cdiv class=\"relative border-subtlest ring-subtlest divide-subtlest bg-base\"\u003e\r\n\u003cdiv\u003e\r\n\u003cdiv\u003e\r\n\u003cdiv\u003e\r\n\u003cdiv class=\"erp-sidecar:min-h-[var(--sidecar-content-height)] erp-mobile-sidecar:min-h-[var(--mobile-sidecar-content-height)] min-h-[var(--page-content-height)]\"\u003e\r\n\u003cdiv class=\"pt-[var(--thread-visual-spacing)] md:pt-lg pb-[var(--thread-visual-spacing)] px-[var(--thread-visual-spacing)] border-subtlest ring-subtlest divide-subtlest bg-transparent\"\u003e\r\n\u003cdiv class=\"isolate mx-auto flex flex-col max-w-threadContentWidth\"\u003e\r\n\u003cdiv id=\"radix-:r1e:-content-default\" class=\"focus:outline-none\" tabindex=\"0\" role=\"tabpanel\" data-state=\"active\" data-orientation=\"horizontal\" aria-labelledby=\"radix-:r1e:-trigger-default\"\u003e\r\n\u003cdiv class=\"flex flex-col gap-y-lg\"\u003e\r\n\u003cdiv class=\"gap-y-lg flex flex-col\"\u003e\r\n\u003cdiv class=\"grid w-full min-w-0 grid-cols-[minmax(0,1fr)]\" dir=\"ltr\" data-orientation=\"horizontal\"\u003e\r\n\u003cdiv class=\"col-start-1 row-start-2\"\u003e\r\n\u003cdiv id=\"radix-:r15c:-content-thread\" class=\"focus:outline-none\" tabindex=\"0\" role=\"tabpanel\" data-state=\"active\" data-orientation=\"horizontal\" aria-labelledby=\"radix-:r15c:-trigger-thread\"\u003e\r\n\u003cdiv class=\"border-subtlest ring-subtlest divide-subtlest bg-transparent\"\u003e\r\n\u003cdiv class=\"gap-y-md flex flex-col\"\u003e\r\n\u003cdiv class=\"relative font-sans text-base text-foreground selection:bg-super\/50 selection:text-foreground dark:selection:bg-super\/10 dark:selection:text-super\"\u003e\r\n\u003cdiv class=\"min-w-0 break-words [word-break:break-word]\"\u003e\r\n\u003cdiv id=\"markdown-content-11\" class=\"gap-y-md after:clear-both after:block after:content-['']\" dir=\"auto\"\u003e\r\n\u003cdiv class=\"has-inline-images my-2 first:mt-0 [\u0026amp;:has([data-inline-type=image])+\u0026amp;:has([data-inline-type=image])_[data-inline-type=image]]:hidden [\u0026amp;:has(table)_[data-inline-type=image]]:hidden\"\u003e\r\n\u003cdiv class=\"relative\"\u003e\r\n\u003cdiv class=\"prose dark:prose-invert inline leading-relaxed break-words min-w-0 [word-break:break-word] prose-strong:font-medium visRefresh2026Fonts:prose-strong:font-bold [\u0026amp;_\u0026gt;*:first-child]:mt-0\"\u003e\r\n\u003ch2 id=\"xelucip-120-mg-tablet-generic-orgovyxrelugolix--fa\" class=\"mb-2 mt-4 [.has-inline-images_\u0026amp;]:clear-end font-sans visRefresh2026AnswerSerif:font-editorial font-semimedium visRefresh2026Fonts:font-bold text-base visRefresh2026Fonts:text-lg first:mt-0 md:text-lg [hr+\u0026amp;]:mt-4\"\u003eXelucip 120 mg Tablet (Generic Orgovyx\/Relugolix) – FAQ | Waldrugmart Pharmacy\u003c\/h2\u003e\r\n\u003cp class=\"my-2 [\u0026amp;+p]:mt-4 [\u0026amp;_strong:has(+br)]:inline-block [\u0026amp;_strong:has(+br)]:pb-2\"\u003e\u003cstrong\u003eXelucip\u003c\/strong\u003e: Affordable generic Relugolix for advanced prostate cancer – worldwide shipping USA\/Australia from Waldrugmart. Prescription oral GnRH antagonist rapidly lowers testosterone to slow hormone-sensitive tumors.\u003c\/p\u003e\r\n\u003ch2 class=\"mb-2 mt-4 [.has-inline-images_\u0026amp;]:clear-end font-sans visRefresh2026AnswerSerif:font-editorial font-semimedium visRefresh2026Fonts:font-bold text-base first:mt-0\"\u003e\u003cstrong\u003eWhat is Xelucip used for?\u003c\/strong\u003e\u003c\/h2\u003e\r\n\u003cp class=\"my-2 [\u0026amp;+p]:mt-4 [\u0026amp;_strong:has(+br)]:inline-block [\u0026amp;_strong:has(+br)]:pb-2\"\u003eXelucip treats advanced or metastatic hormone-sensitive prostate cancer in adult men through once-daily androgen deprivation therapy (ADT).\u003cbr\u003eContains Relugolix – blocks pituitary GnRH receptors to suppress testosterone production fueling cancer growth.\u003c\/p\u003e\r\n\u003ch2 class=\"mb-2 mt-4 [.has-inline-images_\u0026amp;]:clear-end font-sans visRefresh2026AnswerSerif:font-editorial font-semimedium visRefresh2026Fonts:font-bold text-base first:mt-0\"\u003e\u003cstrong\u003eXelucip vs Orgovyx – Are they the same?\u003c\/strong\u003e\u003c\/h2\u003e\r\n\u003cp class=\"my-2 [\u0026amp;+p]:mt-4 [\u0026amp;_strong:has(+br)]:inline-block [\u0026amp;_strong:has(+br)]:pb-2\"\u003e\u003cstrong\u003eYes, bioequivalent generic\u003c\/strong\u003e – identical 120 mg Relugolix active ingredient, same rapid efficacy, \u003cstrong\u003e70%+ savings\u003c\/strong\u003e at Waldrugmart.\u003c\/p\u003e\r\n\u003ch2 class=\"mb-2 mt-4 [.has-inline-images_\u0026amp;]:clear-end font-sans visRefresh2026AnswerSerif:font-editorial font-semimedium visRefresh2026Fonts:font-bold text-base first:mt-0\"\u003e\u003cstrong\u003eWho can take Xelucip?\u003c\/strong\u003e\u003c\/h2\u003e\r\n\u003cp class=\"my-2 [\u0026amp;+p]:mt-4 [\u0026amp;_strong:has(+br)]:inline-block [\u0026amp;_strong:has(+br)]:pb-2\"\u003eAdult men with advanced prostate cancer requiring testosterone suppression. \u003cstrong\u003eNot for women, children, pregnancy, or Relugolix allergy\u003c\/strong\u003e.\u003c\/p\u003e\r\n\u003ch2 class=\"mb-2 mt-4 [.has-inline-images_\u0026amp;]:clear-end font-sans visRefresh2026AnswerSerif:font-editorial font-semimedium visRefresh2026Fonts:font-bold text-base first:mt-0\"\u003e\u003cstrong\u003eHow does Xelucip work?\u003c\/strong\u003e\u003c\/h2\u003e\r\n\u003cp class=\"my-2 [\u0026amp;+p]:mt-4 [\u0026amp;_strong:has(+br)]:inline-block [\u0026amp;_strong:has(+br)]:pb-2\"\u003eRelugolix competitively binds GnRH receptors → rapidly reduces LH\/FSH → testosterone drops to castrate levels (\u0026lt;50 ng\/dL) by Day 4 in 98%+ patients.\u003cbr\u003eControls PSA rise and cancer symptoms without injections.\u003c\/p\u003e\r\n\u003ch2 class=\"mb-2 mt-4 [.has-inline-images_\u0026amp;]:clear-end font-sans visRefresh2026AnswerSerif:font-editorial font-semimedium visRefresh2026Fonts:font-bold text-base first:mt-0\"\u003e\u003cstrong\u003eXelucip dosage instructions?\u003c\/strong\u003e\u003c\/h2\u003e\r\n\u003cul class=\"marker:text-quiet list-disc\"\u003e\r\n\u003cli class=\"py-0 my-0 prose-p:pt-0 prose-p:mb-2 prose-p:my-0 [\u0026amp;\u0026gt;p]:pt-0 [\u0026amp;\u0026gt;p]:mb-2 [\u0026amp;\u0026gt;p]:my-0\"\u003e\r\n\u003cp class=\"my-2 [\u0026amp;+p]:mt-4 [\u0026amp;_strong:has(+br)]:inline-block [\u0026amp;_strong:has(+br)]:pb-2\"\u003e\u003cstrong\u003eDay 1\u003c\/strong\u003e: Loading dose 360 mg (3 × 120 mg tablets)\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli class=\"py-0 my-0 prose-p:pt-0 prose-p:mb-2 prose-p:my-0 [\u0026amp;\u0026gt;p]:pt-0 [\u0026amp;\u0026gt;p]:mb-2 [\u0026amp;\u0026gt;p]:my-0\"\u003e\r\n\u003cp class=\"my-2 [\u0026amp;+p]:mt-4 [\u0026amp;_strong:has(+br)]:inline-block [\u0026amp;_strong:has(+br)]:pb-2\"\u003e\u003cstrong\u003eDay 2+\u003c\/strong\u003e: 120 mg once daily, same time, with\/without food – swallow whole.\u003cbr\u003e\u003cstrong\u003eMissed dose\u003c\/strong\u003e: \u0026lt;12h late = take now; \u0026gt;12h = skip, resume normally.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2 class=\"mb-2 mt-4 [.has-inline-images_\u0026amp;]:clear-end font-sans visRefresh2026AnswerSerif:font-editorial font-semimedium visRefresh2026Fonts:font-bold text-base first:mt-0\"\u003e\u003cstrong\u003eHow long do I take Xelucip?\u003c\/strong\u003e\u003c\/h2\u003e\r\n\u003cp class=\"my-2 [\u0026amp;+p]:mt-4 [\u0026amp;_strong:has(+br)]:inline-block [\u0026amp;_strong:has(+br)]:pb-2\"\u003eLong-term (months-years) based on PSA response, cancer stage, and specialist guidance. Regular monitoring required.\u003c\/p\u003e\r\n\u003ch2 class=\"mb-2 mt-4 [.has-inline-images_\u0026amp;]:clear-end font-sans visRefresh2026AnswerSerif:font-editorial font-semimedium visRefresh2026Fonts:font-bold text-base first:mt-0\"\u003e\u003cstrong\u003eCommon Xelucip side effects?\u003c\/strong\u003e\u003c\/h2\u003e\r\n\u003cul class=\"marker:text-quiet list-disc\"\u003e\r\n\u003cli class=\"py-0 my-0 prose-p:pt-0 prose-p:mb-2 prose-p:my-0 [\u0026amp;\u0026gt;p]:pt-0 [\u0026amp;\u0026gt;p]:mb-2 [\u0026amp;\u0026gt;p]:my-0\"\u003e\r\n\u003cp class=\"my-2 [\u0026amp;+p]:mt-4 [\u0026amp;_strong:has(+br)]:inline-block [\u0026amp;_strong:has(+br)]:pb-2\"\u003eHot flushes (54% most frequent)\u003cspan class=\"inline-flex\" aria-label=\"FAQs | ORGOVYX® (relugolix) for Patients\" data-state=\"closed\"\u003e​\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli class=\"py-0 my-0 prose-p:pt-0 prose-p:mb-2 prose-p:my-0 [\u0026amp;\u0026gt;p]:pt-0 [\u0026amp;\u0026gt;p]:mb-2 [\u0026amp;\u0026gt;p]:my-0\"\u003e\r\n\u003cp class=\"my-2 [\u0026amp;+p]:mt-4 [\u0026amp;_strong:has(+br)]:inline-block [\u0026amp;_strong:has(+br)]:pb-2\"\u003eFatigue (26%), joint\/muscle pain (22%), diarrhoea\/constipation (12%)\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli class=\"py-0 my-0 prose-p:pt-0 prose-p:mb-2 prose-p:my-0 [\u0026amp;\u0026gt;p]:pt-0 [\u0026amp;\u0026gt;p]:mb-2 [\u0026amp;\u0026gt;p]:my-0\"\u003e\r\n\u003cp class=\"my-2 [\u0026amp;+p]:mt-4 [\u0026amp;_strong:has(+br)]:inline-block [\u0026amp;_strong:has(+br)]:pb-2\"\u003e↑Blood glucose\/lipids, anaemia, weight gain, gynecomastia\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2 class=\"mb-2 mt-4 [.has-inline-images_\u0026amp;]:clear-end font-sans visRefresh2026AnswerSerif:font-editorial font-semimedium visRefresh2026Fonts:font-bold text-base first:mt-0\"\u003e\u003cstrong\u003eSerious side effects to watch?\u003c\/strong\u003e\u003c\/h2\u003e\r\n\u003cp class=\"my-2 [\u0026amp;+p]:mt-4 [\u0026amp;_strong:has(+br)]:inline-block [\u0026amp;_strong:has(+br)]:pb-2\"\u003eQT prolongation (palpitations, dizziness), cardiovascular events, severe allergic reactions, liver injury – \u003cstrong\u003eseek emergency care\u003c\/strong\u003e.\u003c\/p\u003e\r\n\u003ch2 class=\"mb-2 mt-4 [.has-inline-images_\u0026amp;]:clear-end font-sans visRefresh2026AnswerSerif:font-editorial font-semimedium visRefresh2026Fonts:font-bold text-base first:mt-0\"\u003e\u003cstrong\u003eDoes Xelucip cause infertility or affect sex drive?\u003c\/strong\u003e\u003c\/h2\u003e\r\n\u003cp class=\"my-2 [\u0026amp;+p]:mt-4 [\u0026amp;_strong:has(+br)]:inline-block [\u0026amp;_strong:has(+br)]:pb-2\"\u003e\u003cstrong\u003eYes\u003c\/strong\u003e – expect reduced libido, erectile dysfunction, temporary infertility during treatment. Sperm banking recommended pre-start.\u003c\/p\u003e\r\n\u003ch2 class=\"mb-2 mt-4 [.has-inline-images_\u0026amp;]:clear-end font-sans visRefresh2026AnswerSerif:font-editorial font-semimedium visRefresh2026Fonts:font-bold text-base first:mt-0\"\u003e\u003cstrong\u003eBone health risks with Xelucip?\u003c\/strong\u003e\u003c\/h2\u003e\r\n\u003cp class=\"my-2 [\u0026amp;+p]:mt-4 [\u0026amp;_strong:has(+br)]:inline-block [\u0026amp;_strong:has(+br)]:pb-2\"\u003eTestosterone suppression increases osteoporosis\/fracture risk. \u003cstrong\u003eWaldrugmart bundles\u003c\/strong\u003e: Calcium + Vitamin D3 (20% off when bought together).\u003c\/p\u003e\r\n\u003ch2 class=\"mb-2 mt-4 [.has-inline-images_\u0026amp;]:clear-end font-sans visRefresh2026AnswerSerif:font-editorial font-semimedium visRefresh2026Fonts:font-bold text-base first:mt-0\"\u003e\u003cstrong\u003eDrug interactions with Xelucip?\u003c\/strong\u003e\u003c\/h2\u003e\r\n\u003cp class=\"my-2 [\u0026amp;+p]:mt-4 [\u0026amp;_strong:has(+br)]:inline-block [\u0026amp;_strong:has(+br)]:pb-2\"\u003eStrong CYP3A4\/P-gp inhibitors (e.g., ketoconazole) or inducers alter levels. \u003cstrong\u003eFREE medication review\u003c\/strong\u003e by Waldrugmart pharmacists before dispatch.\u003cspan class=\"inline-flex\" aria-label=\"ORGOVYX (relugolix) tablets, for oral use - accessdata.fda.gov\" data-state=\"closed\"\u003e​\u003c\/span\u003e\u003c\/p\u003e\r\n\u003ch2 class=\"mb-2 mt-4 [.has-inline-images_\u0026amp;]:clear-end font-sans visRefresh2026AnswerSerif:font-editorial font-semimedium visRefresh2026Fonts:font-bold text-base first:mt-0\"\u003e\u003cstrong\u003eMonitoring needed on Xelucip?\u003c\/strong\u003e\u003c\/h2\u003e\r\n\u003cul class=\"marker:text-quiet list-disc\"\u003e\r\n\u003cli class=\"py-0 my-0 prose-p:pt-0 prose-p:mb-2 prose-p:my-0 [\u0026amp;\u0026gt;p]:pt-0 [\u0026amp;\u0026gt;p]:mb-2 [\u0026amp;\u0026gt;p]:my-0\"\u003e\r\n\u003cp class=\"my-2 [\u0026amp;+p]:mt-4 [\u0026amp;_strong:has(+br)]:inline-block [\u0026amp;_strong:has(+br)]:pb-2\"\u003ePSA\/testosterone every 3 months\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli class=\"py-0 my-0 prose-p:pt-0 prose-p:mb-2 prose-p:my-0 [\u0026amp;\u0026gt;p]:pt-0 [\u0026amp;\u0026gt;p]:mb-2 [\u0026amp;\u0026gt;p]:my-0\"\u003e\r\n\u003cp class=\"my-2 [\u0026amp;+p]:mt-4 [\u0026amp;_strong:has(+br)]:inline-block [\u0026amp;_strong:has(+br)]:pb-2\"\u003eBaseline + periodic: ECG, LFTs, HbA1c, lipids, hemoglobin\u003cbr\u003eOrder lab kits through Waldrugmart.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2 class=\"mb-2 mt-4 [.has-inline-images_\u0026amp;]:clear-end font-sans visRefresh2026AnswerSerif:font-editorial font-semimedium visRefresh2026Fonts:font-bold text-base first:mt-0\"\u003e\u003cstrong\u003eXelucip storage \u0026amp; packaging?\u003c\/strong\u003e\u003c\/h2\u003e\r\n\u003cp class=\"my-2 [\u0026amp;+p]:mt-4 [\u0026amp;_strong:has(+br)]:inline-block [\u0026amp;_strong:has(+br)]:pb-2\"\u003eRoom temperature (\u0026lt;25°C), blister packs of 10\/30 tablets. \u003cstrong\u003eUnopened 30-day guarantee\u003c\/strong\u003e.\u003c\/p\u003e\r\n\u003ch2 class=\"mb-2 mt-4 [.has-inline-images_\u0026amp;]:clear-end font-sans visRefresh2026AnswerSerif:font-editorial font-semimedium visRefresh2026Fonts:font-bold text-base first:mt-0\"\u003e\u003cstrong\u003eDoes Waldrugmart ship Xelucip worldwide?\u003c\/strong\u003e\u003c\/h2\u003e\r\n\u003cp class=\"my-2 [\u0026amp;+p]:mt-4 [\u0026amp;_strong:has(+br)]:inline-block [\u0026amp;_strong:has(+br)]:pb-2\"\u003e\u003cstrong\u003eYes\u003c\/strong\u003e – \u003cstrong\u003eFree shipping $150+, \u003c\/strong\u003eTracked Shipment number \u003c\/p\u003e\r\n\u003ch2 class=\"mb-2 mt-4 [.has-inline-images_\u0026amp;]:clear-end font-sans visRefresh2026AnswerSerif:font-editorial font-semimedium visRefresh2026Fonts:font-bold text-base first:mt-0\"\u003e\u003cstrong\u003ePrescription requirements for international Xelucip orders?\u003c\/strong\u003e\u003c\/h2\u003e\r\n\u003cp class=\"my-2 [\u0026amp;+p]:mt-4 [\u0026amp;_strong:has(+br)]:inline-block [\u0026amp;_strong:has(+br)]:pb-2\"\u003eUpload scanned script – verified in 2 hours. USA patients: We provide personal import guidance.\u003cspan class=\"inline-flex\" aria-label=\"Buy Rexigo 120mg Tablet Online\" data-state=\"closed\"\u003e​\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp class=\"my-2 [\u0026amp;+p]:mt-4 [\u0026amp;_strong:has(+br)]:inline-block [\u0026amp;_strong:has(+br)]:pb-2\"\u003e\u003cstrong\u003eOrder Xelucip 120mg (Generic Orgovyx) Now\u003c\/strong\u003e – Waldrugmart Pharmacy Australia. Licensed worldwide exporter. \u003c\/p\u003e\r\n\u003cp class=\"my-2 [\u0026amp;+p]:mt-4 [\u0026amp;_strong:has(+br)]:inline-block [\u0026amp;_strong:has(+br)]:pb-2\"\u003e\u003cstrong\u003eUpload Rx for same-day dispatch\u003c\/strong\u003e.\u003c\/p\u003e\r\n\u003cp class=\"my-2 [\u0026amp;+p]:mt-4 [\u0026amp;_strong:has(+br)]:inline-block [\u0026amp;_strong:has(+br)]:pb-2\"\u003eTag: Xelucip Relugolix buy USA Australia, generic Orgovyx prostate cancer, Waldrugmart worldwide shipping ADT medication.\u003c\/p\u003e\r\n\u003cp class=\"my-2 [\u0026amp;+p]:mt-4 [\u0026amp;_strong:has(+br)]:inline-block [\u0026amp;_strong:has(+br)]:pb-2\"\u003e\u003cem\u003ePrescription only. Consult your oncologist.\u003c\/em\u003e\u003c\/p\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003cdiv class=\"flex items-center justify-between\"\u003e\r\n\u003cdiv class=\"-ml-sm gap-xs flex flex-shrink-0 items-center\"\u003e\r\n\u003cdiv class=\"rounded-full\"\u003e \u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003cdiv class=\"gap-x-xs flex flex-shrink-0 items-center\"\u003e\r\n\u003cdiv\u003e\r\n\u003cdiv class=\"gap-xs flex items-center border-subtlest ring-subtlest divide-subtlest bg-transparent\"\u003e \u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003cdiv\u003e \u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003cdiv class=\"gap-y-lg flex flex-col first:mt-0\"\u003e \u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003cdiv class=\"erp-sidecar:fixed erp-sidecar:w-full bottom-safeAreaInsetBottom p-md pointer-events-none z-10 absolute border-subtlest ring-subtlest divide-subtlest bg-transparent\"\u003e\r\n\u003cdiv class=\"max-w-threadContentWidth mx-auto\"\u003e\r\n\u003cdiv class=\"pointer-events-auto\"\u003e\r\n\u003cdiv class=\"pointer-events-none h-0\"\u003e \u003c\/div\u003e\r\n\u003cdiv\u003e\r\n\u003cdiv class=\"w-full\"\u003e\r\n\u003cdiv class=\"relative\"\u003e\r\n\u003cdiv class=\"bg-base rounded-2xl\"\u003e\r\n\u003cdiv class=\"shadow-[0_1px_8px_2px_oklch(var(--foreground-color)\/0.05),0_36px_16px_36px_oklch(var(--background-base-color))] dark:shadow-[0_4px_12px_rgba(0,0,0,0.12),0_32px_16px_36px_oklch(var(--dark-background-base-color))] relative rounded-2xl border-subtlest ring-subtlest divide-subtlest bg-subtler\"\u003e\r\n\u003cdiv class=\"\"\u003e\r\n\u003cdiv class=\"relative rounded-2xl\"\u003e\r\n\u003cdiv class=\"bg-raised w-full outline-none flex items-center border rounded-2xl dark:bg-offset duration-75 transition-all border-subtler shadow-sm dark:shadow-md shadow-super\/10 dark:shadow-black\/10 px-0 pt-3 pb-3 gap-y-md grid items-center\"\u003e\r\n\u003cdiv class=\"px-3.5 grid-rows-1fr-auto grid grid-cols-3\"\u003e\r\n\u003cdiv class=\"overflow-hidden relative flex h-full w-full col-start-1 col-end-4 pb-3\"\u003e\r\n\u003cdiv data-grammarly-part=\"button\"\u003e\r\n\u003cdiv\u003e\r\n\u003cdiv\u003e\r\n\u003cdiv class=\"amkYk\"\u003e\r\n\u003cdiv\u003e\r\n\u003cdiv class=\"ptGJG\"\u003e\r\n\u003cdiv\u003e \u003c\/div\u003e\r\n\u003cdiv class=\"jeWQ0 q44yz\"\u003e\r\n\u003cdiv class=\"i8HXG\"\u003e \u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003cbutton class=\"vkuMN\" type=\"button\" data-grammarly-part=\"gbutton\" data-gbutton-checking-status=\"idle\" aria-label=\"Open Grammarly.\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003cdiv data-grammarly-part=\"highlights\"\u003e\r\n\u003cdiv\u003e\r\n\u003cdiv\u003e \u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735708172571,"sku":"Generic Equivalent to Orgovyx (Relugolix) 120mg","price":995.49,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0992\/3303\/8619\/files\/untitled_400_x_400_px_3.png?v=1770407504"},{"product_id":"orgovyx-relugolix120mg-x-30-tablets","title":"Orgovyx (Relugolix)120mg x 30 Tablets","description":"\u003ch4\u003eWhat is Orgovyx (Relugolix)120mg x 30 Tablets ?\u003c\/h4\u003e\u003cp\u003eOrgovyx (Relugolix)120mg x 30 Tablets  is a tablet supplied in 120mg. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735708238107,"sku":"Orgovyx (Relugolix)120mg x30 Tablets","price":1464.0,"currency_code":"USD","in_stock":true}]},{"product_id":"retevmo-selpercatinib-80mg-120-capsules","title":"Retevmo (Selpercatinib) 80mg 120 Capsules","description":"\u003cdiv class=\"flex-shrink-0 flex flex-col relative items-end\"\u003e\r\n\u003cdiv\u003e\r\n\u003cdiv class=\"pt-0\"\u003e\r\n\u003cdiv class=\"gizmo-bot-avatar flex h-8 w-8 items-center justify-center overflow-hidden rounded-full\"\u003e\r\n\u003cdiv class=\"relative p-1 rounded-sm flex items-center justify-center bg-token-main-surface-primary text-token-text-primary h-8 w-8\"\u003e\u003cspan style=\"font-size: 18px; color: #333333; font-family: 'Open Sans', 'Helvetica Neue', Helvetica, Arial, sans-serif; font-weight: 600;\"\u003eRetevmo (Selpercatinib) - Comprehensive Product Description\u003c\/span\u003e\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003cdiv class=\"group\/conversation-turn relative flex w-full min-w-0 flex-col agent-turn\"\u003e\r\n\u003cdiv class=\"flex-col gap-1 md:gap-3\"\u003e\r\n\u003cdiv class=\"flex max-w-full flex-col flex-grow\"\u003e\r\n\u003cdiv class=\"min-h-8 text-message flex w-full flex-col items-end gap-2 whitespace-normal break-words [.text-message+\u0026amp;]:mt-5\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"3bf195a6-32d9-4efb-b5a8-08d2eb69d967\" data-message-model-slug=\"gpt-4o\"\u003e\r\n\u003cdiv class=\"flex w-full flex-col gap-1 empty:hidden first:pt-[3px]\"\u003e\r\n\u003cdiv class=\"markdown prose w-full break-words dark:prose-invert dark\"\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eRetevmo\u003c\/strong\u003e is a prescription medication containing the active ingredient \u003cstrong\u003eSelpercatinib\u003c\/strong\u003e, a targeted cancer therapy used to treat certain types of cancers driven by \u003cstrong\u003eRET gene mutations or fusions\u003c\/strong\u003e. It is specifically indicated for the treatment of patients with \u003cstrong\u003enon-small cell lung cancer (NSCLC)\u003c\/strong\u003e, \u003cstrong\u003emedullary thyroid cancer (MTC)\u003c\/strong\u003e, and \u003cstrong\u003eother types of thyroid cancer\u003c\/strong\u003e that have RET alterations. Retevmo works by inhibiting the activity of the RET protein, which plays a crucial role in the growth and survival of cancer cells.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eDrug Class\u003c\/strong\u003e:\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eDrug Class\u003c\/strong\u003e: Kinase Inhibitor, Targeted Therapy\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eCategories\u003c\/strong\u003e: Cancer Treatment, Precision Medicine, Targeted Cancer Therapy\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eActive Ingredient Name\u003c\/strong\u003e:\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eActive Ingredient\u003c\/strong\u003e: \u003cstrong\u003eSelpercatinib\u003c\/strong\u003e\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003ePopular and Other Names\u003c\/strong\u003e:\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eBrand Name\u003c\/strong\u003e: Retevmo\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eGeneric Name\u003c\/strong\u003e: Selpercatinib\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eOther Names\u003c\/strong\u003e: RET Inhibitor, Selpercatinib Capsules\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eMode of Action\u003c\/strong\u003e:\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003eRetevmo targets and inhibits the activity of the \u003cstrong\u003eRET (Rearranged during Transfection) kinase\u003c\/strong\u003e, a protein that is abnormally activated in cancers with \u003cstrong\u003eRET gene mutations or fusions\u003c\/strong\u003e. By blocking the RET protein’s activity, Retevmo helps:\u003c\/span\u003e\u003c\/p\u003e\r\n\u003col\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eInhibit Tumor Growth\u003c\/strong\u003e: Prevents cancer cells from proliferating, thereby reducing tumor size and slowing disease progression.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eInduce Cancer Cell Death\u003c\/strong\u003e: Triggers mechanisms within the cancer cells that lead to apoptosis (programmed cell death), effectively eliminating some cancer cells.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eMinimize Metastasis\u003c\/strong\u003e: Helps reduce the spread of cancer to other parts of the body, improving patient outcomes.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003eThis targeted approach ensures that the therapy is more specific to cancer cells with RET alterations, while having a lesser effect on normal, healthy cells.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eHow to Use It\u003c\/strong\u003e:\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003eRetevmo is taken orally in capsule form, typically under the supervision of an oncologist. It is important to follow the prescribed dosing schedule for optimal results.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003ch3\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eRecommended Dosage\u003c\/strong\u003e:\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eAdults and Pediatric Patients (≥12 Years)\u003c\/strong\u003e:\u003c\/span\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eBody Weight ≥50 kg\u003c\/strong\u003e: \u003cstrong\u003e160 mg twice daily\u003c\/strong\u003e.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eBody Weight \u0026lt;50 kg\u003c\/strong\u003e: \u003cstrong\u003e120 mg twice daily\u003c\/strong\u003e.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eDuration\u003c\/strong\u003e: Treatment continues until disease progression or unacceptable toxicity occurs. Always follow your oncologist's recommendations for dosing and duration.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eDirections\u003c\/strong\u003e:\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003col\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eTake with or without Food\u003c\/strong\u003e: Swallow the capsules whole with water. Do not crush, chew, or open the capsules.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eConsistent Timing\u003c\/strong\u003e: Take the medication at the same time each day to maintain stable blood levels.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eMissed Dose\u003c\/strong\u003e: If a dose is missed by more than 6 hours, skip the missed dose and resume the regular schedule. Do not take an extra dose to make up for the missed one.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eCautions\u003c\/strong\u003e:\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eLiver Monitoring\u003c\/strong\u003e: Retevmo may cause liver toxicity. Regular monitoring of liver function tests is recommended.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eBlood Pressure Monitoring\u003c\/strong\u003e: Patients should have their blood pressure monitored regularly, as hypertension may occur.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eAvoid in Pregnancy\u003c\/strong\u003e: Retevmo can harm an unborn baby. It should not be used during pregnancy, and effective contraception should be used during treatment and for at least 1 week after the last dose.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eDrug Interactions\u003c\/strong\u003e: Avoid taking Retevmo with certain medications that can affect liver enzymes, as they may alter the effectiveness of the treatment. Inform your doctor about all medications you are taking.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eManaging Side Effects\u003c\/strong\u003e:\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eCommon Side Effects\u003c\/strong\u003e: Include dry mouth, diarrhea, high blood pressure, fatigue, nausea, and constipation.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eSerious Side Effects\u003c\/strong\u003e: May include liver problems, severe hypertension, bleeding, allergic reactions, and heart rhythm abnormalities (QT prolongation). If you experience any serious symptoms, contact your healthcare provider immediately.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eManagement Tips\u003c\/strong\u003e: Stay hydrated and eat small, frequent meals to manage nausea. Monitor blood pressure regularly and follow dietary recommendations if advised by your healthcare team.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eGuidelines\u003c\/strong\u003e:\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003col\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eRegular Monitoring\u003c\/strong\u003e: Follow your healthcare provider’s instructions for regular monitoring of blood tests, liver function, and blood pressure.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eReport Symptoms\u003c\/strong\u003e: Inform your healthcare provider of any new or worsening symptoms, including unexplained bleeding, chest pain, or swelling.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eUse Effective Birth Control\u003c\/strong\u003e: Use contraception during treatment and for 1 week after the last dose if you are of childbearing potential.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eFrequently Asked Questions (FAQs)\u003c\/strong\u003e\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003col\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eWhat is Retevmo used for?\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003eRetevmo is used to treat certain types of cancers with RET gene mutations or fusions, including non-small cell lung cancer, medullary thyroid cancer, and other thyroid cancers.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eHow does Retevmo work?\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003eRetevmo inhibits the RET protein's activity, which is involved in cancer cell growth and survival. By blocking this protein, it helps reduce tumor growth and spread.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eCan Retevmo be used as a first-line treatment?\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003eYes, Retevmo can be used as a first-line treatment for patients with RET-positive cancers.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eHow long should I take Retevmo?\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003eTreatment with Retevmo typically continues until the cancer progresses or significant side effects occur. Your oncologist will determine the duration based on your response.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eWhat should I do if I miss a dose of Retevmo?\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003eIf you miss a dose by more than 6 hours, skip it and resume your regular dosing schedule. Do not take a double dose to make up for the missed one.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eAre there any dietary restrictions while taking Retevmo?\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003eThere are no specific dietary restrictions, but avoid grapefruit and grapefruit juice, as they may interact with the medication.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eCan I take Retevmo if I’m pregnant?\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003eNo, Retevmo can harm an unborn baby. It should not be used during pregnancy, and effective contraception should be used during treatment.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eDoes Retevmo cause high blood pressure?\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003eYes, high blood pressure is a common side effect. Regular monitoring and management by your healthcare provider are recommended.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eQuick Links\u003c\/strong\u003e:\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003ca href=\"https:\/\/uspl.lilly.com\/retevmo\/retevmo.html#pi\"\u003eRetevmo Product Information\u003c\/a\u003e\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003ca href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8599646\/\"\u003eRET Inhibitors in Cancer Treatment\u003c\/a\u003e\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003ca href=\"https:\/\/www.cancer.gov\/about-cancer\/treatment\/types\/targeted-therapies\"\u003eManaging Side Effects of Targeted Cancer Therapies\u003c\/a\u003e\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003ca href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7328108\/\" target=\"_new\" rel=\"noopener\"\u003eUnderstanding RET Gene Mutations\u003c\/a\u003e\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003ca href=\"https:\/\/www.mayoclinic.org\/drugs-supplements\/selpercatinib-oral-route\/proper-use\/drg-20512415\" target=\"_new\" rel=\"noopener\"\u003eRetevmo Dosage Guidelines\u003c\/a\u003e\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735708270875,"sku":"Retevmo (Selpercatinib) 80mg x 120 Capsules","price":6744.6,"currency_code":"USD","in_stock":true}]},{"product_id":"retevmo-selpercatinib-40mg-120-capsules","title":"Retevmo (Selpercatinib) 40mg 120 Capsules","description":"\u003cdiv class=\"flex-shrink-0 flex flex-col relative items-end\"\u003e\r\n\u003cdiv\u003e\r\n\u003cdiv class=\"pt-0\"\u003e\r\n\u003cdiv class=\"gizmo-bot-avatar flex h-8 w-8 items-center justify-center overflow-hidden rounded-full\"\u003e\r\n\u003cdiv class=\"relative p-1 rounded-sm flex items-center justify-center bg-token-main-surface-primary text-token-text-primary h-8 w-8\"\u003e\u003cspan style=\"font-size: 18px; color: #333333; font-family: 'Open Sans', 'Helvetica Neue', Helvetica, Arial, sans-serif; font-weight: 600;\"\u003eRetevmo (Selpercatinib) - Comprehensive Product Description\u003c\/span\u003e\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003cdiv class=\"group\/conversation-turn relative flex w-full min-w-0 flex-col agent-turn\"\u003e\r\n\u003cdiv class=\"flex-col gap-1 md:gap-3\"\u003e\r\n\u003cdiv class=\"flex max-w-full flex-col flex-grow\"\u003e\r\n\u003cdiv class=\"min-h-8 text-message flex w-full flex-col items-end gap-2 whitespace-normal break-words [.text-message+\u0026amp;]:mt-5\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"3bf195a6-32d9-4efb-b5a8-08d2eb69d967\" data-message-model-slug=\"gpt-4o\"\u003e\r\n\u003cdiv class=\"flex w-full flex-col gap-1 empty:hidden first:pt-[3px]\"\u003e\r\n\u003cdiv class=\"markdown prose w-full break-words dark:prose-invert dark\"\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eRetevmo\u003c\/strong\u003e is a prescription medication containing the active ingredient \u003cstrong\u003eSelpercatinib\u003c\/strong\u003e, a targeted cancer therapy used to treat certain types of cancers driven by \u003cstrong\u003eRET gene mutations or fusions\u003c\/strong\u003e. It is specifically indicated for the treatment of patients with \u003cstrong\u003enon-small cell lung cancer (NSCLC)\u003c\/strong\u003e, \u003cstrong\u003emedullary thyroid cancer (MTC)\u003c\/strong\u003e, and \u003cstrong\u003eother types of thyroid cancer\u003c\/strong\u003e that have RET alterations. Retevmo works by inhibiting the activity of the RET protein, which plays a crucial role in the growth and survival of cancer cells.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eDrug Class\u003c\/strong\u003e:\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eDrug Class\u003c\/strong\u003e: Kinase Inhibitor, Targeted Therapy\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eCategories\u003c\/strong\u003e: Cancer Treatment, Precision Medicine, Targeted Cancer Therapy\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eActive Ingredient Name\u003c\/strong\u003e:\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eActive Ingredient\u003c\/strong\u003e: \u003cstrong\u003eSelpercatinib\u003c\/strong\u003e\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003ePopular and Other Names\u003c\/strong\u003e:\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eBrand Name\u003c\/strong\u003e: Retevmo\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eGeneric Name\u003c\/strong\u003e: Selpercatinib\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eOther Names\u003c\/strong\u003e: RET Inhibitor, Selpercatinib Capsules\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eMode of Action\u003c\/strong\u003e:\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003eRetevmo targets and inhibits the activity of the \u003cstrong\u003eRET (Rearranged during Transfection) kinase\u003c\/strong\u003e, a protein that is abnormally activated in cancers with \u003cstrong\u003eRET gene mutations or fusions\u003c\/strong\u003e. By blocking the RET protein’s activity, Retevmo helps:\u003c\/span\u003e\u003c\/p\u003e\r\n\u003col\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eInhibit Tumor Growth\u003c\/strong\u003e: Prevents cancer cells from proliferating, thereby reducing tumor size and slowing disease progression.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eInduce Cancer Cell Death\u003c\/strong\u003e: Triggers mechanisms within the cancer cells that lead to apoptosis (programmed cell death), effectively eliminating some cancer cells.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eMinimize Metastasis\u003c\/strong\u003e: Helps reduce the spread of cancer to other parts of the body, improving patient outcomes.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003eThis targeted approach ensures that the therapy is more specific to cancer cells with RET alterations, while having a lesser effect on normal, healthy cells.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eHow to Use It\u003c\/strong\u003e:\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003eRetevmo is taken orally in capsule form, typically under the supervision of an oncologist. It is important to follow the prescribed dosing schedule for optimal results.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003ch3\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eRecommended Dosage\u003c\/strong\u003e:\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\n\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eAdults and Pediatric Patients (≥12 Years)\u003c\/strong\u003e:\u003c\/span\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eBody Weight ≥50 kg\u003c\/strong\u003e: \u003cstrong\u003e160 mg twice daily\u003c\/strong\u003e.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eBody Weight \u0026lt;50 kg\u003c\/strong\u003e: \u003cstrong\u003e120 mg twice daily\u003c\/strong\u003e.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eDuration\u003c\/strong\u003e: Treatment continues until disease progression or unacceptable toxicity occurs. Always follow your oncologist's recommendations for dosing and duration.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eDirections\u003c\/strong\u003e:\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003col\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eTake with or without Food\u003c\/strong\u003e: Swallow the capsules whole with water. Do not crush, chew, or open the capsules.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eConsistent Timing\u003c\/strong\u003e: Take the medication at the same time each day to maintain stable blood levels.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eMissed Dose\u003c\/strong\u003e: If a dose is missed by more than 6 hours, skip the missed dose and resume the regular schedule. Do not take an extra dose to make up for the missed one.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eCautions\u003c\/strong\u003e:\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eLiver Monitoring\u003c\/strong\u003e: Retevmo may cause liver toxicity. Regular monitoring of liver function tests is recommended.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eBlood Pressure Monitoring\u003c\/strong\u003e: Patients should have their blood pressure monitored regularly, as hypertension may occur.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eAvoid in Pregnancy\u003c\/strong\u003e: Retevmo can harm an unborn baby. It should not be used during pregnancy, and effective contraception should be used during treatment and for at least 1 week after the last dose.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eDrug Interactions\u003c\/strong\u003e: Avoid taking Retevmo with certain medications that can affect liver enzymes, as they may alter the effectiveness of the treatment. Inform your doctor about all medications you are taking.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eManaging Side Effects\u003c\/strong\u003e:\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eCommon Side Effects\u003c\/strong\u003e: Include dry mouth, diarrhea, high blood pressure, fatigue, nausea, and constipation.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eSerious Side Effects\u003c\/strong\u003e: May include liver problems, severe hypertension, bleeding, allergic reactions, and heart rhythm abnormalities (QT prolongation). If you experience any serious symptoms, contact your healthcare provider immediately.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eManagement Tips\u003c\/strong\u003e: Stay hydrated and eat small, frequent meals to manage nausea. Monitor blood pressure regularly and follow dietary recommendations if advised by your healthcare team.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eGuidelines\u003c\/strong\u003e:\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003col\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eRegular Monitoring\u003c\/strong\u003e: Follow your healthcare provider’s instructions for regular monitoring of blood tests, liver function, and blood pressure.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eReport Symptoms\u003c\/strong\u003e: Inform your healthcare provider of any new or worsening symptoms, including unexplained bleeding, chest pain, or swelling.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eUse Effective Birth Control\u003c\/strong\u003e: Use contraception during treatment and for 1 week after the last dose if you are of childbearing potential.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eFrequently Asked Questions (FAQs)\u003c\/strong\u003e\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003col\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eWhat is Retevmo used for?\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003eRetevmo is used to treat certain types of cancers with RET gene mutations or fusions, including non-small cell lung cancer, medullary thyroid cancer, and other thyroid cancers.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eHow does Retevmo work?\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003eRetevmo inhibits the RET protein's activity, which is involved in cancer cell growth and survival. By blocking this protein, it helps reduce tumor growth and spread.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eCan Retevmo be used as a first-line treatment?\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003eYes, Retevmo can be used as a first-line treatment for patients with RET-positive cancers.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eHow long should I take Retevmo?\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003eTreatment with Retevmo typically continues until the cancer progresses or significant side effects occur. Your oncologist will determine the duration based on your response.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eWhat should I do if I miss a dose of Retevmo?\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003eIf you miss a dose by more than 6 hours, skip it and resume your regular dosing schedule. Do not take a double dose to make up for the missed one.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eAre there any dietary restrictions while taking Retevmo?\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003eThere are no specific dietary restrictions, but avoid grapefruit and grapefruit juice, as they may interact with the medication.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eCan I take Retevmo if I’m pregnant?\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003eNo, Retevmo can harm an unborn baby. It should not be used during pregnancy, and effective contraception should be used during treatment.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eDoes Retevmo cause high blood pressure?\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003eYes, high blood pressure is a common side effect. Regular monitoring and management by your healthcare provider are recommended.\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003chr\u003e\r\n\u003ch3\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003cstrong\u003eQuick Links\u003c\/strong\u003e:\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003ca href=\"https:\/\/uspl.lilly.com\/retevmo\/retevmo.html#pi\"\u003eRetevmo Product Information\u003c\/a\u003e\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003ca href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8599646\/\"\u003eRET Inhibitors in Cancer Treatment\u003c\/a\u003e\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003ca href=\"https:\/\/www.cancer.gov\/about-cancer\/treatment\/types\/targeted-therapies\"\u003eManaging Side Effects of Targeted Cancer Therapies\u003c\/a\u003e\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003ca href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7328108\/\" target=\"_new\" rel=\"noopener\"\u003eUnderstanding RET Gene Mutations\u003c\/a\u003e\u003c\/span\u003e\u003c\/li\u003e\r\n\u003cli\u003e\u003cspan style=\"font-size: 18px;\"\u003e\u003ca href=\"https:\/\/www.mayoclinic.org\/drugs-supplements\/selpercatinib-oral-route\/proper-use\/drg-20512415\" target=\"_new\" rel=\"noopener\"\u003eRetevmo Dosage Guidelines\u003c\/a\u003e\u003c\/span\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735708303643,"sku":"Retevmo (Selpercatinib) 40mg x 120 Capsules","price":6204.6,"currency_code":"USD","in_stock":true}]},{"product_id":"stivarga-regorafenib-40mg-x-28-tablets","title":"Stivarga (Regorafenib) 40mg x 28 Tablets","description":"\u003ch4\u003eWhat is  Stivarga (Regorafenib) 40mg x 28 Tablets?\u003c\/h4\u003e\u003cp\u003e Stivarga (Regorafenib) 40mg x 28 Tablets is a tablet supplied in 40mg. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735708336411,"sku":"Generic Equivalent to Stivarga (Regorafenib) 40mg x 28 Tablets","price":780.0,"currency_code":"USD","in_stock":true}]},{"product_id":"stivarge-or-nublexa-regorafenib-40mg-x-28-tablets","title":"Stivarge or Nublexa (Regorafenib) 40mg x 28 Tablets","description":"\u003ch4\u003eWhat is Stivarge or Nublexa (Regorafenib) 40mg x 28 Tablets?\u003c\/h4\u003e\u003cp\u003eStivarge or Nublexa (Regorafenib) 40mg x 28 Tablets is a tablet supplied in 40mg. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735708369179,"sku":"Stivarge or Nublexa (Regorafenib) 40mg x 28 Tablets","price":998.05,"currency_code":"USD","in_stock":true}]},{"product_id":"erleada-apalutamide-60mg-x-120-tablets","title":"Erleada (Apalutamide) 60mg x 120 Tablets","description":"\u003ch4\u003eWhat is  Erleada (Apalutamide) 60mg x 120 Tablets?\u003c\/h4\u003e\u003cp\u003e Erleada (Apalutamide) 60mg x 120 Tablets is a tablet supplied in 60mg. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735708401947,"sku":"Generic Equivalent to Erleada (Apalutamide) 60mg x 120 Tablets","price":720.0,"currency_code":"USD","in_stock":true}]},{"product_id":"tagrisso-osimertinib-80mg-x-10-tablets","title":"Tagrisso (Osimertinib) 80mg x 10 Tablets","description":"\u003ch4\u003eWhat is Tagrisso (Osimertinib) 80mg x 10 Tablets?\u003c\/h4\u003e\u003cp\u003eTagrisso (Osimertinib) 80mg x 10 Tablets is a tablet supplied in 80mg. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735708434715,"sku":"Tagrisso (Osimertinib) 80mg x 10 Tablets","price":2760.0,"currency_code":"USD","in_stock":true}]},{"product_id":"afinitor-everolimus-5mg","title":"Afinitor (Everolimus) 5mg","description":"\u003cp\u003e\u003cstrong\u003eMedicine Description:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cp\u003eEverolimus is a medication used to treat certain types of cancer, as well as certain non-cancerous conditions. It belongs to a class of drugs called mTOR inhibitors, which work by slowing or stopping the growth of cancer cells and abnormal blood vessels.\u003c\/p\u003e\r\n\u003cp\u003e\u003cstrong\u003eUnique Benefits over Other Similar Products:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cp\u003eEverolimus offers unique benefits compared to other similar products due to its targeted mechanism of action. It specifically inhibits the mTOR pathway, which plays a key role in the growth and spread of cancer cells. This targeted approach may result in fewer side effects compared to traditional chemotherapy drugs while still effectively controlling tumor growth.\u003c\/p\u003e\r\n\u003cp\u003e\u003cstrong\u003eDosage:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cp\u003eThe dosage of Everolimus can vary depending on the specific condition being treated, the patient's medical history, and other factors. It is usually taken orally once daily, either with or without food. Your doctor will determine the appropriate dose for you based on your individual needs.\u003c\/p\u003e\r\n\u003cp\u003e\u003cstrong\u003eDirections\/Instructions for Use:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cp\u003eSwallow the Everolimus tablet whole with a glass of water. Do not crush, chew, or break the tablet. Take Everolimus at the same time each day to maintain a consistent level of the medication in your body. Follow your doctor's instructions carefully and do not adjust your dose without consulting them first.\u003c\/p\u003e\r\n\u003cp\u003e\u003cstrong\u003eUse During Pregnancy:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cp\u003eEverolimus can cause harm to an unborn baby and is not recommended for use during pregnancy. If you are pregnant or planning to become pregnant, inform your doctor immediately. Effective contraception should be used during treatment with Everolimus and for a period of time after discontinuing the medication.\u003c\/p\u003e\r\n\u003cp\u003e\u003cstrong\u003eFood \u0026amp; Drug Interactions:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cp\u003eCertain foods and medications may interact with Everolimus, potentially affecting its effectiveness or increasing the risk of side effects. It is important to inform your doctor about all medications, supplements, and herbal products you are taking before starting Everolimus. Additionally, avoid consuming grapefruit or grapefruit juice while taking Everolimus, as it may increase the levels of the medication in your body. Your doctor will provide guidance on any specific food or drug interactions to be aware of.\u003c\/p\u003e\r\n\u003cp\u003e\u003cstrong\u003eMost Frequently Asked Questions:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003col\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eHow does Everolimus work?\u003c\/strong\u003e Everolimus works by inhibiting the mTOR pathway, which is involved in the growth and spread of cancer cells. By blocking this pathway, Everolimus helps slow or stop the growth of tumors.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eWhat conditions can Everolimus treat?\u003c\/strong\u003e Everolimus is used to treat certain types of cancer, including breast cancer, kidney cancer, pancreatic neuroendocrine tumors, and certain types of advanced or metastatic cancers. It is also used to treat non-cancerous conditions such as tuberous sclerosis complex (TSC) and subependymal giant cell astrocytoma (SEGA).\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eWhat are the common side effects of Everolimus?\u003c\/strong\u003e Common side effects of Everolimus may include mouth sores, diarrhea, nausea, fatigue, rash, and decreased appetite. It is important to report any side effects to your doctor, as they can provide guidance on managing them effectively.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eHow should Everolimus be stored?\u003c\/strong\u003e Everolimus should be stored at room temperature away from moisture and heat. Keep the medication in its original packaging and out of reach of children and pets.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eWhat should I do if I miss a dose of Everolimus?\u003c\/strong\u003e If you miss a dose of Everolimus, take it as soon as you remember, unless it is almost time for your next dose. In that case, skip the missed dose and take your next dose at the regular time. Do not take a double dose to make up for a missed one. If you are unsure what to do, consult your doctor or pharmacist.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eCan I drink alcohol while taking Everolimus?\u003c\/strong\u003e It is generally recommended to avoid alcohol while taking Everolimus, as it may increase the risk of certain side effects such as liver toxicity. However, it is important to consult your doctor for personalized advice based on your individual medical history and condition.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735708467483,"sku":"Generic Equivalent to Afinitor (Evrolimus) 5mg","price":498.0,"currency_code":"USD","in_stock":true}]},{"product_id":"sutent-sunitinib-12-5mg-x-28-tab","title":"Sutent (Sunitinib) 12.5mg x 28 Tab","description":"\u003ch4\u003eWhat is  Sutent (Sunitinib) 12.5mg x 28 Tab?\u003c\/h4\u003e\u003cp\u003e Sutent (Sunitinib) 12.5mg x 28 Tab is a tablet supplied in 5mg. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735708500251,"sku":"Generic Equivalent to Sutent (Sunitinib) 12.5mg x 28 Tab","price":156.0,"currency_code":"USD","in_stock":true}]},{"product_id":"sutent-sunitinib-25mg-x-28-tablets","title":"Sutent (Sunitinib) 25mg x 28 tablets","description":"\u003cp\u003e\u003cstrong\u003eMedicine Description:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cp\u003eSunitinib is a medication used to treat certain types of cancer, including kidney cancer (renal cell carcinoma) and gastrointestinal stromal tumor (GIST). It belongs to a class of drugs called tyrosine kinase inhibitors, which work by blocking specific enzymes involved in the growth of cancer cells.\u003c\/p\u003e\r\n\u003cp\u003e\u003cstrong\u003eUnique Benefits over Other Similar Products:\u003c\/strong\u003e One unique benefit of Sunitinib is its dual activity against multiple targets involved in tumor growth and angiogenesis (formation of new blood vessels to support tumor growth). This targeted approach may result in more effective tumor shrinkage and slower progression compared to other similar medications.\u003c\/p\u003e\r\n\u003cp\u003e\u003cstrong\u003eDosage:\u003c\/strong\u003e The dosage of Sunitinib can vary depending on the type of cancer being treated, the patient's medical history, and other factors. It is usually taken orally once daily, with or without food. Your doctor will determine the appropriate dose for you based on your individual condition and response to treatment.\u003c\/p\u003e\r\n\u003cp\u003e\u003cstrong\u003eDirections\/Instructions for Use:\u003c\/strong\u003e Take Sunitinib exactly as prescribed by your doctor. Swallow the capsules whole with a glass of water, without chewing or crushing them. It is important to take Sunitinib consistently at the same time each day to maintain a steady level of the medication in your body. Do not change the dosage or stop taking Sunitinib without consulting your doctor.\u003c\/p\u003e\r\n\u003cp\u003e\u003cstrong\u003eUse During Pregnancy:\u003c\/strong\u003e Sunitinib may cause harm to an unborn baby and is not recommended for use during pregnancy. If you are pregnant or planning to become pregnant, discuss the potential risks and benefits of Sunitinib with your doctor. Effective contraception should be used during treatment with Sunitinib and for a period of time after discontinuing the medication.\u003c\/p\u003e\r\n\u003cp\u003e\u003cstrong\u003eFood \u0026amp; Drug Interactions:\u003c\/strong\u003e Certain foods and medications may interact with Sunitinib, potentially affecting its effectiveness or increasing the risk of side effects. It is important to inform your doctor about all medications, supplements, and herbal products you are taking before starting Sunitinib. Additionally, avoid consuming grapefruit or grapefruit juice while taking Sunitinib, as it may increase the levels of the medication in your body.\u003c\/p\u003e\r\n\u003cp\u003e\u003cstrong\u003eMost Frequently Asked Questions:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003col\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eHow does Sunitinib work?\u003c\/strong\u003e Sunitinib works by blocking specific enzymes called tyrosine kinases, which are involved in the growth and spread of cancer cells. By inhibiting these enzymes, Sunitinib helps slow down or stop the growth of tumors.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eWhat types of cancer is Sunitinib used to treat?\u003c\/strong\u003e Sunitinib is primarily used to treat kidney cancer (renal cell carcinoma) and gastrointestinal stromal tumor (GIST). It may also be prescribed for other types of cancer as determined by your doctor.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eWhat are the common side effects of Sunitinib?\u003c\/strong\u003e Common side effects of Sunitinib may include fatigue, diarrhea, nausea, vomiting, loss of appetite, and changes in taste. These side effects are usually mild to moderate and can often be managed with supportive care.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eHow long will I need to take Sunitinib?\u003c\/strong\u003e The duration of Sunitinib treatment can vary depending on your response to the medication and the type of cancer being treated. Your doctor will monitor your condition closely and adjust your treatment plan as needed.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eCan I drink alcohol while taking Sunitinib?\u003c\/strong\u003e It is generally recommended to avoid alcohol while taking Sunitinib, as it may increase the risk of liver toxicity and other side effects. However, it is important to consult your doctor for personalized advice based on your individual medical history and condition.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735708533019,"sku":"Generic Equivalent to Sutent (Sunitinib) 25mg x 28 tablets","price":178.08,"currency_code":"USD","in_stock":true}]},{"product_id":"sutent-sunitinib-50mg-x-28-tablets","title":"Sutent (Sunitinib) 50mg x 28 Tablets","description":"\u003cp\u003e\u003cstrong\u003eMedicine Description:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003cp\u003eSunitinib is a medication used to treat certain types of cancer, including kidney cancer (renal cell carcinoma) and gastrointestinal stromal tumor (GIST). It belongs to a class of drugs called tyrosine kinase inhibitors, which work by blocking specific enzymes involved in the growth of cancer cells.\u003c\/p\u003e\r\n\u003cp\u003e\u003cstrong\u003eUnique Benefits over Other Similar Products:\u003c\/strong\u003e One unique benefit of Sunitinib is its dual activity against multiple targets involved in tumor growth and angiogenesis (formation of new blood vessels to support tumor growth). This targeted approach may result in more effective tumor shrinkage and slower progression compared to other similar medications.\u003c\/p\u003e\r\n\u003cp\u003e\u003cstrong\u003eDosage:\u003c\/strong\u003e The dosage of Sunitinib can vary depending on the type of cancer being treated, the patient's medical history, and other factors. It is usually taken orally once daily, with or without food. Your doctor will determine the appropriate dose for you based on your individual condition and response to treatment.\u003c\/p\u003e\r\n\u003cp\u003e\u003cstrong\u003eDirections\/Instructions for Use:\u003c\/strong\u003e Take Sunitinib exactly as prescribed by your doctor. Swallow the capsules whole with a glass of water, without chewing or crushing them. It is important to take Sunitinib consistently at the same time each day to maintain a steady level of the medication in your body. Do not change the dosage or stop taking Sunitinib without consulting your doctor.\u003c\/p\u003e\r\n\u003cp\u003e\u003cstrong\u003eUse During Pregnancy:\u003c\/strong\u003e Sunitinib may cause harm to an unborn baby and is not recommended for use during pregnancy. If you are pregnant or planning to become pregnant, discuss the potential risks and benefits of Sunitinib with your doctor. Effective contraception should be used during treatment with Sunitinib and for a period of time after discontinuing the medication.\u003c\/p\u003e\r\n\u003cp\u003e\u003cstrong\u003eFood \u0026amp; Drug Interactions:\u003c\/strong\u003e Certain foods and medications may interact with Sunitinib, potentially affecting its effectiveness or increasing the risk of side effects. It is important to inform your doctor about all medications, supplements, and herbal products you are taking before starting Sunitinib. Additionally, avoid consuming grapefruit or grapefruit juice while taking Sunitinib, as it may increase the levels of the medication in your body.\u003c\/p\u003e\r\n\u003cp\u003e\u003cstrong\u003eMost Frequently Asked Questions:\u003c\/strong\u003e\u003c\/p\u003e\r\n\u003col\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eHow does Sunitinib work?\u003c\/strong\u003e Sunitinib works by blocking specific enzymes called tyrosine kinases, which are involved in the growth and spread of cancer cells. By inhibiting these enzymes, Sunitinib helps slow down or stop the growth of tumors.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eWhat types of cancer is Sunitinib used to treat?\u003c\/strong\u003e Sunitinib is primarily used to treat kidney cancer (renal cell carcinoma) and gastrointestinal stromal tumor (GIST). It may also be prescribed for other types of cancer as determined by your doctor.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eWhat are the common side effects of Sunitinib?\u003c\/strong\u003e Common side effects of Sunitinib may include fatigue, diarrhea, nausea, vomiting, loss of appetite, and changes in taste. These side effects are usually mild to moderate and can often be managed with supportive care.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eHow long will I need to take Sunitinib?\u003c\/strong\u003e The duration of Sunitinib treatment can vary depending on your response to the medication and the type of cancer being treated. Your doctor will monitor your condition closely and adjust your treatment plan as needed.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cstrong\u003eCan I drink alcohol while taking Sunitinib?\u003c\/strong\u003e It is generally recommended to avoid alcohol while taking Sunitinib, as it may increase the risk of liver toxicity and other side effects. However, it is important to consult your doctor for personalized advice based on your individual medical history and condition.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e","brand":"EZ Chemist","offers":[{"title":"Default Title","offer_id":51735708565787,"sku":"Generic Equivalent to Sutent (Sunitinib) 50mg x 28 Tablets","price":307.2,"currency_code":"USD","in_stock":true}]},{"product_id":"xeljanz","title":"Xeljanz","description":"\u003ch3 data-start=\"279\" data-end=\"301\"\u003eWhat is Xeljanz?\u003c\/h3\u003e\r\n\u003cp data-start=\"302\" data-end=\"733\"\u003e\u003cstrong data-start=\"302\" data-end=\"313\"\u003eXeljanz\u003c\/strong\u003e is an oral Janus kinase (JAK) inhibitor used as a disease‑modifying therapy for several immune‑mediated inflammatory conditions. It is approved for the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ulcerative colitis (UC). By modulating the JAK‑STAT signaling pathway, Xeljanz reduces inflammation and immune system overactivity, thereby alleviating symptoms and preventing disease progression.\u003c\/p\u003e\r\n\u003cp data-start=\"735\" data-end=\"854\"\u003e\u003cem data-start=\"735\" data-end=\"854\"\u003eReference: U.S. FDA Xeljanz Prescribing Information; ClinicalTrials.gov (e.g., NCT01039688, NCT01375647, NCT01463232)\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"856\" data-end=\"859\"\u003e\r\n\u003ch3 data-start=\"861\" data-end=\"912\"\u003eWhat are the other popular names for Xeljanz?\u003c\/h3\u003e\r\n\u003cp data-start=\"913\" data-end=\"1177\"\u003eXeljanz is the brand name for the active ingredient \u003cstrong data-start=\"965\" data-end=\"980\"\u003etofacitinib\u003c\/strong\u003e. In addition to Xeljanz, the extended‑release formulation is marketed as \u003cstrong data-start=\"1054\" data-end=\"1068\"\u003eXeljanz XR\u003c\/strong\u003e in some regions. The generic name, tofacitinib, is also used in scientific literature and clinical practice.\u003c\/p\u003e\r\n\u003cp data-start=\"1179\" data-end=\"1213\"\u003e\u003cem data-start=\"1179\" data-end=\"1213\"\u003eReference: U.S. FDA; MedlinePlus\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1215\" data-end=\"1218\"\u003e\r\n\u003ch3 data-start=\"1220\" data-end=\"1269\"\u003eWhat is the drug classification of Xeljanz?\u003c\/h3\u003e\r\n\u003cp data-start=\"1270\" data-end=\"1516\"\u003eXeljanz is classified as an \u003cstrong data-start=\"1298\" data-end=\"1335\"\u003eoral Janus kinase (JAK) inhibitor\u003c\/strong\u003e. It falls under the therapeutic category of immunomodulatory agents and is used to modify the disease course in autoimmune conditions by targeting intracellular signaling pathways.\u003c\/p\u003e\r\n\u003cp data-start=\"1518\" data-end=\"1613\"\u003e\u003cem data-start=\"1518\" data-end=\"1613\"\u003eReference: U.S. FDA; World Health Organization (WHO) guidelines on immunomodulatory therapies\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1615\" data-end=\"1618\"\u003e\r\n\u003ch3 data-start=\"1620\" data-end=\"1664\"\u003eWhat is the mode of action of Xeljanz?\u003c\/h3\u003e\r\n\u003cp data-start=\"1665\" data-end=\"2112\"\u003eXeljanz works by inhibiting one or more of the Janus kinase enzymes (primarily JAK1 and JAK3, and to a lesser extent JAK2). This inhibition blocks the JAK‑STAT pathway, which is essential for the signaling of various pro‑inflammatory cytokines (such as interleukins and interferons). The result is a reduction in inflammatory activity and modulation of the immune response, leading to improved clinical outcomes in conditions like RA, PsA, and UC.\u003c\/p\u003e\r\n\u003cp data-start=\"2114\" data-end=\"2189\"\u003e\u003cem data-start=\"2114\" data-end=\"2189\"\u003eReference: PubMed (e.g., O’Shea et al., 2013 on JAK inhibitors); U.S. FDA\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2191\" data-end=\"2194\"\u003e\r\n\u003ch3 data-start=\"2196\" data-end=\"2239\"\u003eWhat are the primary uses of Xeljanz?\u003c\/h3\u003e\r\n\u003cp data-start=\"2240\" data-end=\"2283\"\u003eXeljanz is approved for the treatment of:\u003c\/p\u003e\r\n\u003cul data-start=\"2284\" data-end=\"2741\"\u003e\r\n\u003cli data-start=\"2284\" data-end=\"2486\"\u003e\n\u003cstrong data-start=\"2286\" data-end=\"2316\"\u003eRheumatoid Arthritis (RA):\u003c\/strong\u003e To reduce joint inflammation, pain, and prevent joint damage in patients with moderate to severe RA who have had an inadequate response or intolerance to methotrexate.\u003c\/li\u003e\r\n\u003cli data-start=\"2487\" data-end=\"2620\"\u003e\n\u003cstrong data-start=\"2489\" data-end=\"2519\"\u003ePsoriatic Arthritis (PsA):\u003c\/strong\u003e To improve signs and symptoms, physical function, and quality of life in patients with active PsA.\u003c\/li\u003e\r\n\u003cli data-start=\"2621\" data-end=\"2741\"\u003e\n\u003cstrong data-start=\"2623\" data-end=\"2651\"\u003eUlcerative Colitis (UC):\u003c\/strong\u003e To induce and maintain remission in adult patients with moderately to severely active UC.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"2743\" data-end=\"2784\"\u003e\u003cem data-start=\"2743\" data-end=\"2784\"\u003eReference: U.S. FDA; ClinicalTrials.gov\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2786\" data-end=\"2789\"\u003e\r\n\u003ch3 data-start=\"2791\" data-end=\"2859\"\u003eWhat is the recommended dosage and administration for Xeljanz?\u003c\/h3\u003e\r\n\u003cul data-start=\"2860\" data-end=\"3389\"\u003e\r\n\u003cli data-start=\"2860\" data-end=\"3063\"\u003e\n\u003cstrong data-start=\"2862\" data-end=\"2915\"\u003eFor Rheumatoid Arthritis and Psoriatic Arthritis:\u003c\/strong\u003e\r\n\u003cul data-start=\"2920\" data-end=\"3063\"\u003e\r\n\u003cli data-start=\"2920\" data-end=\"2989\"\u003e\n\u003cstrong data-start=\"2922\" data-end=\"2954\"\u003eXeljanz (Immediate-Release):\u003c\/strong\u003e Typically, \u003cstrong data-start=\"2966\" data-end=\"2986\"\u003e5 mg twice daily\u003c\/strong\u003e.\u003c\/li\u003e\r\n\u003cli data-start=\"2992\" data-end=\"3063\"\u003e\n\u003cstrong data-start=\"2994\" data-end=\"3028\"\u003eXeljanz XR (Extended-Release):\u003c\/strong\u003e Generally, \u003cstrong data-start=\"3040\" data-end=\"3060\"\u003e11 mg once daily\u003c\/strong\u003e.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3064\" data-end=\"3221\"\u003e\n\u003cstrong data-start=\"3066\" data-end=\"3093\"\u003eFor Ulcerative Colitis:\u003c\/strong\u003e\r\n\u003cul data-start=\"3098\" data-end=\"3221\"\u003e\r\n\u003cli data-start=\"3098\" data-end=\"3163\"\u003e\n\u003cstrong data-start=\"3100\" data-end=\"3120\"\u003eInduction Phase:\u003c\/strong\u003e 10 mg twice daily for the first 8 weeks.\u003c\/li\u003e\r\n\u003cli data-start=\"3166\" data-end=\"3221\"\u003e\n\u003cstrong data-start=\"3168\" data-end=\"3190\"\u003eMaintenance Phase:\u003c\/strong\u003e 5 mg twice daily thereafter.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3222\" data-end=\"3389\"\u003e\n\u003cstrong data-start=\"3224\" data-end=\"3243\"\u003eAdministration:\u003c\/strong\u003e\r\n\u003cul data-start=\"3248\" data-end=\"3389\"\u003e\r\n\u003cli data-start=\"3248\" data-end=\"3389\"\u003eXeljanz is taken orally, with or without food. Consistent daily dosing at the same time is recommended to maintain therapeutic drug levels.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"3391\" data-end=\"3497\"\u003e\u003cem data-start=\"3391\" data-end=\"3497\"\u003eReference: U.S. FDA Xeljanz Prescribing Information; ClinicalTrials.gov (e.g., NCT01039688, NCT01463232)\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"3499\" data-end=\"3502\"\u003e\r\n\u003ch3 data-start=\"3504\" data-end=\"3564\"\u003eWhat prescribing information is important for Xeljanz?\u003c\/h3\u003e\r\n\u003cul data-start=\"3565\" data-end=\"4293\"\u003e\r\n\u003cli data-start=\"3565\" data-end=\"3754\"\u003e\n\u003cstrong data-start=\"3567\" data-end=\"3583\"\u003eIndications:\u003c\/strong\u003e\r\n\u003cul data-start=\"3588\" data-end=\"3754\"\u003e\r\n\u003cli data-start=\"3588\" data-end=\"3754\"\u003eXeljanz is indicated for adult patients with RA, PsA, or UC who have shown inadequate response or intolerance to conventional therapies (e.g., methotrexate for RA).\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3755\" data-end=\"3931\"\u003e\n\u003cstrong data-start=\"3757\" data-end=\"3779\"\u003eContraindications:\u003c\/strong\u003e\r\n\u003cul data-start=\"3784\" data-end=\"3931\"\u003e\r\n\u003cli data-start=\"3784\" data-end=\"3931\"\u003eIt is contraindicated in patients with severe infections, active tuberculosis, or known hypersensitivity to tofacitinib or any of its components.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3932\" data-end=\"4085\"\u003e\n\u003cstrong data-start=\"3934\" data-end=\"3949\"\u003eMonitoring:\u003c\/strong\u003e\r\n\u003cul data-start=\"3954\" data-end=\"4085\"\u003e\r\n\u003cli data-start=\"3954\" data-end=\"4085\"\u003eRegular monitoring of complete blood counts, liver enzymes, lipid profiles, and assessment for signs of infection is recommended.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"4086\" data-end=\"4293\"\u003e\n\u003cstrong data-start=\"4088\" data-end=\"4115\"\u003eSpecial Considerations:\u003c\/strong\u003e\r\n\u003cul data-start=\"4120\" data-end=\"4293\"\u003e\r\n\u003cli data-start=\"4120\" data-end=\"4203\"\u003ePatients should be evaluated for latent tuberculosis before starting treatment.\u003c\/li\u003e\r\n\u003cli data-start=\"4206\" data-end=\"4293\"\u003eUse with caution in patients with a history of cardiovascular disease and malignancy.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"4295\" data-end=\"4404\"\u003e\u003cem data-start=\"4295\" data-end=\"4404\"\u003eReference: U.S. FDA; National Institutes of Health (NIH); American College of Rheumatology (ACR) guidelines\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"4406\" data-end=\"4409\"\u003e\r\n\u003ch3 data-start=\"4411\" data-end=\"4507\"\u003eWhat safety information, side effects, warnings, and cautions are associated with Xeljanz?\u003c\/h3\u003e\r\n\u003cul data-start=\"4508\" data-end=\"5534\"\u003e\r\n\u003cli data-start=\"4508\" data-end=\"4617\"\u003e\n\u003cstrong data-start=\"4510\" data-end=\"4534\"\u003eCommon Side Effects:\u003c\/strong\u003e\r\n\u003cul data-start=\"4539\" data-end=\"4617\"\u003e\r\n\u003cli data-start=\"4539\" data-end=\"4617\"\u003eUpper respiratory tract infections, headache, diarrhea, and nasopharyngitis.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"4618\" data-end=\"4753\"\u003e\n\u003cstrong data-start=\"4620\" data-end=\"4645\"\u003eSerious Side Effects:\u003c\/strong\u003e\r\n\u003cul data-start=\"4650\" data-end=\"4753\"\u003e\r\n\u003cli data-start=\"4650\" data-end=\"4753\"\u003eIncreased risk of serious infections (including tuberculosis), blood clots, and certain malignancies.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"4754\" data-end=\"5374\"\u003e\n\u003cstrong data-start=\"4756\" data-end=\"4780\"\u003eWarnings \u0026amp; Cautions:\u003c\/strong\u003e\r\n\u003cul data-start=\"4785\" data-end=\"5374\"\u003e\r\n\u003cli data-start=\"4785\" data-end=\"4925\"\u003e\n\u003cstrong data-start=\"4787\" data-end=\"4802\"\u003eInfections:\u003c\/strong\u003e There is an increased risk of opportunistic infections; patients should be screened for latent TB and monitored closely.\u003c\/li\u003e\r\n\u003cli data-start=\"4928\" data-end=\"5028\"\u003e\n\u003cstrong data-start=\"4930\" data-end=\"4956\"\u003eThromboembolic Events:\u003c\/strong\u003e Use caution in patients with risk factors for venous thromboembolism.\u003c\/li\u003e\r\n\u003cli data-start=\"5031\" data-end=\"5153\"\u003e\n\u003cstrong data-start=\"5033\" data-end=\"5048\"\u003eMalignancy:\u003c\/strong\u003e Long-term immunosuppression may increase the risk of cancers, particularly lymphomas and skin cancers.\u003c\/li\u003e\r\n\u003cli data-start=\"5156\" data-end=\"5256\"\u003e\n\u003cstrong data-start=\"5158\" data-end=\"5182\"\u003eCardiovascular Risk:\u003c\/strong\u003e Caution is advised in patients with a history of cardiovascular events.\u003c\/li\u003e\r\n\u003cli data-start=\"5259\" data-end=\"5374\"\u003e\n\u003cstrong data-start=\"5261\" data-end=\"5279\"\u003eLipid Changes:\u003c\/strong\u003e Xeljanz may cause an increase in cholesterol levels; periodic lipid monitoring is recommended.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"5375\" data-end=\"5534\"\u003e\n\u003cstrong data-start=\"5377\" data-end=\"5405\"\u003ePregnancy and Lactation:\u003c\/strong\u003e\r\n\u003cul data-start=\"5410\" data-end=\"5534\"\u003e\r\n\u003cli data-start=\"5410\" data-end=\"5534\"\u003eXeljanz is not recommended during pregnancy or breastfeeding due to potential teratogenic effects and limited safety data.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"5536\" data-end=\"5613\"\u003e\u003cem data-start=\"5536\" data-end=\"5613\"\u003eReference: U.S. FDA Xeljanz Prescribing Information; PubMed; ACR Guidelines\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"5615\" data-end=\"5618\"\u003e\r\n\u003ch3 data-start=\"5620\" data-end=\"5683\"\u003eWhat drug interactions should be considered with Xeljanz?\u003c\/h3\u003e\r\n\u003cul data-start=\"5684\" data-end=\"6307\"\u003e\r\n\u003cli data-start=\"5684\" data-end=\"5829\"\u003e\n\u003cstrong data-start=\"5686\" data-end=\"5709\"\u003eImmunosuppressants:\u003c\/strong\u003e\r\n\u003cul data-start=\"5714\" data-end=\"5829\"\u003e\r\n\u003cli data-start=\"5714\" data-end=\"5829\"\u003eConcomitant use with other potent immunosuppressive agents (e.g., biologics) may increase the risk of infections.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"5830\" data-end=\"5998\"\u003e\n\u003cstrong data-start=\"5832\" data-end=\"5854\"\u003eCYP3A4 Inhibitors:\u003c\/strong\u003e\r\n\u003cul data-start=\"5859\" data-end=\"5998\"\u003e\r\n\u003cli data-start=\"5859\" data-end=\"5998\"\u003eDrugs such as ketoconazole or clarithromycin may increase the plasma concentration of tofacitinib, potentially enhancing adverse effects.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"5999\" data-end=\"6122\"\u003e\n\u003cstrong data-start=\"6001\" data-end=\"6014\"\u003eVaccines:\u003c\/strong\u003e\r\n\u003cul data-start=\"6019\" data-end=\"6122\"\u003e\r\n\u003cli data-start=\"6019\" data-end=\"6122\"\u003eLive vaccines should generally be avoided during treatment with Xeljanz due to the risk of infection.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"6123\" data-end=\"6307\"\u003e\n\u003cstrong data-start=\"6125\" data-end=\"6147\"\u003eOther Medications:\u003c\/strong\u003e\r\n\u003cul data-start=\"6152\" data-end=\"6307\"\u003e\r\n\u003cli data-start=\"6152\" data-end=\"6307\"\u003eAlways inform your healthcare provider of all concomitant medications (including over-the-counter drugs and supplements) to avoid potential interactions.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"6309\" data-end=\"6371\"\u003e\u003cem data-start=\"6309\" data-end=\"6371\"\u003eReference: U.S. FDA; Clinical Pharmacology Reviews on PubMed\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"6373\" data-end=\"6376\"\u003e\r\n\u003ch3 data-start=\"6378\" data-end=\"6417\"\u003eFrequently Asked Questions (FAQs)\u003c\/h3\u003e\r\n\u003cp data-start=\"6419\" data-end=\"6592\"\u003e\u003cstrong data-start=\"6419\" data-end=\"6465\"\u003eQ: How quickly does Xeljanz begin to work?\u003c\/strong\u003e\u003cbr data-start=\"6465\" data-end=\"6468\"\u003eA: Some patients may notice improvement in symptoms within 2–4 weeks, although maximum benefits may take longer to manifest.\u003c\/p\u003e\r\n\u003cp data-start=\"6594\" data-end=\"6959\"\u003e\u003cstrong data-start=\"6594\" data-end=\"6638\"\u003eQ: Can Xeljanz be used as a monotherapy?\u003c\/strong\u003e\u003cbr data-start=\"6638\" data-end=\"6641\"\u003eA: For rheumatoid arthritis and psoriatic arthritis, Xeljanz is often used in patients with an inadequate response to conventional therapy, but it can be used as monotherapy or in combination with methotrexate. For ulcerative colitis, it is used in patients who have not responded adequately to conventional treatment.\u003c\/p\u003e\r\n\u003cp data-start=\"6961\" data-end=\"7223\"\u003e\u003cstrong data-start=\"6961\" data-end=\"7020\"\u003eQ: What precautions should I take regarding infections?\u003c\/strong\u003e\u003cbr data-start=\"7020\" data-end=\"7023\"\u003eA: Patients should be screened for latent tuberculosis before starting Xeljanz and monitored for signs of infection during treatment. Contact your doctor immediately if you develop signs of infection.\u003c\/p\u003e\r\n\u003cp data-start=\"7225\" data-end=\"7417\"\u003e\u003cstrong data-start=\"7225\" data-end=\"7265\"\u003eQ: Is Xeljanz safe during pregnancy?\u003c\/strong\u003e\u003cbr data-start=\"7265\" data-end=\"7268\"\u003eA: Xeljanz is not recommended during pregnancy or breastfeeding. Women of childbearing potential should use effective contraception during treatment.\u003c\/p\u003e\r\n\u003cp data-start=\"7419\" data-end=\"7598\"\u003e\u003cstrong data-start=\"7419\" data-end=\"7459\"\u003eQ: How should I manage missed doses?\u003c\/strong\u003e\u003cbr data-start=\"7459\" data-end=\"7462\"\u003eA: If you miss a dose, take it as soon as you remember. If it is near the time of your next dose, skip the missed dose—do not double up.\u003c\/p\u003e\r\n\u003cp data-start=\"7600\" data-end=\"7689\"\u003e\u003cem data-start=\"7600\" data-end=\"7689\"\u003eReference: U.S. FDA Xeljanz Prescribing Information; ACR Guidelines; ClinicalTrials.gov\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"7691\" data-end=\"7694\"\u003e\r\n\u003ch3 data-start=\"7696\" data-end=\"7787\"\u003eWhere can I find additional clinical evidence and detailed information about Xeljanz?\u003c\/h3\u003e\r\n\u003cp data-start=\"7788\" data-end=\"7870\"\u003eFor more comprehensive data on Xeljanz’s efficacy, safety, and dosing, refer to:\u003c\/p\u003e\r\n\u003cul data-start=\"7871\" data-end=\"8218\"\u003e\r\n\u003cli data-start=\"7871\" data-end=\"7959\"\u003e\n\u003cstrong data-start=\"7873\" data-end=\"7925\"\u003eU.S. Food and Drug Administration (FDA) Website:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.fda.gov\/\" target=\"_new\" rel=\"noopener\" data-start=\"7926\" data-end=\"7957\"\u003eFDA.gov\u003c\/a\u003e\n\u003c\/li\u003e\r\n\u003cli data-start=\"7960\" data-end=\"8055\"\u003e\n\u003cstrong data-start=\"7962\" data-end=\"7985\"\u003eClinicalTrials.gov:\u003c\/strong\u003e (e.g., NCT01039688 for RA, NCT01375647 for PsA, NCT01463232 for UC)\u003c\/li\u003e\r\n\u003cli data-start=\"8056\" data-end=\"8122\"\u003e\n\u003cstrong data-start=\"8058\" data-end=\"8069\"\u003ePubMed:\u003c\/strong\u003e For peer‑reviewed research articles on tofacitinib\u003c\/li\u003e\r\n\u003cli data-start=\"8123\" data-end=\"8218\"\u003e\u003cstrong data-start=\"8125\" data-end=\"8218\"\u003eAmerican College of Rheumatology (ACR) and National Institutes of Health (NIH) Guidelines\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"8220\" data-end=\"8274\"\u003e\u003cem data-start=\"8220\" data-end=\"8274\"\u003eReference: U.S. FDA; ClinicalTrials.gov; PubMed; ACR\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"8276\" data-end=\"8279\"\u003e\r\n\u003ch3 data-start=\"8281\" data-end=\"8301\"\u003eFinal Thoughts\u003c\/h3\u003e\r\n\u003cp data-start=\"8302\" data-end=\"8934\"\u003e\u003cstrong data-start=\"8302\" data-end=\"8327\"\u003eXeljanz (tofacitinib)\u003c\/strong\u003e is a powerful oral JAK inhibitor that offers effective symptom relief and disease modification for patients with rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. By blocking key pathways in the immune response, Xeljanz reduces inflammation and improves clinical outcomes. However, its use is associated with an increased risk of infections, thromboembolic events, and potential malignancies, necessitating careful patient selection, thorough monitoring, and management of drug interactions. Always consult your healthcare provider to ensure Xeljanz is appropriate for your treatment plan.\u003c\/p\u003e\r\n\u003cp data-start=\"8936\" data-end=\"9154\"\u003e\u003cem data-start=\"8936\" data-end=\"9154\"\u003eDisclaimer: This guide is intended for educational purposes only and should not replace professional medical advice. Always consult with your healthcare provider before initiating or modifying any medication regimen.\u003c\/em\u003e\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"5mg","offer_id":51735708598555,"sku":"Generic Xeljanz (Tofacitinib) 5mg x 30 tablets-5mg","price":78.0,"currency_code":"USD","in_stock":true}]},{"product_id":"xeljanz-xr","title":"Xeljanz XR","description":"\u003ch3 data-start=\"268\" data-end=\"293\"\u003eWhat is Xeljanz XR?\u003c\/h3\u003e\r\n\u003cp data-start=\"294\" data-end=\"636\"\u003e\u003cstrong data-start=\"294\" data-end=\"308\"\u003eXeljanz XR\u003c\/strong\u003e is an extended‑release formulation of tofacitinib, an oral Janus kinase (JAK) inhibitor used for the treatment of moderately to severely active rheumatoid arthritis (RA). The XR formulation provides once‑daily dosing, offering improved convenience and potentially enhanced adherence compared with the immediate‑release version.\u003c\/p\u003e\r\n\u003cp data-start=\"638\" data-end=\"765\"\u003e\u003cem data-start=\"638\" data-end=\"765\"\u003eReference: U.S. Food and Drug Administration (FDA) Xeljanz XR Prescribing Information; ClinicalTrials.gov (e.g., NCT01039688)\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"767\" data-end=\"770\"\u003e\r\n\u003ch3 data-start=\"772\" data-end=\"826\"\u003eWhat are the other popular names for Xeljanz XR?\u003c\/h3\u003e\r\n\u003cp data-start=\"827\" data-end=\"1104\"\u003eXeljanz XR is marketed under the brand name \u003cstrong data-start=\"871\" data-end=\"885\"\u003eXeljanz XR\u003c\/strong\u003e. It is also known by its generic name, \u003cstrong data-start=\"925\" data-end=\"957\"\u003etofacitinib extended‑release\u003c\/strong\u003e. In some clinical discussions, the immediate‑release version is simply called \u003cstrong data-start=\"1036\" data-end=\"1047\"\u003eXeljanz\u003c\/strong\u003e, while the extended‑release form is distinguished as XR.\u003c\/p\u003e\r\n\u003cp data-start=\"1106\" data-end=\"1140\"\u003e\u003cem data-start=\"1106\" data-end=\"1140\"\u003eReference: U.S. FDA; MedlinePlus\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1142\" data-end=\"1145\"\u003e\r\n\u003ch3 data-start=\"1147\" data-end=\"1199\"\u003eWhat is the drug classification of Xeljanz XR?\u003c\/h3\u003e\r\n\u003cp data-start=\"1200\" data-end=\"1416\"\u003eXeljanz XR is classified as an \u003cstrong data-start=\"1231\" data-end=\"1268\"\u003eoral Janus kinase (JAK) inhibitor\u003c\/strong\u003e. It belongs to the therapeutic class of immunomodulatory agents used in the management of autoimmune conditions—specifically, rheumatoid arthritis.\u003c\/p\u003e\r\n\u003cp data-start=\"1418\" data-end=\"1495\"\u003e\u003cem data-start=\"1418\" data-end=\"1495\"\u003eReference: U.S. FDA; National Institutes of Health (NIH) clinical resources\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1497\" data-end=\"1500\"\u003e\r\n\u003ch3 data-start=\"1502\" data-end=\"1549\"\u003eWhat is the mode of action of Xeljanz XR?\u003c\/h3\u003e\r\n\u003cp data-start=\"1550\" data-end=\"1950\"\u003eXeljanz XR works by inhibiting key JAK enzymes (primarily JAK1 and JAK3) that are involved in the JAK‑STAT signaling pathway. This pathway plays a crucial role in mediating the inflammatory and immune responses seen in rheumatoid arthritis. By blocking JAK activity, Xeljanz XR reduces the production of pro‑inflammatory cytokines, thereby diminishing joint inflammation, pain, and progression of RA.\u003c\/p\u003e\r\n\u003cp data-start=\"1952\" data-end=\"2027\"\u003e\u003cem data-start=\"1952\" data-end=\"2027\"\u003eReference: PubMed (e.g., O’Shea et al., 2013 on JAK inhibitors); U.S. FDA\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2029\" data-end=\"2032\"\u003e\r\n\u003ch3 data-start=\"2034\" data-end=\"2080\"\u003eWhat are the primary uses of Xeljanz XR?\u003c\/h3\u003e\r\n\u003cp data-start=\"2081\" data-end=\"2418\"\u003eXeljanz XR is indicated for the treatment of moderately to severely active rheumatoid arthritis in adults who have had an inadequate response or intolerance to one or more disease‑modifying antirheumatic drugs (DMARDs). Its once‑daily dosing is designed to help control joint pain, swelling, and functional impairment associated with RA.\u003c\/p\u003e\r\n\u003cp data-start=\"2420\" data-end=\"2527\"\u003e\u003cem data-start=\"2420\" data-end=\"2527\"\u003eReference: U.S. FDA Xeljanz XR Prescribing Information; American College of Rheumatology (ACR) guidelines\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2529\" data-end=\"2532\"\u003e\r\n\u003ch3 data-start=\"2534\" data-end=\"2605\"\u003eWhat is the recommended dosage and administration for Xeljanz XR?\u003c\/h3\u003e\r\n\u003cul data-start=\"2606\" data-end=\"3034\"\u003e\r\n\u003cli data-start=\"2606\" data-end=\"2745\"\u003e\n\u003cstrong data-start=\"2608\" data-end=\"2619\"\u003eDosage:\u003c\/strong\u003e\r\n\u003cul data-start=\"2624\" data-end=\"2745\"\u003e\r\n\u003cli data-start=\"2624\" data-end=\"2745\"\u003eThe typical recommended dose for rheumatoid arthritis is \u003cstrong data-start=\"2683\" data-end=\"2703\"\u003e11 mg once daily\u003c\/strong\u003e using the extended‑release formulation.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"2746\" data-end=\"3034\"\u003e\n\u003cstrong data-start=\"2748\" data-end=\"2767\"\u003eAdministration:\u003c\/strong\u003e\r\n\u003cul data-start=\"2772\" data-end=\"3034\"\u003e\r\n\u003cli data-start=\"2772\" data-end=\"2887\"\u003eXeljanz XR is taken orally, with or without food, at the same time each day to maintain consistent drug levels.\u003c\/li\u003e\r\n\u003cli data-start=\"2890\" data-end=\"3034\"\u003eIt should be used exactly as prescribed by a healthcare provider, and patients should not alter the dosage without consulting their physician.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"3036\" data-end=\"3132\"\u003e\u003cem data-start=\"3036\" data-end=\"3132\"\u003eReference: U.S. FDA Xeljanz XR Prescribing Information; ClinicalTrials.gov (e.g., NCT01039688)\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"3134\" data-end=\"3137\"\u003e\r\n\u003ch3 data-start=\"3139\" data-end=\"3202\"\u003eWhat prescribing information is important for Xeljanz XR?\u003c\/h3\u003e\r\n\u003cul data-start=\"3203\" data-end=\"4001\"\u003e\r\n\u003cli data-start=\"3203\" data-end=\"3380\"\u003e\n\u003cstrong data-start=\"3205\" data-end=\"3221\"\u003eIndications:\u003c\/strong\u003e\r\n\u003cul data-start=\"3226\" data-end=\"3380\"\u003e\r\n\u003cli data-start=\"3226\" data-end=\"3380\"\u003eXeljanz XR is approved for adults with moderately to severely active rheumatoid arthritis who have not responded adequately to conventional therapies.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3381\" data-end=\"3586\"\u003e\n\u003cstrong data-start=\"3383\" data-end=\"3405\"\u003eContraindications:\u003c\/strong\u003e\r\n\u003cul data-start=\"3410\" data-end=\"3586\"\u003e\r\n\u003cli data-start=\"3410\" data-end=\"3586\"\u003eIt is contraindicated in patients with active serious infections, known hypersensitivity to tofacitinib or its components, and those with certain hematologic abnormalities.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3587\" data-end=\"3815\"\u003e\n\u003cstrong data-start=\"3589\" data-end=\"3617\"\u003eMonitoring Requirements:\u003c\/strong\u003e\r\n\u003cul data-start=\"3622\" data-end=\"3815\"\u003e\r\n\u003cli data-start=\"3622\" data-end=\"3815\"\u003ePatients should be regularly monitored for signs of infection, complete blood counts, liver enzymes, and lipid profiles, as well as screened for latent tuberculosis before initiating therapy.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3816\" data-end=\"4001\"\u003e\n\u003cstrong data-start=\"3818\" data-end=\"3845\"\u003eSpecial Considerations:\u003c\/strong\u003e\r\n\u003cul data-start=\"3850\" data-end=\"4001\"\u003e\r\n\u003cli data-start=\"3850\" data-end=\"4001\"\u003eXeljanz XR is not recommended during pregnancy or breastfeeding. Women of childbearing potential should use effective contraception during treatment.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"4003\" data-end=\"4112\"\u003e\u003cem data-start=\"4003\" data-end=\"4112\"\u003eReference: U.S. FDA; National Institutes of Health (NIH); American College of Rheumatology (ACR) guidelines\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"4114\" data-end=\"4117\"\u003e\r\n\u003ch3 data-start=\"4119\" data-end=\"4218\"\u003eWhat safety information, side effects, warnings, and cautions are associated with Xeljanz XR?\u003c\/h3\u003e\r\n\u003cul data-start=\"4219\" data-end=\"5175\"\u003e\r\n\u003cli data-start=\"4219\" data-end=\"4330\"\u003e\n\u003cstrong data-start=\"4221\" data-end=\"4245\"\u003eCommon Side Effects:\u003c\/strong\u003e\r\n\u003cul data-start=\"4250\" data-end=\"4330\"\u003e\r\n\u003cli data-start=\"4250\" data-end=\"4330\"\u003eUpper respiratory tract infections, headache, diarrhea, and nasopharyngitis.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"4331\" data-end=\"4500\"\u003e\n\u003cstrong data-start=\"4333\" data-end=\"4358\"\u003eSerious Side Effects:\u003c\/strong\u003e\r\n\u003cul data-start=\"4363\" data-end=\"4500\"\u003e\r\n\u003cli data-start=\"4363\" data-end=\"4500\"\u003eIncreased risk of serious infections (including tuberculosis), blood clots, and potential increases in cholesterol and liver enzymes.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"4501\" data-end=\"5175\"\u003e\n\u003cstrong data-start=\"4503\" data-end=\"4527\"\u003eWarnings \u0026amp; Cautions:\u003c\/strong\u003e\r\n\u003cul data-start=\"4532\" data-end=\"5175\"\u003e\r\n\u003cli data-start=\"4532\" data-end=\"4683\"\u003e\n\u003cstrong data-start=\"4534\" data-end=\"4549\"\u003eInfections:\u003c\/strong\u003e There is a heightened risk of opportunistic infections; patients should be monitored closely and educated about infection symptoms.\u003c\/li\u003e\r\n\u003cli data-start=\"4686\" data-end=\"4793\"\u003e\n\u003cstrong data-start=\"4688\" data-end=\"4714\"\u003eThromboembolic Events:\u003c\/strong\u003e An increased risk of venous thromboembolism has been noted in some patients.\u003c\/li\u003e\r\n\u003cli data-start=\"4796\" data-end=\"4908\"\u003e\n\u003cstrong data-start=\"4798\" data-end=\"4818\"\u003eMalignancy Risk:\u003c\/strong\u003e Long-term immunosuppression may increase the risk of certain cancers, such as lymphoma.\u003c\/li\u003e\r\n\u003cli data-start=\"4911\" data-end=\"5031\"\u003e\n\u003cstrong data-start=\"4913\" data-end=\"4932\"\u003eLiver Function:\u003c\/strong\u003e Regular monitoring of liver enzymes is recommended, as Xeljanz XR can cause hepatic abnormalities.\u003c\/li\u003e\r\n\u003cli data-start=\"5034\" data-end=\"5172\"\u003e\n\u003cstrong data-start=\"5036\" data-end=\"5050\"\u003ePregnancy:\u003c\/strong\u003e Xeljanz XR is contraindicated during pregnancy; effective contraception is mandatory for women of childbearing potential.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"5176\" data-end=\"5305\"\u003e\u003cem data-start=\"5176\" data-end=\"5305\"\u003eReference: U.S. FDA Xeljanz XR Prescribing Information; New England Journal of Medicine (NEJM) clinical studies; ACR guidelines\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"5307\" data-end=\"5310\"\u003e\r\n\u003ch3 data-start=\"5312\" data-end=\"5378\"\u003eWhat drug interactions should be considered with Xeljanz XR?\u003c\/h3\u003e\r\n\u003cul data-start=\"5379\" data-end=\"6047\"\u003e\r\n\u003cli data-start=\"5379\" data-end=\"5566\"\u003e\n\u003cstrong data-start=\"5381\" data-end=\"5403\"\u003eCYP3A4 Inhibitors:\u003c\/strong\u003e\r\n\u003cul data-start=\"5408\" data-end=\"5566\"\u003e\r\n\u003cli data-start=\"5408\" data-end=\"5566\"\u003eConcomitant use with potent CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) may increase tofacitinib levels, potentially enhancing adverse effects.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"5567\" data-end=\"5731\"\u003e\n\u003cstrong data-start=\"5569\" data-end=\"5598\"\u003eOther Immunosuppressants:\u003c\/strong\u003e\r\n\u003cul data-start=\"5603\" data-end=\"5731\"\u003e\r\n\u003cli data-start=\"5603\" data-end=\"5731\"\u003eUse with other potent immunosuppressive agents may increase the risk of serious infections; careful monitoring is essential.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"5732\" data-end=\"5862\"\u003e\n\u003cstrong data-start=\"5734\" data-end=\"5747\"\u003eVaccines:\u003c\/strong\u003e\r\n\u003cul data-start=\"5752\" data-end=\"5862\"\u003e\r\n\u003cli data-start=\"5752\" data-end=\"5862\"\u003eLive vaccines should generally be avoided during treatment with Xeljanz XR due to immunosuppressive effects.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"5863\" data-end=\"6047\"\u003e\n\u003cstrong data-start=\"5865\" data-end=\"5887\"\u003eOther Medications:\u003c\/strong\u003e\r\n\u003cul data-start=\"5892\" data-end=\"6047\"\u003e\r\n\u003cli data-start=\"5892\" data-end=\"6047\"\u003eAlways inform your healthcare provider of all concomitant medications, including over-the-counter drugs and supplements, to avoid potential interactions.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"6049\" data-end=\"6127\"\u003e\u003cem data-start=\"6049\" data-end=\"6127\"\u003eReference: U.S. FDA; Clinical Pharmacology Reviews on PubMed; NIH guidelines\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"6129\" data-end=\"6132\"\u003e\r\n\u003ch3 data-start=\"6134\" data-end=\"6173\"\u003eFrequently Asked Questions (FAQs)\u003c\/h3\u003e\r\n\u003cp data-start=\"6175\" data-end=\"6484\"\u003e\u003cstrong data-start=\"6175\" data-end=\"6240\"\u003eQ: How does Xeljanz XR differ from immediate-release Xeljanz?\u003c\/strong\u003e\u003cbr data-start=\"6240\" data-end=\"6243\"\u003eA: Xeljanz XR provides once‑daily dosing (11 mg once daily) compared to immediate‑release Xeljanz, which is typically dosed at 5 mg twice daily. This extended‑release formulation offers improved convenience and may enhance patient adherence.\u003c\/p\u003e\r\n\u003cp data-start=\"6486\" data-end=\"6709\"\u003e\u003cstrong data-start=\"6486\" data-end=\"6553\"\u003eQ: How quickly can I expect to see improvements in my symptoms?\u003c\/strong\u003e\u003cbr data-start=\"6553\" data-end=\"6556\"\u003eA: Some patients report improvement in joint pain and swelling within 2–4 weeks; however, maximum therapeutic benefits may take longer to become evident.\u003c\/p\u003e\r\n\u003cp data-start=\"6711\" data-end=\"7000\"\u003e\u003cstrong data-start=\"6711\" data-end=\"6770\"\u003eQ: What precautions should I take regarding infections?\u003c\/strong\u003e\u003cbr data-start=\"6770\" data-end=\"6773\"\u003eA: Due to an increased risk of serious infections, patients should be screened for latent tuberculosis and monitored regularly for signs of infection. Report any symptoms such as fever, cough, or persistent malaise immediately.\u003c\/p\u003e\r\n\u003cp data-start=\"7002\" data-end=\"7226\"\u003e\u003cstrong data-start=\"7002\" data-end=\"7047\"\u003eQ: Can Xeljanz XR be used as monotherapy?\u003c\/strong\u003e\u003cbr data-start=\"7047\" data-end=\"7050\"\u003eA: Xeljanz XR may be used as monotherapy or in combination with methotrexate in patients with rheumatoid arthritis, depending on the clinical scenario and treatment guidelines.\u003c\/p\u003e\r\n\u003cp data-start=\"7228\" data-end=\"7458\"\u003e\u003cstrong data-start=\"7228\" data-end=\"7271\"\u003eQ: Is Xeljanz XR safe during pregnancy?\u003c\/strong\u003e\u003cbr data-start=\"7271\" data-end=\"7274\"\u003eA: Xeljanz XR is contraindicated during pregnancy. Women of childbearing potential should use effective contraception during treatment and for a specified period after discontinuation.\u003c\/p\u003e\r\n\u003cp data-start=\"7460\" data-end=\"7532\"\u003e\u003cem data-start=\"7460\" data-end=\"7532\"\u003eReference: U.S. FDA Xeljanz XR Prescribing Information; ACR guidelines\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"7534\" data-end=\"7537\"\u003e\r\n\u003ch3 data-start=\"7539\" data-end=\"7633\"\u003eWhere can I find additional clinical evidence and detailed information about Xeljanz XR?\u003c\/h3\u003e\r\n\u003cp data-start=\"7634\" data-end=\"7720\"\u003eFor more in-depth clinical data, dosing guidelines, and safety monitoring, refer to:\u003c\/p\u003e\r\n\u003cul data-start=\"7721\" data-end=\"8043\"\u003e\r\n\u003cli data-start=\"7721\" data-end=\"7809\"\u003e\n\u003cstrong data-start=\"7723\" data-end=\"7775\"\u003eU.S. Food and Drug Administration (FDA) Website:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.fda.gov\/\" target=\"_new\" rel=\"noopener\" data-start=\"7776\" data-end=\"7807\"\u003eFDA.gov\u003c\/a\u003e\n\u003c\/li\u003e\r\n\u003cli data-start=\"7810\" data-end=\"7872\"\u003e\n\u003cstrong data-start=\"7812\" data-end=\"7835\"\u003eClinicalTrials.gov:\u003c\/strong\u003e (e.g., NCT01039688 for RA studies)\u003c\/li\u003e\r\n\u003cli data-start=\"7873\" data-end=\"7945\"\u003e\n\u003cstrong data-start=\"7875\" data-end=\"7886\"\u003ePubMed:\u003c\/strong\u003e For peer‑reviewed articles on tofacitinib and Xeljanz XR\u003c\/li\u003e\r\n\u003cli data-start=\"7946\" data-end=\"8043\"\u003e\u003cstrong data-start=\"7948\" data-end=\"8041\"\u003eAmerican College of Rheumatology (ACR) and National Institutes of Health (NIH) guidelines\u003c\/strong\u003e\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"8045\" data-end=\"8105\"\u003e\u003cem data-start=\"8045\" data-end=\"8105\"\u003eReference: U.S. FDA; ClinicalTrials.gov; NEJM; PubMed; ACR\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"8107\" data-end=\"8110\"\u003e\r\n\u003ch3 data-start=\"8112\" data-end=\"8132\"\u003eFinal Thoughts\u003c\/h3\u003e\r\n\u003cp data-start=\"8133\" data-end=\"8759\"\u003e\u003cstrong data-start=\"8133\" data-end=\"8164\"\u003eXeljanz XR (tofacitinib XR)\u003c\/strong\u003e is an effective oral JAK inhibitor designed to manage rheumatoid arthritis by reducing inflammation through inhibition of the JAK‑STAT pathway. With its convenient once‑daily dosing, Xeljanz XR offers an attractive option for patients seeking to improve their symptoms and quality of life. However, due to the potential for serious adverse effects, including infections and thromboembolic events, careful patient selection, monitoring, and management of drug interactions are essential. Always consult your healthcare provider to ensure Xeljanz XR is the appropriate therapy for your condition.\u003c\/p\u003e\r\n\u003cp data-start=\"8761\" data-end=\"8979\"\u003e\u003cem data-start=\"8761\" data-end=\"8979\"\u003eDisclaimer: This guide is intended for educational purposes only and should not replace professional medical advice. Always consult with your healthcare provider before initiating or modifying any medication regimen.\u003c\/em\u003e\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"11mg","offer_id":51735708631323,"sku":"Generic Xeljanz XR (Tofacitinib Extended Release) 11mg-1","price":81.6,"currency_code":"USD","in_stock":true}]},{"product_id":"casodex","title":"CASODEX","description":"\n\u003ch4\u003eCASODEX (Bicalutamide) - Comprehensive Q\u0026amp;A Product Description\u003c\/h4\u003e\n\u003cp\u003eCASODEX, known by its generic name Bicalutamide, is an oral medication primarily used in the treatment of prostate cancer. It is classified as an anti-androgen, which means it works by blocking the effects of male hormones (androgens) that can promote the growth of prostate cancer cells.\u003c\/p\u003e\n\n\u003ch4\u003eHow Does CASODEX Work?\u003c\/h4\u003e\n\u003cp\u003eCASODEX inhibits the action of testosterone and other androgens by binding to androgen receptors in prostate cells. This action helps to slow or stop the growth of cancerous cells, making it an effective treatment option for patients diagnosed with advanced prostate cancer.\u003c\/p\u003e\n\n\u003ch4\u003eIndications\u003c\/h4\u003e\n\u003cp\u003eCASODEX is indicated for:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eAdvanced prostate cancer, typically in combination with other therapies.\u003c\/li\u003e\n    \u003cli\u003eAs a monotherapy in patients who are intolerant or contraindicated to other treatments.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003eDosage and Administration\u003c\/h4\u003e\n\u003cp\u003eThe usual recommended dosage of CASODEX is one 50 mg tablet taken once daily, with or without food. It is important to follow your healthcare provider’s instructions regarding dosage and duration of treatment.\u003c\/p\u003e\n\n\u003ch4\u003ePotential Side Effects\u003c\/h4\u003e\n\u003cp\u003eCommon side effects may include:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eHot flashes\u003c\/li\u003e\n    \u003cli\u003eBreast tenderness or enlargement\u003c\/li\u003e\n    \u003cli\u003eNausea\u003c\/li\u003e\n    \u003cli\u003eFatigue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSerious side effects can occur, and patients should seek immediate medical attention if they experience symptoms such as liver problems, severe allergic reactions, or signs of a heart attack.\u003c\/p\u003e\n\n\u003ch4\u003eDrug Interactions\u003c\/h4\u003e\n\u003cp\u003eCASODEX may interact with other medications. It is essential to inform your healthcare provider about all medications, supplements, and herbal products you are taking to avoid potential interactions.\u003c\/p\u003e\n\n\u003ch4\u003eContraindications\u003c\/h4\u003e\n\u003cp\u003eCASODEX should not be used in women or children. It is contraindicated in patients with a known hypersensitivity to Bicalutamide or any of its components.\u003c\/p\u003e\n\n\u003ch4\u003eConclusion\u003c\/h4\u003e\n\u003cp\u003eCASODEX (Bicalutamide) is a vital treatment option for patients with advanced prostate cancer, offering a mechanism to combat hormone-related cancer growth. Always consult with your healthcare provider for personalized medical advice and treatment plans.\u003c\/p\u003e\n","brand":"EZ Chemist","offers":[{"title":"50mg","offer_id":51735708664091,"sku":"CASODEX50mg","price":549.8,"currency_code":"USD","in_stock":true}]},{"product_id":"gleevec","title":"GLEEVEC","description":"\n\u003ch4\u003eGLEEVEC (Imatinib) Product Description\u003c\/h4\u003e\n\u003cp\u003eGLEEVEC, known generically as Imatinib, is a targeted therapy medication used primarily to treat certain types of cancer, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). It works by inhibiting specific proteins that promote cancer cell growth, effectively slowing or stopping the progression of the disease.\u003c\/p\u003e\n\n\u003ch4\u003eIndications\u003c\/h4\u003e\n\u003cp\u003eGLEEVEC is indicated for:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eChronic myeloid leukemia (CML) in the chronic phase, accelerated phase, and blast crisis.\u003c\/li\u003e\n    \u003cli\u003eGastrointestinal stromal tumors (GISTs) that are unresectable or metastatic.\u003c\/li\u003e\n    \u003cli\u003eOther conditions as determined by a healthcare provider.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003eMechanism of Action\u003c\/h4\u003e\n\u003cp\u003eImatinib specifically targets and inhibits the BCR-ABL tyrosine kinase, a protein produced by the Philadelphia chromosome abnormality found in CML. By blocking this enzyme, GLEEVEC disrupts the signaling pathways that promote cancer cell proliferation and survival.\u003c\/p\u003e\n\n\u003ch4\u003eDosage and Administration\u003c\/h4\u003e\n\u003cp\u003eGLEEVEC is typically administered orally, with the dosage determined based on the type of cancer being treated. It is important to follow the prescribed dosage and schedule provided by your healthcare provider.\u003c\/p\u003e\n\n\u003ch4\u003ePossible Side Effects\u003c\/h4\u003e\n\u003cp\u003eCommon side effects may include:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eNausea and vomiting\u003c\/li\u003e\n    \u003cli\u003eDiarrhea\u003c\/li\u003e\n    \u003cli\u003eFatigue\u003c\/li\u003e\n    \u003cli\u003eSwelling or fluid retention\u003c\/li\u003e\n    \u003cli\u003eSkin rashes\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSerious side effects can occur and should be reported to a healthcare provider immediately.\u003c\/p\u003e\n\n\u003ch4\u003ePrecautions\u003c\/h4\u003e\n\u003cp\u003eBefore starting GLEEVEC, inform your healthcare provider about any existing medical conditions, allergies, or medications you are currently taking. Regular monitoring and follow-up are essential during treatment to assess effectiveness and manage side effects.\u003c\/p\u003e\n\n\u003ch4\u003eConclusion\u003c\/h4\u003e\n\u003cp\u003eGLEEVEC (Imatinib) is a vital medication in the management of specific cancers. Its targeted action helps improve patient outcomes and quality of life. Always consult with a healthcare professional for personalized medical advice and treatment plans.\u003c\/p\u003e\n","brand":"EZ Chemist","offers":[{"title":"400mg","offer_id":51735708696859,"sku":"GLEEVEC400mg","price":749.51,"currency_code":"USD","in_stock":true}]},{"product_id":"mexate","title":"MEXATE","description":"\n\u003ch4\u003eProduct Description for MEXATE (Methotrexate)\u003c\/h4\u003e\n\u003cp\u003eMEXATE, also known as Methotrexate, is a medication primarily used to treat certain types of cancer, autoimmune diseases, and ectopic pregnancies. It works by inhibiting the growth of rapidly dividing cells, making it effective in managing conditions such as rheumatoid arthritis and psoriasis.\u003c\/p\u003e\n\n\u003ch4\u003eHow MEXATE Works\u003c\/h4\u003e\n\u003cp\u003eMethotrexate interferes with the metabolism of folate, which is essential for DNA synthesis and cell replication. By blocking this process, MEXATE helps to slow down the proliferation of cancer cells and modulate the immune response in autoimmune disorders.\u003c\/p\u003e\n\n\u003ch4\u003eIndications\u003c\/h4\u003e\n\u003cul\u003e\n    \u003cli\u003eCertain types of cancer (e.g., leukemia, lymphoma)\u003c\/li\u003e\n    \u003cli\u003eRheumatoid arthritis\u003c\/li\u003e\n    \u003cli\u003ePsoriasis\u003c\/li\u003e\n    \u003cli\u003eEctopic pregnancy\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch4\u003eDosage and Administration\u003c\/h4\u003e\n\u003cp\u003eThe dosage of MEXATE varies depending on the condition being treated. It is typically administered orally or via injection. Patients should follow their healthcare provider's instructions regarding dosage and frequency to ensure optimal results and minimize side effects.\u003c\/p\u003e\n\n\u003ch4\u003ePossible Side Effects\u003c\/h4\u003e\n\u003cp\u003eCommon side effects of MEXATE may include nausea, vomiting, fatigue, and mouth sores. More serious side effects can occur, such as liver damage and decreased bone marrow function. Regular monitoring by a healthcare provider is essential during treatment.\u003c\/p\u003e\n\n\u003ch4\u003ePrecautions\u003c\/h4\u003e\n\u003cp\u003eBefore starting MEXATE, patients should inform their healthcare provider of any pre-existing conditions, allergies, or medications they are taking. MEXATE is not recommended for pregnant or breastfeeding women due to potential risks to the fetus or infant.\u003c\/p\u003e\n\n\u003ch4\u003eConclusion\u003c\/h4\u003e\n\u003cp\u003eMEXATE (Methotrexate) is a versatile medication with significant therapeutic benefits for various conditions. Patients should work closely with their healthcare providers to manage their treatment effectively and monitor for any adverse reactions.\u003c\/p\u003e\n","brand":"EZ Chemist","offers":[{"title":"25mg","offer_id":51735708729627,"sku":"MEXATE25mg","price":51.66,"currency_code":"USD","in_stock":true},{"title":"7.5mg","offer_id":51735708762395,"sku":"MEXATE7.5mg","price":71.88,"currency_code":"USD","in_stock":true}]},{"product_id":"inlyta","title":"INLYTA","description":"\u003ch4\u003eWhat is INLYTA ?\u003c\/h4\u003e\u003cp\u003eINLYTA  is a other supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"1mg","offer_id":51735708795163,"sku":"INLYTA1mg","price":0.0,"currency_code":"USD","in_stock":true},{"title":"5mg","offer_id":51735708827931,"sku":"INLYTA5mg","price":0.0,"currency_code":"USD","in_stock":true}]},{"product_id":"femera","title":"FEMERA","description":"","brand":"EZ Chemist","offers":[{"title":"2.5mg","offer_id":51735708860699,"sku":"FEMERA2.5mg","price":29.52,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0992\/3303\/8619\/files\/untitled_design_86.png?v=1770407525"},{"product_id":"giotrif","title":"Giotrif","description":"\u003ch4\u003eWhat is Giotrif ?\u003c\/h4\u003e\u003cp\u003eGiotrif  is a other supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"30mg","offer_id":51735708893467,"sku":"Giotrif30mg","price":688.36,"currency_code":"USD","in_stock":true},{"title":"40mg","offer_id":51735708926235,"sku":"Giotrif40mg","price":717.02,"currency_code":"USD","in_stock":true},{"title":"50mg","offer_id":51735708959003,"sku":"Giotrif50mg","price":803.08,"currency_code":"USD","in_stock":true}]},{"product_id":"afinitor","title":"Afinitor","description":"\u003cp\u003e\u003cstrong\u003eMedicine Description:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEverolimus is a medication used to treat certain types of cancer, as well as certain non-cancerous conditions. It belongs to a class of drugs called mTOR inhibitors, which work by slowing or stopping the growth of cancer cells and abnormal blood vessels.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eUnique Benefits over Other Similar Products:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEverolimus offers unique benefits compared to other similar products due to its targeted mechanism of action. It specifically inhibits the mTOR pathway, which plays a key role in the growth and spread of cancer cells. This targeted approach may result in fewer side effects compared to traditional chemotherapy drugs while still effectively controlling tumor growth.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDosage:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe dosage of Everolimus can vary depending on the specific condition being treated, the patient's medical history, and other factors. It is usually taken orally once daily, either with or without food. Your doctor will determine the appropriate dose for you based on your individual needs.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDirections\/Instructions for Use:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSwallow the Everolimus tablet whole with a glass of water. Do not crush, chew, or break the tablet. Take Everolimus at the same time each day to maintain a consistent level of the medication in your body. Follow your doctor's instructions carefully and do not adjust your dose without consulting them first.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eUse During Pregnancy:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEverolimus can cause harm to an unborn baby and is not recommended for use during pregnancy. If you are pregnant or planning to become pregnant, inform your doctor immediately. Effective contraception should be used during treatment with Everolimus and for a period of time after discontinuing the medication.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFood \u0026amp; Drug Interactions:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCertain foods and medications may interact with Everolimus, potentially affecting its effectiveness or increasing the risk of side effects. It is important to inform your doctor about all medications, supplements, and herbal products you are taking before starting Everolimus. Additionally, avoid consuming grapefruit or grapefruit juice while taking Everolimus, as it may increase the levels of the medication in your body. Your doctor will provide guidance on any specific food or drug interactions to be aware of.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMost Frequently Asked Questions:\u003c\/strong\u003e\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHow does Everolimus work?\u003c\/strong\u003e Everolimus works by inhibiting the mTOR pathway, which is involved in the growth and spread of cancer cells. By blocking this pathway, Everolimus helps slow or stop the growth of tumors.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eWhat conditions can Everolimus treat?\u003c\/strong\u003e Everolimus is used to treat certain types of cancer, including breast cancer, kidney cancer, pancreatic neuroendocrine tumors, and certain types of advanced or metastatic cancers. It is also used to treat non-cancerous conditions such as tuberous sclerosis complex (TSC) and subependymal giant cell astrocytoma (SEGA).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eWhat are the common side effects of Everolimus?\u003c\/strong\u003e Common side effects of Everolimus may include mouth sores, diarrhea, nausea, fatigue, rash, and decreased appetite. It is important to report any side effects to your doctor, as they can provide guidance on managing them effectively.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHow should Everolimus be stored?\u003c\/strong\u003e Everolimus should be stored at room temperature away from moisture and heat. Keep the medication in its original packaging and out of reach of children and pets.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eWhat should I do if I miss a dose of Everolimus?\u003c\/strong\u003e If you miss a dose of Everolimus, take it as soon as you remember, unless it is almost time for your next dose. In that case, skip the missed dose and take your next dose at the regular time. Do not take a double dose to make up for a missed one. If you are unsure what to do, consult your doctor or pharmacist.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eCan I drink alcohol while taking Everolimus?\u003c\/strong\u003e It is generally recommended to avoid alcohol while taking Everolimus, as it may increase the risk of certain side effects such as liver toxicity. However, it is important to consult your doctor for personalized advice based on your individual medical history and condition.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e","brand":"EZ Chemist","offers":[{"title":"10mg","offer_id":51735708991771,"sku":"Afinitor10mg","price":708.0,"currency_code":"USD","in_stock":true}]},{"product_id":"zytiga","title":"Zytiga","description":"\u003ch3\u003e\u003cspan style=\"font-size: 20px;\"\u003eDrug Description for Abiraterone Acetate\u003c\/span\u003e\u003c\/h3\u003e\n\u003ch4\u003e\u003cspan style=\"font-size: 20px;\"\u003eProduct Name:\u003c\/span\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eAbiraterone Acetate\u003c\/span\u003e\u003c\/p\u003e\n\u003ch4\u003e\u003cspan style=\"font-size: 20px;\"\u003eActive Ingredient:\u003c\/span\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eAbiraterone Acetate\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003e\u003cspan style=\"font-size: 20px;\"\u003eOther Names:\u003c\/span\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eZytiga (brand name)\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eYonsa (brand name)\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003e\u003cspan style=\"font-size: 20px;\"\u003eMode of Action:\u003c\/span\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eAbiraterone Acetate works by inhibiting the enzyme CYP17, which is involved in the production of androgens (male hormones). Androgens can stimulate the growth of prostate cancer cells. By reducing androgen levels, Abiraterone Acetate helps slow the progression of prostate cancer.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch4\u003e\u003cspan style=\"font-size: 20px;\"\u003eHow to Use:\u003c\/span\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eTake Abiraterone Acetate exactly as prescribed by your healthcare provider.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eIt should be taken on an empty stomach, at least one hour before or two hours after a meal.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eSwallow the tablets whole with water; do not crush, chew, or split the tablets.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eTypically taken once daily in combination with prednisone to manage side effects.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003e\u003cspan style=\"font-size: 20px;\"\u003eRecommended Dosage:\u003c\/span\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003e\u003cstrong\u003eStandard Dosage:\u003c\/strong\u003e 1,000 mg (four 250 mg tablets) taken orally once daily.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003e\u003cstrong\u003eWith Prednisone:\u003c\/strong\u003e Typically, 5 mg of prednisone taken twice daily.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003e\u003cspan style=\"font-size: 20px;\"\u003eDirections:\u003c\/span\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eTake the medication at the same time each day to maintain consistent blood levels.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eAdhere strictly to the prescribed dosing schedule and do not skip doses.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eContinue taking Abiraterone Acetate even if you feel well, as it is part of your ongoing cancer treatment.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003e\u003cspan style=\"font-size: 20px;\"\u003eCautions:\u003c\/span\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eInform your healthcare provider of any allergies or medical conditions, especially heart problems, liver issues, or a history of adrenal or pituitary disorders.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eAbiraterone Acetate can cause high blood pressure, low potassium levels, and fluid retention; regular monitoring by your healthcare provider is essential.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003ePregnant women should avoid handling Abiraterone Acetate tablets due to potential risks to an unborn baby.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003e\u003cspan style=\"font-size: 20px;\"\u003eGuidelines:\u003c\/span\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eRegular blood tests are necessary to monitor liver function and potassium levels.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eMaintain good hydration and follow a balanced diet to support overall health during treatment.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eStore Abiraterone Acetate at room temperature, away from moisture and heat. Keep it out of reach of children.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eReport any severe or persistent side effects to your healthcare provider immediately.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003e\u003cspan style=\"font-size: 20px;\"\u003eFAQs:\u003c\/span\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003e\u003cstrong\u003eQ: What should I do if I miss a dose of Abiraterone Acetate?\u003c\/strong\u003e \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eA: If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed dose.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003e\u003cstrong\u003eQ: Can Abiraterone Acetate cure prostate cancer?\u003c\/strong\u003e \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eA: Abiraterone Acetate is not a cure for prostate cancer but helps manage the disease by reducing androgen levels, which slows cancer progression.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003e\u003cstrong\u003eQ: What are the common side effects of Abiraterone Acetate?\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003e A: Common side effects include high blood pressure, low potassium levels, fluid retention, and liver function changes. Contact your healthcare provider if these effects persist or worsen.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003e\u003cstrong\u003eQ: Can I take other medications while using Abiraterone Acetate?\u003c\/strong\u003e \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eA: Some medications can interact with Abiraterone Acetate, potentially decreasing its effectiveness or increasing side effects. Always inform your healthcare provider about all the medications and supplements you are taking.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003e\u003cstrong\u003eQ: Is Abiraterone Acetate safe during pregnancy?\u003c\/strong\u003e \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eA: Abiraterone Acetate should not be used during pregnancy. Pregnant women should avoid handling the tablets due to potential risks to an unborn baby.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003e\u003cstrong\u003eQ: How should I store Abiraterone Acetate?\u003c\/strong\u003e \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eA: Store at room temperature, away from moisture and heat. Keep it out of reach of children.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003e\u003cstrong\u003eQ: Can I drive while taking Abiraterone Acetate?\u003c\/strong\u003e \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eA: Abiraterone Acetate is not known to affect your ability to drive. However, if you experience side effects such as dizziness, use caution when driving or operating machinery.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003e\u003cstrong\u003eQ: How long do I need to take Abiraterone Acetate?\u003c\/strong\u003e \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eA: The duration of treatment depends on your specific condition and response to the medication. Follow your healthcare provider’s instructions regarding the length of treatment.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003e\u003cstrong\u003eQ: What if I experience severe side effects while taking Abiraterone Acetate?\u003c\/strong\u003e \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eA: If you experience severe side effects such as symptoms of high blood pressure, significant changes in liver function, or low potassium levels, seek medical attention immediately.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 20px;\"\u003eBy following these guidelines and using Abiraterone Acetate as prescribed, you can effectively manage your prostate cancer treatment and maintain your health. Always consult your healthcare provider for personalized advice and information.\u003c\/span\u003e\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"500mg","offer_id":51735709024539,"sku":"Zytiga500mg","price":816.0,"currency_code":"USD","in_stock":true},{"title":"250mg","offer_id":51735709057307,"sku":"ZYTIGA250mg","price":804.0,"currency_code":"USD","in_stock":true}]},{"product_id":"valdoxan","title":"VALDOXAN","description":"\u003ch4\u003eWhat is  VALDOXAN ?\u003c\/h4\u003e\u003cp\u003e VALDOXAN  is a other supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"25mg","offer_id":51735709090075,"sku":"VALDOXAN25mg","price":98.59,"currency_code":"USD","in_stock":true}]},{"product_id":"arimidex","title":"ARIMIDEX","description":"\u003ch4\u003eWhat is  ARIMIDEX ?\u003c\/h4\u003e\u003cp\u003e ARIMIDEX  is a other supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"1mg","offer_id":51735709122843,"sku":"ARIMIDEX1mg","price":46.7,"currency_code":"USD","in_stock":true}]},{"product_id":"casodex-1","title":"CASODEX","description":"\u003ch4\u003eWhat is  CASODEX  ?\u003c\/h4\u003e\u003cp\u003e CASODEX   is a other supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"50mg","offer_id":51735709155611,"sku":"CASODEX50mg-1","price":56.74,"currency_code":"USD","in_stock":true}]},{"product_id":"cytoxan","title":"CYTOXAN","description":"\u003ch4\u003eWhat is  CYTOXAN ?\u003c\/h4\u003e\u003cp\u003e CYTOXAN  is a other supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"50mg","offer_id":51735709188379,"sku":"CYTOXAN50mg","price":20.57,"currency_code":"USD","in_stock":true}]},{"product_id":"sprycel","title":"SPRYCEL","description":"\u003ch4\u003eWhat is SPRYCEL ?\u003c\/h4\u003e\u003cp\u003eSPRYCEL  is a other supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"50mg","offer_id":51735709221147,"sku":"SPRYCEL50mg","price":4305.61,"currency_code":"USD","in_stock":true},{"title":"70mg","offer_id":51735709253915,"sku":"SPRYCEL70mg","price":7467.19,"currency_code":"USD","in_stock":true}]},{"product_id":"exjade","title":"EXJADE","description":"\u003ch4\u003eWhat is  EXJADE ?\u003c\/h4\u003e\u003cp\u003e EXJADE  is a other supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"250mg","offer_id":51735709286683,"sku":"EXJADE250mg","price":453.42,"currency_code":"USD","in_stock":true},{"title":"500mg","offer_id":51735709319451,"sku":"EXJADE500mg","price":1078.06,"currency_code":"USD","in_stock":true}]},{"product_id":"minrin","title":"MINRIN","description":"\u003ch4\u003eWhat is MINRIN ?\u003c\/h4\u003e\u003cp\u003eMINRIN  is a other supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"0.1mg","offer_id":51735709352219,"sku":"MINRIN0.1mg","price":43.46,"currency_code":"USD","in_stock":true},{"title":"0.2mg","offer_id":51735709384987,"sku":"MINRIN0.2mg","price":65.94,"currency_code":"USD","in_stock":true}]},{"product_id":"promacta-revolade","title":"PROMACTA, REVOLADE","description":"\u003ch4\u003eWhat is PROMACTA, REVOLADE ?\u003c\/h4\u003e\u003cp\u003ePROMACTA, REVOLADE  is a other supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"25mg","offer_id":51735709548827,"sku":"PROMACTA,REVOLADE25mg","price":675.0,"currency_code":"USD","in_stock":true},{"title":"50mg","offer_id":51735709581595,"sku":"PROMACTA,REVOLADE50mg","price":1125.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0992\/3303\/8619\/files\/untitled_design_36__2.png?v=1770407539"},{"product_id":"erlocip","title":"Erlocip","description":"\u003ch3 data-start=\"276\" data-end=\"300\"\u003eWhat is Erlotinib?\u003c\/h3\u003e\r\n\u003cp data-start=\"301\" data-end=\"624\"\u003e\u003cstrong data-start=\"301\" data-end=\"314\"\u003eErlotinib\u003c\/strong\u003e is an oral epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) used primarily in the treatment of non‑small cell lung cancer (NSCLC) and pancreatic cancer. By inhibiting EGFR signaling, erlotinib slows tumor growth and helps improve patient outcomes in cancers that express EGFR mutations.\u003c\/p\u003e\r\n\u003cp data-start=\"626\" data-end=\"719\"\u003e\u003cem data-start=\"626\" data-end=\"719\"\u003eReference: U.S. FDA Tarceva Prescribing Information; ClinicalTrials.gov (e.g., NCT00322452)\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"721\" data-end=\"724\"\u003e\r\n\u003ch3 data-start=\"726\" data-end=\"779\"\u003eWhat are the other popular names for Erlotinib?\u003c\/h3\u003e\r\n\u003cp data-start=\"780\" data-end=\"927\"\u003eErlotinib is most widely marketed under the brand name \u003cstrong data-start=\"835\" data-end=\"847\"\u003eTarceva®\u003c\/strong\u003e. In clinical literature, it is also referred to by its generic name, erlotinib.\u003c\/p\u003e\r\n\u003cp data-start=\"929\" data-end=\"963\"\u003e\u003cem data-start=\"929\" data-end=\"963\"\u003eReference: MedlinePlus; U.S. FDA\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"965\" data-end=\"968\"\u003e\r\n\u003ch3 data-start=\"970\" data-end=\"1021\"\u003eWhat is the drug classification of Erlotinib?\u003c\/h3\u003e\r\n\u003cp data-start=\"1022\" data-end=\"1217\"\u003eErlotinib is classified as an \u003cstrong data-start=\"1052\" data-end=\"1092\"\u003eEGFR tyrosine kinase inhibitor (TKI)\u003c\/strong\u003e. It belongs to the class of targeted anticancer agents used primarily in oncology for the treatment of EGFR‑mutated cancers.\u003c\/p\u003e\r\n\u003cp data-start=\"1219\" data-end=\"1293\"\u003e\u003cem data-start=\"1219\" data-end=\"1293\"\u003eReference: World Health Organization (WHO) Oncology Guidelines; U.S. FDA\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1295\" data-end=\"1298\"\u003e\r\n\u003ch3 data-start=\"1300\" data-end=\"1346\"\u003eWhat is the mode of action of Erlotinib?\u003c\/h3\u003e\r\n\u003cp data-start=\"1347\" data-end=\"1752\"\u003eErlotinib functions by competitively binding to the ATP-binding site of the intracellular domain of the EGFR. This binding inhibits receptor autophosphorylation and downstream signaling pathways (such as the MAPK and PI3K\/AKT pathways), which are critical for tumor cell proliferation, survival, and metastasis. This inhibition leads to reduced tumor growth and increased apoptosis in EGFR‑driven cancers.\u003c\/p\u003e\r\n\u003cp data-start=\"1754\" data-end=\"1818\"\u003e\u003cem data-start=\"1754\" data-end=\"1818\"\u003eReference: PubMed (Lynch et al., 2004, N Engl J Med); U.S. FDA\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1820\" data-end=\"1823\"\u003e\r\n\u003ch3 data-start=\"1825\" data-end=\"1870\"\u003eWhat are the primary uses of Erlotinib?\u003c\/h3\u003e\r\n\u003cp data-start=\"1871\" data-end=\"1910\"\u003eErlotinib is primarily indicated for:\u003c\/p\u003e\r\n\u003cul data-start=\"1911\" data-end=\"2177\"\u003e\r\n\u003cli data-start=\"1911\" data-end=\"2051\"\u003e\n\u003cstrong data-start=\"1913\" data-end=\"1952\"\u003eNon‑Small Cell Lung Cancer (NSCLC):\u003c\/strong\u003e Particularly in patients with advanced or metastatic NSCLC harboring EGFR-sensitizing mutations.\u003c\/li\u003e\r\n\u003cli data-start=\"2052\" data-end=\"2177\"\u003e\n\u003cstrong data-start=\"2054\" data-end=\"2076\"\u003ePancreatic Cancer:\u003c\/strong\u003e In combination with gemcitabine for locally advanced, unresectable, or metastatic pancreatic cancer.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"2179\" data-end=\"2252\"\u003e\u003cem data-start=\"2179\" data-end=\"2252\"\u003eReference: U.S. FDA Tarceva Prescribing Information; ClinicalTrials.gov\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2254\" data-end=\"2257\"\u003e\r\n\u003ch3 data-start=\"2259\" data-end=\"2329\"\u003eWhat is the recommended dosage and administration for Erlotinib?\u003c\/h3\u003e\r\n\u003cul data-start=\"2330\" data-end=\"2728\"\u003e\r\n\u003cli data-start=\"2330\" data-end=\"2406\"\u003e\n\u003cstrong data-start=\"2332\" data-end=\"2353\"\u003eDosage for NSCLC:\u003c\/strong\u003e The standard oral dosage is \u003cstrong data-start=\"2382\" data-end=\"2403\"\u003e150 mg once daily\u003c\/strong\u003e.\u003c\/li\u003e\r\n\u003cli data-start=\"2407\" data-end=\"2527\"\u003e\n\u003cstrong data-start=\"2409\" data-end=\"2442\"\u003eDosage for Pancreatic Cancer:\u003c\/strong\u003e Often used at the same dosage (150 mg once daily) in combination with gemcitabine.\u003c\/li\u003e\r\n\u003cli data-start=\"2528\" data-end=\"2728\"\u003e\n\u003cstrong data-start=\"2530\" data-end=\"2549\"\u003eAdministration:\u003c\/strong\u003e\r\n\u003cul data-start=\"2554\" data-end=\"2728\"\u003e\r\n\u003cli data-start=\"2554\" data-end=\"2667\"\u003eErlotinib should be taken on an empty stomach (1 hour before or 2 hours after a meal) to maximize absorption.\u003c\/li\u003e\r\n\u003cli data-start=\"2670\" data-end=\"2728\"\u003eConsistent daily dosing at the same time is recommended.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"2730\" data-end=\"2823\"\u003e\u003cem data-start=\"2730\" data-end=\"2823\"\u003eReference: U.S. FDA Tarceva Prescribing Information; ClinicalTrials.gov (e.g., NCT00322452)\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2825\" data-end=\"2828\"\u003e\r\n\u003ch3 data-start=\"2830\" data-end=\"2892\"\u003eWhat prescribing information is important for Erlotinib?\u003c\/h3\u003e\r\n\u003cul data-start=\"2893\" data-end=\"3509\"\u003e\r\n\u003cli data-start=\"2893\" data-end=\"3033\"\u003e\n\u003cstrong data-start=\"2895\" data-end=\"2911\"\u003eIndications:\u003c\/strong\u003e\r\n\u003cul data-start=\"2916\" data-end=\"3033\"\u003e\r\n\u003cli data-start=\"2916\" data-end=\"3033\"\u003eApproved for advanced NSCLC with EGFR mutations and for use in combination with gemcitabine in pancreatic cancer.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3034\" data-end=\"3163\"\u003e\n\u003cstrong data-start=\"3036\" data-end=\"3058\"\u003eContraindications:\u003c\/strong\u003e\r\n\u003cul data-start=\"3063\" data-end=\"3163\"\u003e\r\n\u003cli data-start=\"3063\" data-end=\"3163\"\u003eContraindicated in patients with a known hypersensitivity to erlotinib or any of its components.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3164\" data-end=\"3294\"\u003e\n\u003cstrong data-start=\"3166\" data-end=\"3181\"\u003eMonitoring:\u003c\/strong\u003e\r\n\u003cul data-start=\"3186\" data-end=\"3294\"\u003e\r\n\u003cli data-start=\"3186\" data-end=\"3294\"\u003eRegular monitoring of liver function, complete blood counts, and dermatologic assessments are necessary.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3295\" data-end=\"3509\"\u003e\n\u003cstrong data-start=\"3297\" data-end=\"3324\"\u003eSpecial Considerations:\u003c\/strong\u003e\r\n\u003cul data-start=\"3329\" data-end=\"3509\"\u003e\r\n\u003cli data-start=\"3329\" data-end=\"3435\"\u003eEGFR mutation testing is recommended prior to treatment in NSCLC to identify patients likely to benefit.\u003c\/li\u003e\r\n\u003cli data-start=\"3438\" data-end=\"3509\"\u003eDose adjustments may be required in patients with hepatic impairment.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"3511\" data-end=\"3581\"\u003e\u003cem data-start=\"3511\" data-end=\"3581\"\u003eReference: U.S. FDA Tarceva Prescribing Information; NCCN Guidelines\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"3583\" data-end=\"3586\"\u003e\r\n\u003ch3 data-start=\"3588\" data-end=\"3686\"\u003eWhat safety information, side effects, warnings, and cautions are associated with Erlotinib?\u003c\/h3\u003e\r\n\u003cul data-start=\"3687\" data-end=\"4756\"\u003e\r\n\u003cli data-start=\"3687\" data-end=\"3809\"\u003e\n\u003cstrong data-start=\"3689\" data-end=\"3713\"\u003eCommon Side Effects:\u003c\/strong\u003e\r\n\u003cul data-start=\"3718\" data-end=\"3809\"\u003e\r\n\u003cli data-start=\"3718\" data-end=\"3809\"\u003eSkin rash (often acneiform), diarrhea, nausea, vomiting, loss of appetite, and fatigue.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3810\" data-end=\"3996\"\u003e\n\u003cstrong data-start=\"3812\" data-end=\"3837\"\u003eSerious Side Effects:\u003c\/strong\u003e\r\n\u003cul data-start=\"3842\" data-end=\"3996\"\u003e\r\n\u003cli data-start=\"3842\" data-end=\"3996\"\u003eInterstitial lung disease (ILD)\/pneumonitis, which can be life‑threatening; severe skin reactions (e.g., Stevens-Johnson syndrome) and liver toxicity.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3997\" data-end=\"4587\"\u003e\n\u003cstrong data-start=\"3999\" data-end=\"4023\"\u003eWarnings \u0026amp; Cautions:\u003c\/strong\u003e\r\n\u003cul data-start=\"4028\" data-end=\"4587\"\u003e\r\n\u003cli data-start=\"4028\" data-end=\"4147\"\u003e\n\u003cstrong data-start=\"4030\" data-end=\"4053\"\u003ePulmonary Toxicity:\u003c\/strong\u003e Monitor for new or worsening respiratory symptoms; discontinue therapy if ILD is suspected.\u003c\/li\u003e\r\n\u003cli data-start=\"4150\" data-end=\"4245\"\u003e\n\u003cstrong data-start=\"4152\" data-end=\"4179\"\u003eDermatologic Reactions:\u003c\/strong\u003e Severe skin rash may require dose reduction or discontinuation.\u003c\/li\u003e\r\n\u003cli data-start=\"4248\" data-end=\"4363\"\u003e\n\u003cstrong data-start=\"4250\" data-end=\"4269\"\u003eHepatotoxicity:\u003c\/strong\u003e Regular liver function tests are essential; significant abnormalities warrant intervention.\u003c\/li\u003e\r\n\u003cli data-start=\"4366\" data-end=\"4481\"\u003e\n\u003cstrong data-start=\"4368\" data-end=\"4381\"\u003eDiarrhea:\u003c\/strong\u003e Can lead to dehydration; advise patients to maintain hydration and seek medical advice if severe.\u003c\/li\u003e\r\n\u003cli data-start=\"4484\" data-end=\"4587\"\u003e\n\u003cstrong data-start=\"4486\" data-end=\"4508\"\u003eDrug Interactions:\u003c\/strong\u003e Concomitant use with CYP3A4 inhibitors or inducers may alter erlotinib levels.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"4588\" data-end=\"4756\"\u003e\n\u003cstrong data-start=\"4590\" data-end=\"4604\"\u003ePregnancy:\u003c\/strong\u003e\r\n\u003cul data-start=\"4609\" data-end=\"4756\"\u003e\r\n\u003cli data-start=\"4609\" data-end=\"4756\"\u003eErlotinib is contraindicated in pregnancy due to potential teratogenic effects; women of childbearing potential must use effective contraception.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"4758\" data-end=\"4825\"\u003e\u003cem data-start=\"4758\" data-end=\"4825\"\u003eReference: U.S. FDA Tarceva Prescribing Information; NEJM; PubMed\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"4827\" data-end=\"4830\"\u003e\r\n\u003ch3 data-start=\"4832\" data-end=\"4897\"\u003eWhat drug interactions should be considered with Erlotinib?\u003c\/h3\u003e\r\n\u003cul data-start=\"4898\" data-end=\"5291\"\u003e\r\n\u003cli data-start=\"4898\" data-end=\"5055\"\u003e\n\u003cstrong data-start=\"4900\" data-end=\"4922\"\u003eCYP3A4 Inhibitors:\u003c\/strong\u003e\r\n\u003cul data-start=\"4927\" data-end=\"5055\"\u003e\r\n\u003cli data-start=\"4927\" data-end=\"5055\"\u003eStrong inhibitors (e.g., ketoconazole, clarithromycin) can increase erlotinib plasma levels, enhancing the risk of toxicity.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"5056\" data-end=\"5178\"\u003e\n\u003cstrong data-start=\"5058\" data-end=\"5078\"\u003eCYP3A4 Inducers:\u003c\/strong\u003e\r\n\u003cul data-start=\"5083\" data-end=\"5178\"\u003e\r\n\u003cli data-start=\"5083\" data-end=\"5178\"\u003eInducers (e.g., rifampin, carbamazepine) may lower erlotinib levels, reducing its efficacy.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"5179\" data-end=\"5291\"\u003e\n\u003cstrong data-start=\"5181\" data-end=\"5203\"\u003eOther Medications:\u003c\/strong\u003e\r\n\u003cul data-start=\"5208\" data-end=\"5291\"\u003e\r\n\u003cli data-start=\"5208\" data-end=\"5291\"\u003eCaution with drugs that may compound gastrointestinal toxicity or hepatotoxicity.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"5293\" data-end=\"5355\"\u003e\u003cem data-start=\"5293\" data-end=\"5355\"\u003eReference: U.S. FDA; Clinical Pharmacology Reviews on PubMed\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"5357\" data-end=\"5360\"\u003e\r\n\u003ch3 data-start=\"5362\" data-end=\"5399\"\u003eFrequently Asked Questions (FAQs)\u003c\/h3\u003e\r\n\u003cp data-start=\"5401\" data-end=\"5602\"\u003e\u003cstrong data-start=\"5401\" data-end=\"5451\"\u003eQ: How soon will I see results with Erlotinib?\u003c\/strong\u003e\u003cbr data-start=\"5451\" data-end=\"5454\"\u003eA: Improvement in symptoms may occur within a few weeks, though maximum benefit in tumor response might take several months of continuous treatment.\u003c\/p\u003e\r\n\u003cp data-start=\"5604\" data-end=\"5781\"\u003e\u003cstrong data-start=\"5604\" data-end=\"5644\"\u003eQ: Can Erlotinib be taken with food?\u003c\/strong\u003e\u003cbr data-start=\"5644\" data-end=\"5647\"\u003eA: For optimal absorption, it is recommended that erlotinib be taken on an empty stomach—either 1 hour before or 2 hours after a meal.\u003c\/p\u003e\r\n\u003cp data-start=\"5783\" data-end=\"6003\"\u003e\u003cstrong data-start=\"5783\" data-end=\"5839\"\u003eQ: What should I do if I develop a severe skin rash?\u003c\/strong\u003e\u003cbr data-start=\"5839\" data-end=\"5842\"\u003eA: Contact your healthcare provider immediately. Severe rash may indicate a need for dose adjustment or discontinuation due to risk of serious adverse reactions.\u003c\/p\u003e\r\n\u003cp data-start=\"6005\" data-end=\"6190\"\u003e\u003cstrong data-start=\"6005\" data-end=\"6073\"\u003eQ: Is EGFR mutation testing necessary before starting Erlotinib?\u003c\/strong\u003e\u003cbr data-start=\"6073\" data-end=\"6076\"\u003eA: Yes, EGFR mutation testing is essential to ensure that the patient is likely to benefit from erlotinib therapy.\u003c\/p\u003e\r\n\u003cp data-start=\"6192\" data-end=\"6399\"\u003e\u003cstrong data-start=\"6192\" data-end=\"6272\"\u003eQ: What precautions should I take regarding liver health while on Erlotinib?\u003c\/strong\u003e\u003cbr data-start=\"6272\" data-end=\"6275\"\u003eA: Regular liver function tests are important; report any symptoms such as jaundice, severe fatigue, or dark urine promptly.\u003c\/p\u003e\r\n\u003cp data-start=\"6401\" data-end=\"6595\"\u003e\u003cstrong data-start=\"6401\" data-end=\"6443\"\u003eQ: How should missed doses be managed?\u003c\/strong\u003e\u003cbr data-start=\"6443\" data-end=\"6446\"\u003eA: If you miss a dose, take it as soon as you remember, unless it is nearly time for your next dose. Do not double doses to make up for a missed one.\u003c\/p\u003e\r\n\u003cp data-start=\"6597\" data-end=\"6643\"\u003e\u003cem data-start=\"6597\" data-end=\"6643\"\u003eReference: U.S. FDA; NCCN Guidelines; PubMed\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"6645\" data-end=\"6648\"\u003e\r\n\u003ch3 data-start=\"6650\" data-end=\"6743\"\u003eWhere can I find additional clinical evidence and detailed information about Erlotinib?\u003c\/h3\u003e\r\n\u003cp data-start=\"6744\" data-end=\"6845\"\u003eFor further details on clinical studies, dosing guidelines, and safety monitoring, please refer to:\u003c\/p\u003e\r\n\u003cul data-start=\"6846\" data-end=\"7231\"\u003e\r\n\u003cli data-start=\"6846\" data-end=\"6934\"\u003e\n\u003cstrong data-start=\"6848\" data-end=\"6900\"\u003eU.S. Food and Drug Administration (FDA) Website:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.fda.gov\/\" target=\"_new\" rel=\"noopener\" data-start=\"6901\" data-end=\"6932\"\u003eFDA.gov\u003c\/a\u003e\n\u003c\/li\u003e\r\n\u003cli data-start=\"6935\" data-end=\"6995\"\u003e\n\u003cstrong data-start=\"6937\" data-end=\"6960\"\u003eClinicalTrials.gov:\u003c\/strong\u003e (e.g., NCT00322452, NCT00121090)\u003c\/li\u003e\r\n\u003cli data-start=\"6996\" data-end=\"7060\"\u003e\n\u003cstrong data-start=\"6998\" data-end=\"7009\"\u003ePubMed:\u003c\/strong\u003e For peer‑reviewed research articles on erlotinib\u003c\/li\u003e\r\n\u003cli data-start=\"7061\" data-end=\"7138\"\u003e\n\u003cstrong data-start=\"7063\" data-end=\"7099\"\u003eWorld Health Organization (WHO):\u003c\/strong\u003e Guidelines on lung cancer management\u003c\/li\u003e\r\n\u003cli data-start=\"7139\" data-end=\"7231\"\u003e\n\u003cstrong data-start=\"7141\" data-end=\"7201\"\u003eNational Comprehensive Cancer Network (NCCN) Guidelines:\u003c\/strong\u003e For NSCLC treatment protocols\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"7233\" data-end=\"7299\"\u003e\u003cem data-start=\"7233\" data-end=\"7299\"\u003eReference: U.S. FDA; ClinicalTrials.gov; NEJM; PubMed; NCCN; WHO\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"7301\" data-end=\"7304\"\u003e\r\n\u003ch3 data-start=\"7306\" data-end=\"7326\"\u003eFinal Thoughts\u003c\/h3\u003e\r\n\u003cp data-start=\"7327\" data-end=\"7992\"\u003e\u003cstrong data-start=\"7327\" data-end=\"7340\"\u003eErlotinib\u003c\/strong\u003e is not to be confused with Gefitinib; however, Erlotinib\u003cstrong data-start=\"7388\" data-end=\"7411\"\u003e (Tarceva®)\u003c\/strong\u003e remains a cornerstone in targeted therapy for non‑small cell lung cancer with EGFR mutations. Its mechanism of action—blocking EGFR tyrosine kinase activity—leads to inhibition of tumor growth and enhanced apoptosis in cancer cells. With careful patient selection, regular monitoring for adverse effects (particularly interstitial lung disease and hepatotoxicity), and appropriate management of drug interactions, erlotinib can significantly improve clinical outcomes. Always consult your healthcare provider to ensure that erlotinib is the appropriate therapy for your condition.\u003c\/p\u003e\r\n\u003cp data-start=\"7994\" data-end=\"8207\"\u003e\u003cem data-start=\"7994\" data-end=\"8207\"\u003eDisclaimer: This guide is intended for educational purposes only and should not replace professional medical advice. Always consult your healthcare provider before initiating or modifying any medication regimen.\u003c\/em\u003e\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"100mg","offer_id":51735709614363,"sku":"TARCEVA100mg","price":225.0,"currency_code":"USD","in_stock":true},{"title":"150MG","offer_id":51735709647131,"sku":"TARCEVA150mg","price":355.8,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0992\/3303\/8619\/files\/untitled_design_85.png?v=1770407541"},{"product_id":"tarceva","title":"Tarceva","description":"\u003ch3 data-start=\"276\" data-end=\"300\"\u003eWhat is Erlotinib?\u003c\/h3\u003e\r\n\u003cp data-start=\"301\" data-end=\"624\"\u003e\u003cstrong data-start=\"301\" data-end=\"314\"\u003eErlotinib\u003c\/strong\u003e is an oral epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) used primarily in the treatment of non‑small cell lung cancer (NSCLC) and pancreatic cancer. By inhibiting EGFR signaling, erlotinib slows tumor growth and helps improve patient outcomes in cancers that express EGFR mutations.\u003c\/p\u003e\r\n\u003cp data-start=\"626\" data-end=\"719\"\u003e\u003cem data-start=\"626\" data-end=\"719\"\u003eReference: U.S. FDA Tarceva Prescribing Information; ClinicalTrials.gov (e.g., NCT00322452)\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"721\" data-end=\"724\"\u003e\r\n\u003ch3 data-start=\"726\" data-end=\"779\"\u003eWhat are the other popular names for Erlotinib?\u003c\/h3\u003e\r\n\u003cp data-start=\"780\" data-end=\"927\"\u003eErlotinib is most widely marketed under the brand name \u003cstrong data-start=\"835\" data-end=\"847\"\u003eTarceva®\u003c\/strong\u003e. In clinical literature, it is also referred to by its generic name, erlotinib.\u003c\/p\u003e\r\n\u003cp data-start=\"929\" data-end=\"963\"\u003e\u003cem data-start=\"929\" data-end=\"963\"\u003eReference: MedlinePlus; U.S. FDA\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"965\" data-end=\"968\"\u003e\r\n\u003ch3 data-start=\"970\" data-end=\"1021\"\u003eWhat is the drug classification of Erlotinib?\u003c\/h3\u003e\r\n\u003cp data-start=\"1022\" data-end=\"1217\"\u003eErlotinib is classified as an \u003cstrong data-start=\"1052\" data-end=\"1092\"\u003eEGFR tyrosine kinase inhibitor (TKI)\u003c\/strong\u003e. It belongs to the class of targeted anticancer agents used primarily in oncology for the treatment of EGFR‑mutated cancers.\u003c\/p\u003e\r\n\u003cp data-start=\"1219\" data-end=\"1293\"\u003e\u003cem data-start=\"1219\" data-end=\"1293\"\u003eReference: World Health Organization (WHO) Oncology Guidelines; U.S. FDA\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1295\" data-end=\"1298\"\u003e\r\n\u003ch3 data-start=\"1300\" data-end=\"1346\"\u003eWhat is the mode of action of Erlotinib?\u003c\/h3\u003e\r\n\u003cp data-start=\"1347\" data-end=\"1752\"\u003eErlotinib functions by competitively binding to the ATP-binding site of the intracellular domain of the EGFR. This binding inhibits receptor autophosphorylation and downstream signaling pathways (such as the MAPK and PI3K\/AKT pathways), which are critical for tumor cell proliferation, survival, and metastasis. This inhibition leads to reduced tumor growth and increased apoptosis in EGFR‑driven cancers.\u003c\/p\u003e\r\n\u003cp data-start=\"1754\" data-end=\"1818\"\u003e\u003cem data-start=\"1754\" data-end=\"1818\"\u003eReference: PubMed (Lynch et al., 2004, N Engl J Med); U.S. FDA\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1820\" data-end=\"1823\"\u003e\r\n\u003ch3 data-start=\"1825\" data-end=\"1870\"\u003eWhat are the primary uses of Erlotinib?\u003c\/h3\u003e\r\n\u003cp data-start=\"1871\" data-end=\"1910\"\u003eErlotinib is primarily indicated for:\u003c\/p\u003e\r\n\u003cul data-start=\"1911\" data-end=\"2177\"\u003e\r\n\u003cli data-start=\"1911\" data-end=\"2051\"\u003e\n\u003cstrong data-start=\"1913\" data-end=\"1952\"\u003eNon‑Small Cell Lung Cancer (NSCLC):\u003c\/strong\u003e Particularly in patients with advanced or metastatic NSCLC harboring EGFR-sensitizing mutations.\u003c\/li\u003e\r\n\u003cli data-start=\"2052\" data-end=\"2177\"\u003e\n\u003cstrong data-start=\"2054\" data-end=\"2076\"\u003ePancreatic Cancer:\u003c\/strong\u003e In combination with gemcitabine for locally advanced, unresectable, or metastatic pancreatic cancer.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"2179\" data-end=\"2252\"\u003e\u003cem data-start=\"2179\" data-end=\"2252\"\u003eReference: U.S. FDA Tarceva Prescribing Information; ClinicalTrials.gov\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2254\" data-end=\"2257\"\u003e\r\n\u003ch3 data-start=\"2259\" data-end=\"2329\"\u003eWhat is the recommended dosage and administration for Erlotinib?\u003c\/h3\u003e\r\n\u003cul data-start=\"2330\" data-end=\"2728\"\u003e\r\n\u003cli data-start=\"2330\" data-end=\"2406\"\u003e\n\u003cstrong data-start=\"2332\" data-end=\"2353\"\u003eDosage for NSCLC:\u003c\/strong\u003e The standard oral dosage is \u003cstrong data-start=\"2382\" data-end=\"2403\"\u003e150 mg once daily\u003c\/strong\u003e.\u003c\/li\u003e\r\n\u003cli data-start=\"2407\" data-end=\"2527\"\u003e\n\u003cstrong data-start=\"2409\" data-end=\"2442\"\u003eDosage for Pancreatic Cancer:\u003c\/strong\u003e Often used at the same dosage (150 mg once daily) in combination with gemcitabine.\u003c\/li\u003e\r\n\u003cli data-start=\"2528\" data-end=\"2728\"\u003e\n\u003cstrong data-start=\"2530\" data-end=\"2549\"\u003eAdministration:\u003c\/strong\u003e\r\n\u003cul data-start=\"2554\" data-end=\"2728\"\u003e\r\n\u003cli data-start=\"2554\" data-end=\"2667\"\u003eErlotinib should be taken on an empty stomach (1 hour before or 2 hours after a meal) to maximize absorption.\u003c\/li\u003e\r\n\u003cli data-start=\"2670\" data-end=\"2728\"\u003eConsistent daily dosing at the same time is recommended.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"2730\" data-end=\"2823\"\u003e\u003cem data-start=\"2730\" data-end=\"2823\"\u003eReference: U.S. FDA Tarceva Prescribing Information; ClinicalTrials.gov (e.g., NCT00322452)\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2825\" data-end=\"2828\"\u003e\r\n\u003ch3 data-start=\"2830\" data-end=\"2892\"\u003eWhat prescribing information is important for Erlotinib?\u003c\/h3\u003e\r\n\u003cul data-start=\"2893\" data-end=\"3509\"\u003e\r\n\u003cli data-start=\"2893\" data-end=\"3033\"\u003e\n\u003cstrong data-start=\"2895\" data-end=\"2911\"\u003eIndications:\u003c\/strong\u003e\r\n\u003cul data-start=\"2916\" data-end=\"3033\"\u003e\r\n\u003cli data-start=\"2916\" data-end=\"3033\"\u003eApproved for advanced NSCLC with EGFR mutations and for use in combination with gemcitabine in pancreatic cancer.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3034\" data-end=\"3163\"\u003e\n\u003cstrong data-start=\"3036\" data-end=\"3058\"\u003eContraindications:\u003c\/strong\u003e\r\n\u003cul data-start=\"3063\" data-end=\"3163\"\u003e\r\n\u003cli data-start=\"3063\" data-end=\"3163\"\u003eContraindicated in patients with a known hypersensitivity to erlotinib or any of its components.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3164\" data-end=\"3294\"\u003e\n\u003cstrong data-start=\"3166\" data-end=\"3181\"\u003eMonitoring:\u003c\/strong\u003e\r\n\u003cul data-start=\"3186\" data-end=\"3294\"\u003e\r\n\u003cli data-start=\"3186\" data-end=\"3294\"\u003eRegular monitoring of liver function, complete blood counts, and dermatologic assessments are necessary.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3295\" data-end=\"3509\"\u003e\n\u003cstrong data-start=\"3297\" data-end=\"3324\"\u003eSpecial Considerations:\u003c\/strong\u003e\r\n\u003cul data-start=\"3329\" data-end=\"3509\"\u003e\r\n\u003cli data-start=\"3329\" data-end=\"3435\"\u003eEGFR mutation testing is recommended prior to treatment in NSCLC to identify patients likely to benefit.\u003c\/li\u003e\r\n\u003cli data-start=\"3438\" data-end=\"3509\"\u003eDose adjustments may be required in patients with hepatic impairment.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"3511\" data-end=\"3581\"\u003e\u003cem data-start=\"3511\" data-end=\"3581\"\u003eReference: U.S. FDA Tarceva Prescribing Information; NCCN Guidelines\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"3583\" data-end=\"3586\"\u003e\r\n\u003ch3 data-start=\"3588\" data-end=\"3686\"\u003eWhat safety information, side effects, warnings, and cautions are associated with Erlotinib?\u003c\/h3\u003e\r\n\u003cul data-start=\"3687\" data-end=\"4756\"\u003e\r\n\u003cli data-start=\"3687\" data-end=\"3809\"\u003e\n\u003cstrong data-start=\"3689\" data-end=\"3713\"\u003eCommon Side Effects:\u003c\/strong\u003e\r\n\u003cul data-start=\"3718\" data-end=\"3809\"\u003e\r\n\u003cli data-start=\"3718\" data-end=\"3809\"\u003eSkin rash (often acneiform), diarrhea, nausea, vomiting, loss of appetite, and fatigue.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3810\" data-end=\"3996\"\u003e\n\u003cstrong data-start=\"3812\" data-end=\"3837\"\u003eSerious Side Effects:\u003c\/strong\u003e\r\n\u003cul data-start=\"3842\" data-end=\"3996\"\u003e\r\n\u003cli data-start=\"3842\" data-end=\"3996\"\u003eInterstitial lung disease (ILD)\/pneumonitis, which can be life‑threatening; severe skin reactions (e.g., Stevens-Johnson syndrome) and liver toxicity.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3997\" data-end=\"4587\"\u003e\n\u003cstrong data-start=\"3999\" data-end=\"4023\"\u003eWarnings \u0026amp; Cautions:\u003c\/strong\u003e\r\n\u003cul data-start=\"4028\" data-end=\"4587\"\u003e\r\n\u003cli data-start=\"4028\" data-end=\"4147\"\u003e\n\u003cstrong data-start=\"4030\" data-end=\"4053\"\u003ePulmonary Toxicity:\u003c\/strong\u003e Monitor for new or worsening respiratory symptoms; discontinue therapy if ILD is suspected.\u003c\/li\u003e\r\n\u003cli data-start=\"4150\" data-end=\"4245\"\u003e\n\u003cstrong data-start=\"4152\" data-end=\"4179\"\u003eDermatologic Reactions:\u003c\/strong\u003e Severe skin rash may require dose reduction or discontinuation.\u003c\/li\u003e\r\n\u003cli data-start=\"4248\" data-end=\"4363\"\u003e\n\u003cstrong data-start=\"4250\" data-end=\"4269\"\u003eHepatotoxicity:\u003c\/strong\u003e Regular liver function tests are essential; significant abnormalities warrant intervention.\u003c\/li\u003e\r\n\u003cli data-start=\"4366\" data-end=\"4481\"\u003e\n\u003cstrong data-start=\"4368\" data-end=\"4381\"\u003eDiarrhea:\u003c\/strong\u003e Can lead to dehydration; advise patients to maintain hydration and seek medical advice if severe.\u003c\/li\u003e\r\n\u003cli data-start=\"4484\" data-end=\"4587\"\u003e\n\u003cstrong data-start=\"4486\" data-end=\"4508\"\u003eDrug Interactions:\u003c\/strong\u003e Concomitant use with CYP3A4 inhibitors or inducers may alter erlotinib levels.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"4588\" data-end=\"4756\"\u003e\n\u003cstrong data-start=\"4590\" data-end=\"4604\"\u003ePregnancy:\u003c\/strong\u003e\r\n\u003cul data-start=\"4609\" data-end=\"4756\"\u003e\r\n\u003cli data-start=\"4609\" data-end=\"4756\"\u003eErlotinib is contraindicated in pregnancy due to potential teratogenic effects; women of childbearing potential must use effective contraception.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"4758\" data-end=\"4825\"\u003e\u003cem data-start=\"4758\" data-end=\"4825\"\u003eReference: U.S. FDA Tarceva Prescribing Information; NEJM; PubMed\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"4827\" data-end=\"4830\"\u003e\r\n\u003ch3 data-start=\"4832\" data-end=\"4897\"\u003eWhat drug interactions should be considered with Erlotinib?\u003c\/h3\u003e\r\n\u003cul data-start=\"4898\" data-end=\"5291\"\u003e\r\n\u003cli data-start=\"4898\" data-end=\"5055\"\u003e\n\u003cstrong data-start=\"4900\" data-end=\"4922\"\u003eCYP3A4 Inhibitors:\u003c\/strong\u003e\r\n\u003cul data-start=\"4927\" data-end=\"5055\"\u003e\r\n\u003cli data-start=\"4927\" data-end=\"5055\"\u003eStrong inhibitors (e.g., ketoconazole, clarithromycin) can increase erlotinib plasma levels, enhancing the risk of toxicity.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"5056\" data-end=\"5178\"\u003e\n\u003cstrong data-start=\"5058\" data-end=\"5078\"\u003eCYP3A4 Inducers:\u003c\/strong\u003e\r\n\u003cul data-start=\"5083\" data-end=\"5178\"\u003e\r\n\u003cli data-start=\"5083\" data-end=\"5178\"\u003eInducers (e.g., rifampin, carbamazepine) may lower erlotinib levels, reducing its efficacy.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"5179\" data-end=\"5291\"\u003e\n\u003cstrong data-start=\"5181\" data-end=\"5203\"\u003eOther Medications:\u003c\/strong\u003e\r\n\u003cul data-start=\"5208\" data-end=\"5291\"\u003e\r\n\u003cli data-start=\"5208\" data-end=\"5291\"\u003eCaution with drugs that may compound gastrointestinal toxicity or hepatotoxicity.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"5293\" data-end=\"5355\"\u003e\u003cem data-start=\"5293\" data-end=\"5355\"\u003eReference: U.S. FDA; Clinical Pharmacology Reviews on PubMed\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"5357\" data-end=\"5360\"\u003e\r\n\u003ch3 data-start=\"5362\" data-end=\"5399\"\u003eFrequently Asked Questions (FAQs)\u003c\/h3\u003e\r\n\u003cp data-start=\"5401\" data-end=\"5602\"\u003e\u003cstrong data-start=\"5401\" data-end=\"5451\"\u003eQ: How soon will I see results with Erlotinib?\u003c\/strong\u003e\u003cbr data-start=\"5451\" data-end=\"5454\"\u003eA: Improvement in symptoms may occur within a few weeks, though maximum benefit in tumor response might take several months of continuous treatment.\u003c\/p\u003e\r\n\u003cp data-start=\"5604\" data-end=\"5781\"\u003e\u003cstrong data-start=\"5604\" data-end=\"5644\"\u003eQ: Can Erlotinib be taken with food?\u003c\/strong\u003e\u003cbr data-start=\"5644\" data-end=\"5647\"\u003eA: For optimal absorption, it is recommended that erlotinib be taken on an empty stomach—either 1 hour before or 2 hours after a meal.\u003c\/p\u003e\r\n\u003cp data-start=\"5783\" data-end=\"6003\"\u003e\u003cstrong data-start=\"5783\" data-end=\"5839\"\u003eQ: What should I do if I develop a severe skin rash?\u003c\/strong\u003e\u003cbr data-start=\"5839\" data-end=\"5842\"\u003eA: Contact your healthcare provider immediately. Severe rash may indicate a need for dose adjustment or discontinuation due to risk of serious adverse reactions.\u003c\/p\u003e\r\n\u003cp data-start=\"6005\" data-end=\"6190\"\u003e\u003cstrong data-start=\"6005\" data-end=\"6073\"\u003eQ: Is EGFR mutation testing necessary before starting Erlotinib?\u003c\/strong\u003e\u003cbr data-start=\"6073\" data-end=\"6076\"\u003eA: Yes, EGFR mutation testing is essential to ensure that the patient is likely to benefit from erlotinib therapy.\u003c\/p\u003e\r\n\u003cp data-start=\"6192\" data-end=\"6399\"\u003e\u003cstrong data-start=\"6192\" data-end=\"6272\"\u003eQ: What precautions should I take regarding liver health while on Erlotinib?\u003c\/strong\u003e\u003cbr data-start=\"6272\" data-end=\"6275\"\u003eA: Regular liver function tests are important; report any symptoms such as jaundice, severe fatigue, or dark urine promptly.\u003c\/p\u003e\r\n\u003cp data-start=\"6401\" data-end=\"6595\"\u003e\u003cstrong data-start=\"6401\" data-end=\"6443\"\u003eQ: How should missed doses be managed?\u003c\/strong\u003e\u003cbr data-start=\"6443\" data-end=\"6446\"\u003eA: If you miss a dose, take it as soon as you remember, unless it is nearly time for your next dose. Do not double doses to make up for a missed one.\u003c\/p\u003e\r\n\u003cp data-start=\"6597\" data-end=\"6643\"\u003e\u003cem data-start=\"6597\" data-end=\"6643\"\u003eReference: U.S. FDA; NCCN Guidelines; PubMed\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"6645\" data-end=\"6648\"\u003e\r\n\u003ch3 data-start=\"6650\" data-end=\"6743\"\u003eWhere can I find additional clinical evidence and detailed information about Erlotinib?\u003c\/h3\u003e\r\n\u003cp data-start=\"6744\" data-end=\"6845\"\u003eFor further details on clinical studies, dosing guidelines, and safety monitoring, please refer to:\u003c\/p\u003e\r\n\u003cul data-start=\"6846\" data-end=\"7231\"\u003e\r\n\u003cli data-start=\"6846\" data-end=\"6934\"\u003e\n\u003cstrong data-start=\"6848\" data-end=\"6900\"\u003eU.S. Food and Drug Administration (FDA) Website:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.fda.gov\/\" target=\"_new\" rel=\"noopener\" data-start=\"6901\" data-end=\"6932\"\u003eFDA.gov\u003c\/a\u003e\n\u003c\/li\u003e\r\n\u003cli data-start=\"6935\" data-end=\"6995\"\u003e\n\u003cstrong data-start=\"6937\" data-end=\"6960\"\u003eClinicalTrials.gov:\u003c\/strong\u003e (e.g., NCT00322452, NCT00121090)\u003c\/li\u003e\r\n\u003cli data-start=\"6996\" data-end=\"7060\"\u003e\n\u003cstrong data-start=\"6998\" data-end=\"7009\"\u003ePubMed:\u003c\/strong\u003e For peer‑reviewed research articles on erlotinib\u003c\/li\u003e\r\n\u003cli data-start=\"7061\" data-end=\"7138\"\u003e\n\u003cstrong data-start=\"7063\" data-end=\"7099\"\u003eWorld Health Organization (WHO):\u003c\/strong\u003e Guidelines on lung cancer management\u003c\/li\u003e\r\n\u003cli data-start=\"7139\" data-end=\"7231\"\u003e\n\u003cstrong data-start=\"7141\" data-end=\"7201\"\u003eNational Comprehensive Cancer Network (NCCN) Guidelines:\u003c\/strong\u003e For NSCLC treatment protocols\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"7233\" data-end=\"7299\"\u003e\u003cem data-start=\"7233\" data-end=\"7299\"\u003eReference: U.S. FDA; ClinicalTrials.gov; NEJM; PubMed; NCCN; WHO\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"7301\" data-end=\"7304\"\u003e\r\n\u003ch3 data-start=\"7306\" data-end=\"7326\"\u003eFinal Thoughts\u003c\/h3\u003e\r\n\u003cp data-start=\"7327\" data-end=\"7992\"\u003e\u003cstrong data-start=\"7327\" data-end=\"7340\"\u003eGefitinib\u003c\/strong\u003e is not to be confused with erlotinib; however, \u003cstrong data-start=\"7388\" data-end=\"7411\"\u003eErlotinib (Tarceva®)\u003c\/strong\u003e remains a cornerstone in targeted therapy for non‑small cell lung cancer with EGFR mutations. Its mechanism of action—blocking EGFR tyrosine kinase activity—leads to inhibition of tumor growth and enhanced apoptosis in cancer cells. With careful patient selection, regular monitoring for adverse effects (particularly interstitial lung disease and hepatotoxicity), and appropriate management of drug interactions, erlotinib can significantly improve clinical outcomes. Always consult your healthcare provider to ensure that erlotinib is the appropriate therapy for your condition.\u003c\/p\u003e\r\n\u003cp data-start=\"7994\" data-end=\"8207\"\u003e\u003cem data-start=\"7994\" data-end=\"8207\"\u003eDisclaimer: This guide is intended for educational purposes only and should not replace professional medical advice. Always consult your healthcare provider before initiating or modifying any medication regimen.\u003c\/em\u003e\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"150MG","offer_id":51735711645979,"sku":"TARCEVA150mg-1","price":3300.0,"currency_code":"USD","in_stock":true},{"title":"100mg","offer_id":51735711678747,"sku":"config-tarceva-brand-100mg","price":2850.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0992\/3303\/8619\/files\/untitled_design_81__1.png?v=1770407545"},{"product_id":"vepesid-injection","title":"VEPESID INJECTION","description":"\u003ch4\u003eWhat is  VEPESID INJECTION ?\u003c\/h4\u003e\u003cp\u003e VEPESID INJECTION  is a injection supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"50mg","offer_id":51735711711515,"sku":"VEPESIDINJECTION50mg","price":68.41,"currency_code":"USD","in_stock":true}]},{"product_id":"afinitor-1","title":"AFINITOR","description":"\u003ch4\u003eWhat is AFINITOR ?\u003c\/h4\u003e\u003cp\u003eAFINITOR  is a other supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"10mg","offer_id":51735711777051,"sku":"AFINITOR10mg-1","price":2703.24,"currency_code":"USD","in_stock":true},{"title":"5mg","offer_id":51735711809819,"sku":"AFINITOR5mg","price":3278.62,"currency_code":"USD","in_stock":true}]},{"product_id":"aromasin","title":"AROMASIN","description":"\u003ch4\u003eWhat is AROMASIN ?\u003c\/h4\u003e\u003cp\u003eAROMASIN  is a other supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"25mg","offer_id":51735711842587,"sku":"AROMASIN25mg","price":243.02,"currency_code":"USD","in_stock":true}]},{"product_id":"euflex","title":"EUFLEX","description":"\u003ch4\u003eWhat is  EUFLEX    ?\u003c\/h4\u003e\u003cp\u003e EUFLEX     is a other supplied in 1 unit. Use only under medical supervision.\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"250mg","offer_id":51735711875355,"sku":"EUFLEX250mg","price":34.79,"currency_code":"USD","in_stock":true}]},{"product_id":"iressa","title":"IRESSA","description":"\u003cdiv class=\"flex-1 overflow-hidden @container\/thread translate-y-[2rem] -mt-[2rem] pb-[1.5rem]\"\u003e\r\n\u003cdiv class=\"relative h-full\"\u003e\r\n\u003cdiv class=\"flex h-full flex-col overflow-y-auto [scrollbar-gutter:stable]\"\u003e\r\n\u003cdiv class=\"flex flex-col text-sm md:pb-9\"\u003e\r\n\u003carticle class=\"w-full text-token-text-primary focus-visible:outline-2 focus-visible:outline-offset-[-4px]\" dir=\"auto\" data-testid=\"conversation-turn-87\" data-scroll-anchor=\"true\"\u003e\r\n\u003cdiv class=\"m-auto text-base py-[18px] px-6\"\u003e\r\n\u003cdiv class=\"mx-auto flex flex-1 text-base gap-4 md:gap-5 lg:gap-6 md:max-w-3xl lg:max-w-[40rem] xl:max-w-[48rem]\"\u003e\r\n\u003cdiv class=\"group\/conversation-turn relative flex w-full min-w-0 flex-col agent-turn @xs\/thread:px-0 @sm\/thread:px-1.5 @md\/thread:px-4\"\u003e\r\n\u003cdiv class=\"flex-col gap-1 md:gap-3\"\u003e\r\n\u003cdiv class=\"flex max-w-full flex-col flex-grow\"\u003e\r\n\u003cdiv class=\"min-h-8 text-message flex w-full flex-col items-end gap-2 whitespace-normal break-words text-start [.text-message+\u0026amp;]:mt-5\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"b0c554ce-a28b-4131-a896-ffbb9a42fa15\" data-message-model-slug=\"o3-mini\"\u003e\r\n\u003cdiv class=\"flex w-full flex-col gap-1 empty:hidden first:pt-[3px]\"\u003e\r\n\u003cdiv class=\"markdown prose w-full break-words dark:prose-invert light\"\u003e\r\n\u003ch3 data-start=\"432\" data-end=\"456\"\u003eWhat is Gefitinib?\u003c\/h3\u003e\r\n\u003cp data-start=\"457\" data-end=\"849\"\u003e\u003cstrong data-start=\"457\" data-end=\"470\"\u003eGefitinib\u003c\/strong\u003e is an oral epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor used primarily for the treatment of non‑small cell lung cancer (NSCLC) in patients whose tumors harbor specific EGFR mutations. By blocking EGFR signaling, gefitinib helps to inhibit tumor cell proliferation and induce apoptosis, thereby improving clinical outcomes in appropriately selected patients.\u003c\/p\u003e\r\n\u003cp data-start=\"851\" data-end=\"977\"\u003e\u003cem data-start=\"851\" data-end=\"977\"\u003eReference: U.S. Food and Drug Administration (FDA) Gefitinib Prescribing Information; ClinicalTrials.gov (e.g., NCT00121090)\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"979\" data-end=\"982\"\u003e\r\n\u003ch3 data-start=\"984\" data-end=\"1037\"\u003eWhat are the other popular names for Gefitinib?\u003c\/h3\u003e\r\n\u003cp data-start=\"1038\" data-end=\"1164\"\u003eGefitinib is most commonly marketed under the brand name \u003cstrong data-start=\"1095\" data-end=\"1106\"\u003eIressa®\u003c\/strong\u003e. It is also known by its research designation \u003cstrong data-start=\"1153\" data-end=\"1163\"\u003eZD1839\u003c\/strong\u003e.\u003c\/p\u003e\r\n\u003cp data-start=\"1166\" data-end=\"1200\"\u003e\u003cem data-start=\"1166\" data-end=\"1200\"\u003eReference: MedlinePlus; U.S. FDA\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1202\" data-end=\"1205\"\u003e\r\n\u003ch3 data-start=\"1207\" data-end=\"1258\"\u003eWhat is the drug classification of Gefitinib?\u003c\/h3\u003e\r\n\u003cp data-start=\"1259\" data-end=\"1459\"\u003eGefitinib is classified as an \u003cstrong data-start=\"1289\" data-end=\"1329\"\u003eEGFR tyrosine kinase inhibitor (TKI)\u003c\/strong\u003e, a subset of targeted anticancer agents. It belongs to the broader category of \u003cstrong data-start=\"1409\" data-end=\"1441\"\u003emolecular targeted therapies\u003c\/strong\u003e used in oncology.\u003c\/p\u003e\r\n\u003cp data-start=\"1461\" data-end=\"1546\"\u003e\u003cem data-start=\"1461\" data-end=\"1546\"\u003eReference: World Health Organization (WHO) guidelines on cancer treatment; U.S. FDA\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1548\" data-end=\"1551\"\u003e\r\n\u003ch3 data-start=\"1553\" data-end=\"1599\"\u003eWhat is the mode of action of Gefitinib?\u003c\/h3\u003e\r\n\u003cp data-start=\"1600\" data-end=\"2009\"\u003eGefitinib acts by selectively binding to the adenosine triphosphate (ATP) binding site of the EGFR tyrosine kinase domain. This inhibits the receptor’s autophosphorylation and downstream signaling through pathways such as MAPK, PI3K\/AKT, and STAT, which are critical for tumor growth and survival. Consequently, gefitinib impedes cancer cell proliferation and promotes apoptosis in tumors with EGFR mutations.\u003c\/p\u003e\r\n\u003cp data-start=\"2011\" data-end=\"2200\"\u003e\u003cem data-start=\"2011\" data-end=\"2200\"\u003eReference: PubMed (e.g., Lynch et al., 2004, “Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib”); U.S. FDA\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2202\" data-end=\"2205\"\u003e\r\n\u003ch3 data-start=\"2207\" data-end=\"2252\"\u003eWhat are the primary uses of Gefitinib?\u003c\/h3\u003e\r\n\u003cp data-start=\"2253\" data-end=\"2571\"\u003eGefitinib is primarily used for the treatment of advanced or metastatic non‑small cell lung cancer (NSCLC) in patients whose tumors have specific activating mutations in the EGFR gene. It is typically prescribed for patients who have either progressed on or are intolerant to standard chemotherapy or other treatments.\u003c\/p\u003e\r\n\u003cp data-start=\"2573\" data-end=\"2647\"\u003e\u003cem data-start=\"2573\" data-end=\"2647\"\u003eReference: U.S. FDA; ClinicalTrials.gov (e.g., NCT00121090, NCT00333590)\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2649\" data-end=\"2652\"\u003e\r\n\u003ch3 data-start=\"2654\" data-end=\"2724\"\u003eWhat is the recommended dosage and administration for Gefitinib?\u003c\/h3\u003e\r\n\u003cul data-start=\"2725\" data-end=\"3051\"\u003e\r\n\u003cli data-start=\"2725\" data-end=\"2805\"\u003e\n\u003cstrong data-start=\"2727\" data-end=\"2738\"\u003eDosage:\u003c\/strong\u003e The standard oral dosage for gefitinib is \u003cstrong data-start=\"2781\" data-end=\"2802\"\u003e250 mg once daily\u003c\/strong\u003e.\u003c\/li\u003e\r\n\u003cli data-start=\"2806\" data-end=\"3051\"\u003e\n\u003cstrong data-start=\"2808\" data-end=\"2827\"\u003eAdministration:\u003c\/strong\u003e\r\n\u003cul data-start=\"2832\" data-end=\"3051\"\u003e\r\n\u003cli data-start=\"2832\" data-end=\"2960\"\u003eGefitinib is taken by mouth, with or without food, at approximately the same time each day to maintain steady plasma levels.\u003c\/li\u003e\r\n\u003cli data-start=\"2963\" data-end=\"3051\"\u003ePatients should follow dosing instructions as prescribed by their healthcare provider.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"3053\" data-end=\"3128\"\u003e\u003cem data-start=\"3053\" data-end=\"3128\"\u003eReference: U.S. FDA Gefitinib Prescribing Information; ClinicalTrials.gov\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"3130\" data-end=\"3133\"\u003e\r\n\u003ch3 data-start=\"3135\" data-end=\"3197\"\u003eWhat prescribing information is important for Gefitinib?\u003c\/h3\u003e\r\n\u003cul data-start=\"3198\" data-end=\"3917\"\u003e\r\n\u003cli data-start=\"3198\" data-end=\"3307\"\u003e\n\u003cstrong data-start=\"3200\" data-end=\"3216\"\u003eIndications:\u003c\/strong\u003e Gefitinib is indicated for patients with advanced NSCLC with sensitizing EGFR mutations.\u003c\/li\u003e\r\n\u003cli data-start=\"3308\" data-end=\"3522\"\u003e\n\u003cstrong data-start=\"3310\" data-end=\"3332\"\u003eContraindications:\u003c\/strong\u003e\r\n\u003cul data-start=\"3337\" data-end=\"3522\"\u003e\r\n\u003cli data-start=\"3337\" data-end=\"3441\"\u003eIt is contraindicated in patients with known hypersensitivity to gefitinib or any of its components.\u003c\/li\u003e\r\n\u003cli data-start=\"3444\" data-end=\"3522\"\u003eCaution is advised in patients with significant interstitial lung disease.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3523\" data-end=\"3720\"\u003e\n\u003cstrong data-start=\"3525\" data-end=\"3540\"\u003eMonitoring:\u003c\/strong\u003e\r\n\u003cul data-start=\"3545\" data-end=\"3720\"\u003e\r\n\u003cli data-start=\"3545\" data-end=\"3720\"\u003eRegular evaluation of liver function tests, lung imaging (if respiratory symptoms occur), and monitoring for dermatologic and gastrointestinal adverse effects are essential.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3721\" data-end=\"3917\"\u003e\n\u003cstrong data-start=\"3723\" data-end=\"3750\"\u003eSpecial Considerations:\u003c\/strong\u003e\r\n\u003cul data-start=\"3755\" data-end=\"3917\"\u003e\r\n\u003cli data-start=\"3755\" data-end=\"3822\"\u003eEGFR mutation testing is recommended before initiating therapy.\u003c\/li\u003e\r\n\u003cli data-start=\"3825\" data-end=\"3917\"\u003eUse in pregnant or breastfeeding women is not recommended due to potential teratogenicity.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"3919\" data-end=\"4002\"\u003e\u003cem data-start=\"3919\" data-end=\"4002\"\u003eReference: U.S. FDA; National Comprehensive Cancer Network (NCCN) Guidelines; WHO\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"4004\" data-end=\"4007\"\u003e\r\n\u003ch3 data-start=\"4009\" data-end=\"4107\"\u003eWhat safety information, side effects, warnings, and cautions are associated with Gefitinib?\u003c\/h3\u003e\r\n\u003cul data-start=\"4108\" data-end=\"5170\"\u003e\r\n\u003cli data-start=\"4108\" data-end=\"4243\"\u003e\n\u003cstrong data-start=\"4110\" data-end=\"4134\"\u003eCommon Side Effects:\u003c\/strong\u003e\r\n\u003cul data-start=\"4139\" data-end=\"4243\"\u003e\r\n\u003cli data-start=\"4139\" data-end=\"4195\"\u003eSkin rash, diarrhea, nausea, vomiting, and dry skin.\u003c\/li\u003e\r\n\u003cli data-start=\"4198\" data-end=\"4243\"\u003eMild elevations in liver enzymes may occur.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"4244\" data-end=\"4503\"\u003e\n\u003cstrong data-start=\"4246\" data-end=\"4271\"\u003eSerious Side Effects:\u003c\/strong\u003e\r\n\u003cul data-start=\"4276\" data-end=\"4503\"\u003e\r\n\u003cli data-start=\"4276\" data-end=\"4410\"\u003eInterstitial lung disease (ILD), which can be fatal; any new or worsening respiratory symptoms should prompt immediate evaluation.\u003c\/li\u003e\r\n\u003cli data-start=\"4413\" data-end=\"4503\"\u003eHepatotoxicity and rare cases of severe skin reactions such as Stevens-Johnson syndrome.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"4504\" data-end=\"5057\"\u003e\n\u003cstrong data-start=\"4506\" data-end=\"4530\"\u003eWarnings \u0026amp; Cautions:\u003c\/strong\u003e\r\n\u003cul data-start=\"4535\" data-end=\"5057\"\u003e\r\n\u003cli data-start=\"4535\" data-end=\"4669\"\u003e\n\u003cstrong data-start=\"4537\" data-end=\"4567\"\u003eInterstitial Lung Disease:\u003c\/strong\u003e Patients should be monitored for signs of ILD; treatment should be interrupted if ILD is suspected.\u003c\/li\u003e\r\n\u003cli data-start=\"4672\" data-end=\"4830\"\u003e\n\u003cstrong data-start=\"4674\" data-end=\"4693\"\u003eLiver Function:\u003c\/strong\u003e Periodic liver function tests are recommended; dose adjustment or discontinuation may be necessary if significant abnormalities occur.\u003c\/li\u003e\r\n\u003cli data-start=\"4833\" data-end=\"4918\"\u003e\n\u003cstrong data-start=\"4835\" data-end=\"4862\"\u003eDermatologic Reactions:\u003c\/strong\u003e Severe skin reactions require prompt medical attention.\u003c\/li\u003e\r\n\u003cli data-start=\"4921\" data-end=\"5057\"\u003e\n\u003cstrong data-start=\"4923\" data-end=\"4945\"\u003eDrug Interactions:\u003c\/strong\u003e Monitor for potential interactions with CYP3A4 inhibitors or inducers, which may alter gefitinib plasma levels.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"5058\" data-end=\"5170\"\u003e\n\u003cstrong data-start=\"5060\" data-end=\"5074\"\u003ePregnancy:\u003c\/strong\u003e\r\n\u003cul data-start=\"5079\" data-end=\"5170\"\u003e\r\n\u003cli data-start=\"5079\" data-end=\"5170\"\u003eGefitinib is contraindicated in pregnant or breastfeeding women due to teratogenic risks.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"5172\" data-end=\"5240\"\u003e\u003cem data-start=\"5172\" data-end=\"5240\"\u003eReference: U.S. FDA Gefitinib Prescribing Information; PubMed; WHO\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"5242\" data-end=\"5245\"\u003e\r\n\u003ch3 data-start=\"5247\" data-end=\"5312\"\u003eWhat drug interactions should be considered with Gefitinib?\u003c\/h3\u003e\r\n\u003cul data-start=\"5313\" data-end=\"5700\"\u003e\r\n\u003cli data-start=\"5313\" data-end=\"5484\"\u003e\n\u003cstrong data-start=\"5315\" data-end=\"5337\"\u003eCYP3A4 Modulators:\u003c\/strong\u003e\r\n\u003cul data-start=\"5342\" data-end=\"5484\"\u003e\r\n\u003cli data-start=\"5342\" data-end=\"5484\"\u003eStrong CYP3A4 inhibitors (e.g., ketoconazole) can increase gefitinib levels, while inducers (e.g., rifampin) may decrease its effectiveness.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"5485\" data-end=\"5700\"\u003e\n\u003cstrong data-start=\"5487\" data-end=\"5509\"\u003eOther Medications:\u003c\/strong\u003e\r\n\u003cul data-start=\"5514\" data-end=\"5700\"\u003e\r\n\u003cli data-start=\"5514\" data-end=\"5600\"\u003eConcomitant use of drugs that affect liver enzymes may alter gefitinib metabolism.\u003c\/li\u003e\r\n\u003cli data-start=\"5603\" data-end=\"5700\"\u003eUse caution with drugs that can exacerbate gastrointestinal toxicity or dermatologic reactions.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"5702\" data-end=\"5764\"\u003e\u003cem data-start=\"5702\" data-end=\"5764\"\u003eReference: U.S. FDA; Clinical Pharmacology Reviews on PubMed\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"5766\" data-end=\"5769\"\u003e\r\n\u003ch3 data-start=\"5771\" data-end=\"5808\"\u003eFrequently Asked Questions (FAQs)\u003c\/h3\u003e\r\n\u003cp data-start=\"5810\" data-end=\"6038\"\u003e\u003cstrong data-start=\"5810\" data-end=\"5858\"\u003eQ: How quickly does Gefitinib start working?\u003c\/strong\u003e\u003cbr data-start=\"5858\" data-end=\"5861\"\u003eA: Some patients may begin to see improvements in symptoms within a few weeks, but maximum therapeutic effects are usually observed after several months of continuous treatment.\u003c\/p\u003e\r\n\u003cp data-start=\"6040\" data-end=\"6233\"\u003e\u003cstrong data-start=\"6040\" data-end=\"6080\"\u003eQ: Can Gefitinib be taken with food?\u003c\/strong\u003e\u003cbr data-start=\"6080\" data-end=\"6083\"\u003eA: Yes, gefitinib can be taken with or without food. However, it is important to take it at the same time each day to maintain consistent drug levels.\u003c\/p\u003e\r\n\u003cp data-start=\"6235\" data-end=\"6490\"\u003e\u003cstrong data-start=\"6235\" data-end=\"6337\"\u003eQ: What should I do if I experience a severe skin rash or breathing difficulty while on Gefitinib?\u003c\/strong\u003e\u003cbr data-start=\"6337\" data-end=\"6340\"\u003eA: Seek immediate medical attention, as these may be signs of serious adverse reactions such as Stevens-Johnson syndrome or interstitial lung disease.\u003c\/p\u003e\r\n\u003cp data-start=\"6492\" data-end=\"6693\"\u003e\u003cstrong data-start=\"6492\" data-end=\"6559\"\u003eQ: Is EGFR mutation testing required before starting Gefitinib?\u003c\/strong\u003e\u003cbr data-start=\"6559\" data-end=\"6562\"\u003eA: Yes, testing for EGFR mutations is typically recommended to ensure that patients with NSCLC will benefit from gefitinib therapy.\u003c\/p\u003e\r\n\u003cp data-start=\"6695\" data-end=\"6876\"\u003e\u003cstrong data-start=\"6695\" data-end=\"6737\"\u003eQ: How should missed doses be managed?\u003c\/strong\u003e\u003cbr data-start=\"6737\" data-end=\"6740\"\u003eA: If you miss a dose, take it as soon as you remember unless it is near the time of your next dose. Do not double the dose to catch up.\u003c\/p\u003e\r\n\u003cp data-start=\"6878\" data-end=\"6924\"\u003e\u003cem data-start=\"6878\" data-end=\"6924\"\u003eReference: U.S. FDA; NCCN Guidelines; PubMed\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"6926\" data-end=\"6929\"\u003e\r\n\u003ch3 data-start=\"6931\" data-end=\"7024\"\u003eWhere can I find additional clinical evidence and detailed information about Gefitinib?\u003c\/h3\u003e\r\n\u003cp data-start=\"7025\" data-end=\"7118\"\u003eFor more in-depth clinical data, dosing guidelines, and safety monitoring, please refer to:\u003c\/p\u003e\r\n\u003cul data-start=\"7119\" data-end=\"7556\"\u003e\r\n\u003cli data-start=\"7119\" data-end=\"7207\"\u003e\n\u003cstrong data-start=\"7121\" data-end=\"7173\"\u003eU.S. Food and Drug Administration (FDA) Website:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.fda.gov\/\" target=\"_new\" rel=\"noopener\" data-start=\"7174\" data-end=\"7205\"\u003eFDA.gov\u003c\/a\u003e\n\u003c\/li\u003e\r\n\u003cli data-start=\"7208\" data-end=\"7297\"\u003e\n\u003cstrong data-start=\"7210\" data-end=\"7233\"\u003eClinicalTrials.gov:\u003c\/strong\u003e Search for gefitinib studies (e.g., NCT00121090, NCT00333540)\u003c\/li\u003e\r\n\u003cli data-start=\"7298\" data-end=\"7382\"\u003e\n\u003cstrong data-start=\"7300\" data-end=\"7311\"\u003ePubMed:\u003c\/strong\u003e For peer‑reviewed research articles on gefitinib and EGFR inhibitors\u003c\/li\u003e\r\n\u003cli data-start=\"7383\" data-end=\"7460\"\u003e\n\u003cstrong data-start=\"7385\" data-end=\"7421\"\u003eWorld Health Organization (WHO):\u003c\/strong\u003e Guidelines on lung cancer management\u003c\/li\u003e\r\n\u003cli data-start=\"7461\" data-end=\"7556\"\u003e\n\u003cstrong data-start=\"7463\" data-end=\"7523\"\u003eNational Comprehensive Cancer Network (NCCN) Guidelines:\u003c\/strong\u003e For treatment protocols in NSCLC\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"7558\" data-end=\"7618\"\u003e\u003cem data-start=\"7558\" data-end=\"7618\"\u003eReference: U.S. FDA; ClinicalTrials.gov; PubMed; NCCN; WHO\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"7620\" data-end=\"7623\"\u003e\r\n\u003ch3 data-start=\"7625\" data-end=\"7645\"\u003eFinal Thoughts\u003c\/h3\u003e\r\n\u003cp data-start=\"7646\" data-end=\"8301\"\u003e\u003cstrong data-start=\"7646\" data-end=\"7659\"\u003eGefitinib\u003c\/strong\u003e (marketed as \u003cstrong data-start=\"7673\" data-end=\"7684\"\u003eIressa®\u003c\/strong\u003e and known by its research designation \u003cstrong data-start=\"7723\" data-end=\"7733\"\u003eZD1839\u003c\/strong\u003e) is a cornerstone targeted therapy for patients with advanced NSCLC harboring EGFR mutations. By inhibiting the EGFR tyrosine kinase, it effectively reduces tumor growth and improves clinical outcomes. However, careful patient selection (including EGFR mutation testing), monitoring for adverse effects (especially interstitial lung disease and hepatotoxicity), and managing potential drug interactions are essential for safe and effective therapy. Always consult with your healthcare provider to ensure that gefitinib is the appropriate treatment for your condition.\u003c\/p\u003e\r\n\u003cp data-start=\"8303\" data-end=\"8521\"\u003e\u003cem data-start=\"8303\" data-end=\"8521\"\u003eDisclaimer: This guide is intended for educational purposes only and should not replace professional medical advice. Always consult with your healthcare provider before initiating or modifying any medication regimen.\u003c\/em\u003e\u003c\/p\u003e\r\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/article\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"EZ Chemist","offers":[{"title":"250mg","offer_id":51735712071963,"sku":"IRESSA250mg","price":169.14,"currency_code":"USD","in_stock":true}]}],"url":"https:\/\/ezchemist.com\/collections\/cancer-care.oembed?page=6","provider":"EZ Chemist","version":"1.0","type":"link"}